Quarterlytics / Healthcare / Medical - Care Facilities / Cross Country Healthcare, Inc.

Cross Country Healthcare, Inc.

ccrn · NASDAQ Healthcare
Claim this profile
Ticker ccrn
Exchange NASDAQ
Sector Healthcare
Industry Medical - Care Facilities
Employees 9605
← All annual reports
FY2002 Annual Report · Cross Country Healthcare, Inc.
Sign in to download
Loading PDF…
2002 Annual Report

Quality. Commitment. Leadership.

Company Profile

Cross Country, Inc. is one of the largest providers of healthcare staffing services in

the  United  States.  Our  healthcare  staffing  business  segment,  which  represents

approximately 92% of our revenue, is comprised of travel nurse and allied health

staffing, per diem nurse staffing and clinical research trials staffing. Approximately

80% of our total revenue is derived from travel nurse staffing services.

Our  other  human  capital  management  services  business  segment,  which

represents approximately 8% of our revenues, consists of education and training

of healthcare professionals, healthcare consulting, and physician and healthcare

executive search services.

Our  active  client  base  includes  more  than  3,000  hospitals,  pharmaceutical

companies  and  other  healthcare  providers  across  all  50  states.  Our  fees  are 

paid  directly  by  our  clients  rather  than  by  government  or  other  third-party

payors.  As  a  result,  we  have  no  direct  exposure  to  Medicare  or  Medicaid

reimbursements. We are well positioned to take advantage of current industry

dynamics,  including  the  growing  shortage  of  nurses  in  the  United  States,  the

growing  demand  for  healthcare  services  due  to  an  aging  population  and  the

secular trend among healthcare providers toward outsourcing staffing services.

Financial Highlights & Statistics

($ in 000’s, except per share data) 

Revenue from services
Adjusted EBITDA(a)
Income from continuing operations(b)
Net income(b)

Income from continuing operations per diluted share

Cash flow from operations
Debt ratio(c)
FTEs(d)
Average healthcare staffing revenue per FTE per week(e)

2002

2001*

2000*

$ 639,953

$ 504,364

$ 368,332

$

$

$

$

$

$

66,231

33,666

29,783

1.00

41,421

8%

5,535

2,046

$

$

$

$

$

$

57,239

14,404

8,672

0.57

19,795

14%

4,816

1,865

$

$

$

$

$

$

45,211

6,732

4,598

0.29

11,594

56%

4,167

1,619

* Certain amounts in the 2001 and 2000 information have been reclassified to conform to the 2002 presentation.
(a) A non-GAAP financial measure defined as earnings before interest, income taxes, depreciation, amortization, non-recurring secondary offering costs and non-recurring
indirect transaction costs.  Adjusted EBITDA should not be considered a measure of financial performance under generally accepted accounting principles.  Refer to 
our Form 10-K for a more detailed description.

(b) Includes: (1) non-recurring secondary offering costs of $886 pre-tax ($543 after-tax) in 2002, and (2) non-recurring transaction costs of $1,289 pre-tax in 2001.
(c) Defined as total debt less cash, divided by total stockholders’ equity plus total debt.
(d) FTE’s represent the average number of contract staffing personnel on a full-time equivalent basis.
(e) Average healthcare staffing revenue per FTE per week is calculated by dividing the healthcare staffing revenue by the number of weeks worked in the respective periods. 

Healthcare staffing revenue includes revenue from permanent placement of nurses.

Revenue From Services 
($ in millions)

640.0

2002 Revenue Mix

92%
Healthcare Staffing 

504.4

368.3

2002

2001

2000

8%
Other Human Capital
Management Services

Income From Continuing Operations(b)

($ in millions)

Adjusted EBIDTA(a) 

($ in millions)

33.7

66.2

14.4

6.7

2002

2001

2000

57.2

45.2

2002

2001

2000

Net Income(b)

($ in millions)

29.8

Cash Flow From Operations
($ in millions)

41.4

8.7

4.6

2002

2001

2000

19.8

11.6

2000

2002

2001

1

Dear Fellow Shareholders

“...we believe the 
long-term fundamentals
driving our businesses
remain strong.”

In 2002, we achieved record annual revenue, net income and cash flow from opera-

tions. Revenue of $640 million in 2002 was 27% greater than in 2001 and nearly ten

times our revenue when I joined Cross Country in 1993. Our income from continuing

operations, excluding after-tax secondary offering costs, was $34.2 million, or $1.02 per

diluted  share.  Including  such  costs,  income  from  continuing  operations  increased

134% to $33.7 million, or $1.00 per diluted share. Net income increased 243% to $29.8

million, or $0.88 per diluted share. Adjusted EBITDA (a non-GAAP measure defined

as earnings before interest, income taxes, depreciation, amortization and non-recur-

ring secondary offering costs) increased to $66.2 million and cash flow from operations

increased  to  $41.4  million.  In  addition,  during  the  year  we  had  an  average  of  5,535 

full-time equivalent (FTE) nurses and other healthcare professionals working around

the country for our Company.

As we entered 2002, we identified an internal capacity constraint in the recruitment

area to maintaining strong top line growth in the future. During the course of 2002,

we grew our average recruiter count gradually from 75 at year-end 2001 to 121 at year-

end  2002.  We  also  opened  new  avenues  to  nurse  supply,  expanding  our  overseas

recruitment through our Assignment America brand and through our acquisition of

NovaPro in January 2002, which allowed us to better segment the United States nurse

population with differentiated brand offerings.

Despite  these  achievements,  we  are  disappointed  that  our  shareholders  –  including

many  of  our  employees  –  have  had  their  investment  in  Cross  Country  impacted  by,

among  other  things,  an  industry-wide  decline  in  the  valuation  of  healthcare  staffing

companies,  reflecting  a  slowdown  in  demand  for  outsourced  nurse  staffing.  While 

the current environment may continue for some time, we do not believe the current

conditions are long term in nature, as vacancy and turnover rates for full-time nursing

positions have not changed much from the double digit levels we have seen in recent

years.  Moreover,  we  do  not  believe  the  nurse-staffing  actions  many  hospitals  have

undertaken are sustainable over the long term nor do they address the fundamental

issues surrounding the nursing shortage.

2

As we continue to recruit nurses and allied healthcare professionals to fill thousands of

open orders that have been placed with us by our hospital clients, we believe opportu-

nities exist in the current reduced-demand market environment that will allow us to

increase market share, given our high quality service, brand recognition and reputa-

tion  within  the  industry.  Accordingly,  we  continue  to  be  very  focused  on  obtaining 

preferred  provider  status  with  our  acute  care  facility  clients.  And  in  doing  so,  we

believe that Cross Country has the ability to continue to grow not just 

in  supply  constrained  environments,  but  in  demand  constrained 

environments as well.

We  realize  the  ultimate  benefits  of  our  demand,  supply  and

internal  capacity  initiatives  will  take  time.  Our  Company

has been in the healthcare staffing business for 20 years

and we believe the long-term fundamentals driving

our  businesses  remain  strong.  I  believe  in  our

future and in our ability to continue growing.

In closing, I would like to express my appre-

ciation to our investors for their loyalty and

acknowledge our employees for their many

contributions to our success in 2002.

Sincerely,

Joseph A. Boshart
President and Chief Executive Officer 

3

Provider of Choice

Lillee Gelinas, RN, MSN
Vice President and Chief Nursing Officer, VHA

An Interview With VHA
Many of our hospital clients are VHA members. We recently sat down with 

Lillee Gelinas, RN, MSN, vice president and chief nursing officer at VHA.

Cross Country: What is the value proposition that VHA brings to its members?

Lillee Gelinas:  VHA is a member-owned and member-driven health care cooperative.

Our mission is to help our members become the local provider of choice by offering them

products and services to help them improve their clinical and operational performance.

Our relationship with Cross Country clearly helps us achieve that objective.

CC:  How significant is the nursing shortage for VHA members and what 

initiatives are being undertaken to address it?

LG:  The nursing shortage for us is profound. It is estimated that VHA institutions have

an RN shortfall every day that can’t be quantified in terms of impact. Our Tomorrow’s

Work Force initiative is receiving recognition in the healthcare industry for its focus on

achieving work force turnarounds. For example, the nurse turnover rate among VHA

member hospitals averages only 15% – many hospitals have two or more times this rate.

The annual cost to VHA members to replace nurses is $1.6 billion or roughly $717,000

per hospital.

Believe me, the problem is real. Society is in for a real shock. The industry dropped 

the work force ball several years ago to meet the financial pressures of the day – now

hospitals are really paying the price. Travel and temporary staffing companies meet the

real needs of today’s nurse and other healthcare professionals. Hospitals just need to

understand that reality!

VHA is a for-profit cooperative with a
nationwide network of more than 2,200
member community-owned health 
care systems and their physicians. VHA
organizations are in 48 states representing
more than one-quarter of the nation’s
community-owned hospitals. VHA 
member organizations range from single
50-bed facilities to large, integrated
health care systems made up of multiple
hospitals, physician clinics and support
care sites. VHA provides products, pro-
grams and services to help its members
improve operational efficiency and 
clinical effectiveness. VHA also works
with hospital executives, physicians, 
nurses and department heads in many
areas to provide them with programs and
services to help them do their jobs better.

VHA Member Hospitals

4

CC:  Looking ahead over the next five years, what are the future healthcare 

staffing needs of VHA member hospitals?

LG:  We’ve got to come to the recognition that we have too few nurses for too many 

positions. We have to create hospitals that are “employers of choice” to attract the best 

and brightest nursing talent. To accomplish that objective, we will have to do everything

we can to assure “best care for every patient, every day.” That means engaging traveling

and temporary staff to keep nurse-patient ratios at safe, quality levels.

CC:  What are the attributes that led VHA to select Cross Country as an 

approved nurse staffing provider?

LG:  No people, no care. That means we can’t deliver quality patient care without 

nurses! We think Cross Country can help us 1) define clearly today’s work force issues, 

2) provide adequate numbers of nurses and other health care professionals to meet 

today’s needs, and 3) redesign staffing models for the future.

CC:  How can VHA member hospitals optimize their use of nurse staffing 

services to better manage fluctuations in staffing demands, improve patient 

outcomes, improve retention and reduce permanent staff turnover?

LG:  Have an open mind. Temporary staffing resources are expensive – we know that. 

So is the cost of turnover and replacement. Today’s “Generation X” nurse wants a life and

a profession that is different than the workers of previous years. Hospitals have to respect

that position, recruit for it, and retain it. That’s our current reality – and that’s our future.

Lillee Gelinas, RN, MSN, is vice president and chief nursing officer at VHA Inc. As a member of VHA’s
Clinical  Services  team,  she  leads  clinical  improvement  efforts  aimed  at  enhancing  operational  efficiency, 
financial  performance  and  patient  care  delivery.  Gelinas  also  leads  VHA’s  programs  supporting  nursing 
leadership and related activities, and also supports VHA local office nursing programs. She joined VHA in
1991 as VHA’s first chief nursing officer. Gelinas is a nationally recognized speaker on clinical health care 
management and nursing issues. She has published numerous articles and has provided leadership for VHA’s
national efforts focusing on clinical and nursing issues. Gelinas earned her bachelor’s degree in nursing from
the University of Southern Louisiana in Lafayette and a master’s degree in nursing, with honors, from the
University  of  Pennsylvania.  She  also  studied  at  the  Wharton  School  of  Business.  In  addition,  Gelinas  is  a 
member of the board of directors of Exempla Health Care in Denver, Colorado. 

5

Jackie Lara, RN
NovaPro Nurse

“After 14 years at the same hospital, I
was ready for a change. So I took the
advice of some friends and joined
NovaPro. I’m glad I did. Looking
back, it’s hard to believe that at one
point in my life I was ready to leave
nursing behind altogether. Travel
nursing has given me the opportunity
to truly love being a nurse again.”

Healthcare Staffing

Nurse Staffing
We provide hospitals and healthcare organizations with integrated fixed-term, flexible-

term and permanent nurse staffing solutions. We are a leading provider of travel nurse

staffing services in the U.S. We also provide per diem nurse staffing as well as staffing

of allied healthcare professionals, such as radiology technicians, rehabilitation therapists

and respiratory therapists.

In providing our staffing services, we supply credentialed nurses for contracted fixed-

term and flexible-term assignments at public and private, and for-profit and not-for-

profit healthcare facilities primarily located throughout the U.S. The majority of our

assignments are at acute care hospitals, including teaching institutions, trauma centers

and community hospitals located in major metropolitan areas.

In 2002, we organized the integrated delivery of our healthcare staffing services under

Cross Country Staffing to provide hospital clients with a single point of access to our

differentiated nurse recruitment brands. This allows our sales and marketing team to

focus on obtaining preferred provider relationships while consistently delivering an

array of high quality staffing services.

Nurse Recruiting
We  operate  differentiated  nurse  recruitment  brands  consisting  of  Cross  Country

TravCorps, NovaPro, Cross Country Local and Assignment America. This strategy

allows us to segment the nurse population during the recruitment of nurses and allied

healthcare  professionals  on  a  domestic  and  international  basis.  We  have  an  efficient

centralized operating structure that at year-end 2002 included a database of more than

170,000 nurses and other healthcare professionals who completed job applications with

us.  More  than  half  of  our  field  employees  have  been  referred  by  current  or  former

employees, with the remainder attracted by advertisements in trade publications and

online  recruiting  initiatives.  Our  applicant  sourcing  initiatives  resulted  in  approxi-

mately 15,700 field staff applications added to our database last year alone.

6

We provide nurses and other healthcare professionals a high level of customer service

in helping them manage their career path. To accomplish this, we offer a wide range of

diverse assignments at healthcare facilities in appealing locations, attractive compensa-

tion packages, housing and other benefits, as well as substantial training opportunities

through Cross Country University.

Our Cross Country TravCorps and NovaPro brands recruit credentialed nurses and

other healthcare professionals, including operating room technicians, therapists and

other allied health and advanced practice professionals such as radiology technicians,

rehabilitation  therapists  and  respiratory  therapists,  for  placement  on  fixed-term

travel  assignments.  Our  purchase  of  NovaPro  in  January  2002  was  our  first  step

towards  segmenting  the  nurse  population.  The  working  nurses  of  Cross  Country

Travcorps and NovaPro each fit a different demographic. Country TravCorps offers

nurses a more standardized benefits package while NovaPro targets nurses seeking

more customized benefits packages.

Our  Cross  Country  Local  brand  recruits  credentialed  nurses  and  other  healthcare

professionals for local per diem assignments at healthcare facilities to fill day-to-day

and varying-length shift coverage. We operate our per diem nurse staffing services

under a centralized model that leverages the quality of recruitment and credentialing

associated  with  the  reputation  and  brand  recognition  of  our  travel  nurse  staffing

business  while  providing  24x7  call  center  service  from  our  headquarters  in  Boca

Raton, Florida. In 2002, we provided per diem nurse staffing services to healthcare

facilities in 25 states. 

Loretta Ogden, RN
Cross Country Local Nurse

“As a mother of four children, 
I turned to nursing as a way to
manage my time as a wife, mother
and career woman. But after 
several years as a staff nurse, I
realized I wasn’t in control of my
priorities. That’s when I joined
Cross Country Local. 
I now choose my shifts, and the
flexibility has allowed me to
achieve balance between my
career and my lifestyle.”

7

In  2001,  we  initiated  Assignment  America,  our  international  recruitment  brand

designed  to  attract  foreign-trained  nurses  and  supplement  U.S.  and  Canadian  nurse

recruiting activities by our Cross Country TravCorps and NovaPro brands. Assignment

America currently recruits experienced acute-care nurses from English-speaking foreign

countries (the UK, Ireland, New Zealand and Australia), executes their licensure and

immigration requirements, and prepares them personally and professionally for their

transition  into  the  U.S.  prior  to  placing  them  on  long-term  domestic  assignments  in

acute  care  facilities.  Assignment  America  is  presently  focused  on  recruiting  certain

high-demand specialties and includes nurses that have completed their Commission on

Graduates of Foreign Nursing Schools Certificate Program to expedite U.S Boards of

Nursing licensing and current immigration procedures.

Our nurse recruiters are a vital component of our business. They are responsible

for establishing and maintaining key relationships with candidates throughout the

placement process on their first assignment as well as subsequent assignments. We

have a strong retention rate and believe it is a direct result of these relationships.

We substantially increased the number of our nurse recruiters from 75 at year-end

2001  to  121  at  year-end  2002,  thus  increasing  our  internal  capacity  to  match  the

supply of qualified nurse candidates in our database with the demand of positions

from our hospital clients.

Clinical Research and Trials Staffing
Through  our  ClinForce  brand,  we  provide  clinical  research  professionals  for  fixed-

term contract assignments and permanent placement to many of the world's leading

companies in the pharmaceutical, biotechnology, medical device and related industries.

We provide an array of professionals in such areas as clinical research and clinical data

sciences, medical review and writing, and pharmacoeconomics and regulatory affairs.

Jean Turcotte, RN
Cross Country TravCorps Nurse

“Travel nursing started out as a perfect
way to beat the cold winters of
Canada. Now seven years and 16
assignments later, I figure I’ll probably
retire as a Cross Country TravCorps
travel nurse. They make it easy for me
to work where I want to work and
still pursue my professional goals. In
fact, for the last three and a half years,
I’ve been working as an Ambassador
for them. In this role, I’ve been able to
continue teaching and that’s something
I really wanted to accomplish.”

8

Other Human Capital 

Management Services

Search and Recruitment
We provide both retained and contingency search and recruitment services to health-

care organizations throughout the U.S., including hospitals, pharmaceutical companies,

insurance companies and physician groups. Our search services include the placement

of physicians, healthcare executives and nurses.

Healthcare Consulting Services
We  provide  healthcare-oriented  consulting  services,  including  consulting  related  to

physician  compensation,  strategy,  operations,  facilities  planning,  work  force  manage-

ment and merger integration.

Education and Training Services
Cross  Country  University  (CCU)  provides  continuing  education  programs  to  the

healthcare  industry.  CCU  holds  national  conferences  as  well  as  multi-  and  one-day 

seminars on topics relevant to nurses and other healthcare professionals. We also extend

these educational services to our field employees on favorable terms as a recruitment

and retention tool. In 2002, CCU produced 4,623 seminars and conferences that were

attended by approximately 143,700 registrants in 265 cities across the U.S.

Lynne Venus, RN
Assignment America Nurse

“Leaving New Zealand to work in
the U.S. was not in my original
plan when I became a nurse. But
when two of my daughters came
here to attend college, I wanted to
be closer to them and Assignment
America made it happen. I accepted
an 18-month assignment with
them, and now they’re helping me
get my green card. Now I’ll be able
to stay in the states for as long as my
daughters are here…maybe longer.”

9

Selected Cross Country Ads

You

don’t
have to travel far

to go far

Faced with a growing shortage of nursing professionals, hospitals
are  struggling  with  ways  to  find  qualified  staff  to  serve  their 
communities’ needs. Cross  Country  Staffing  is  responding  with  a 
cost-effective nurse staffing solutions.

Cross  Country’s  database  of  more  than  170,000  highly 
qualified health care professionals makes finding candidates much
more efficient. In addition, we eliminate the time you’d spend on
screening,
credentialing  and  training  because  our  rigorous
recruitment and evaluation process handles it all for you.

uccessS onfidenceC

www.crosscountrytravcorps.com
(800) 530-6125 ext 8166

Proud National Sponsor of

M
T

Flexibility. Reliability. Respect. 

Travel nursing, redefined.

I’ve been a nurse for a long time and I have plenty of
experience.  But  that  doesn’t  mean  I  don’t  want  to
learn new things. I still want to put my clinical skills to
the test, but
I don’t want to travel far to do it. I choose
the  assignments  that  offer  me  the  challenges 
I’m  looking  for  and  the  locations  that  work  for  me. 
I get exactly what I want – for my career and my life. 
That’s why I’m a travel nurse. 

Welcome to your future!

Schedule Life.

Imagine a nursing career 
flexible enough 
to fit into your
lifestyle.

Local contracts 
available now!

RNs in Critical Care, Med/Surg, Tele and ER
(888) 542-3210

10

NurseVillage is information about nursing…about

your personal life…about life as a nurse. It’s things

you’ll want to know, things you’ll need to know and

everything in between. Here are just some of the great

features you’ll find:
■ Daily Clinical News

Informative City Guides
E-Cards for any occasion

■ Health & Finance Special Features

Professional Career Advice & Resources

www.nursevillage.com

■
■
■
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

( ANNUAL REPORT PURSUANT TO SECTION 13  OR  15(d) OF  THE

SECURITIES EXCHANGE ACT  OF  1934

For the Fiscal Year Ended December 31, 2002
or

9

TRANSITION REPORT PURSUANT  TO  SECTION 13  OR  15(d) OF  THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from 

 to 
Commission file number 0-33169

(Exact name of registrant as specified in  its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)

13-4066229
(I.R.S. Employer Identification  No.)

6551 Park of Commerce Boulevard, N.W.
Boca Raton, Florida 33487
(Address of principal executive offices,  zip  code)
Registrant’s telephone number, including area code: (561) 998-2232
Securities registered pursuant to Section  12(b) of the  act: None
Securities registered pursuant to Section 12(g) of the act:

Common Stock, $.0001 Par Value Per Share

Indicate by check mark whether the  Registrant: (1) has filed  all reports required to be filed  by
Section 13 or 15(d) of the Securities  Exchange Act  of  1934 during the preceding 12 months (or  for such
shorter period that the Registrant was  required to file  such reports), and (2)  has been  subject to such filing
requirements for the past 90 days. Yes ( No 9

Indicate by check mark if disclosure of  delinquent  filers pursuant to Item 405 of  Regulation S-K  is not

contained herein, and will not be contained, to the best of  Registrant’s knowledge, in definitive proxy or
information statements incorporated  by reference in Part III of this  Form 10-K or any amendment to this
Form 10-K. 9

Indicate by check mark whether the  registrant  is  an accelerated  filer  (as defined in Rule  12b-2 of the

Act). Yes ( No 9

The aggregate market value of the voting stock  held  by non-affiliates of the Registrant, based on the
closing price of Common Stock on June  30,  2002 of $37.80 as reported on the Nasdaq National Market, was
$787,450,242.60. This calculation does not reflect a determination that  persons are  affiliated for any other
purpose.

As of March 18, 2003, 32,273,801 shares of Common  Stock, $.0001 par value per share,  were

outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s definitive  proxy statement pursuant to Regulation 14A, which statement will
be filed not later than 120 days after the  end  of  the fiscal year covered by  this Report, are incorporated by
reference in Part III hereof.

TABLE OF CONTENTS

PART I
ITEM  1.

ITEM  2.
ITEM  3.
ITEM  4.

BUSINESS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
RISK FACTORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PROPERTIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
LEGAL PROCEEDINGS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SUBMISSION OF MATTERS TO A VOTE OF  SECURITY HOLDERS . . . . . . .

PART II
ITEM  5. MARKET FOR REGISTRANT’S  COMMON EQUITY AND RELATED

STOCKHOLDER MATTERS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SELECTED FINANCIAL DATA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ITEM  6.
ITEM  7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS . . . . . . . . . . . . . . . . . . . . . . .

ITEM  7A. QUANTITATIVE AND  QUALITATIVE DISCLOSURES ABOUT MARKET

ITEM  8.
ITEM  9.

RISK . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
FINANCIAL STATEMENTS AND  SUPPLEMENTARY DATA . . . . . . . . . . . . . . .
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS  ON

ACCOUNTING AND FINANCIAL DISCLOSURE . . . . . . . . . . . . . . . . . . . . . .

PART III
ITEM  10. DIRECTORS AND EXECUTIVE OFFICERS  OF THE REGISTRANT . . . . . . . .
ITEM  11. EXECUTIVE COMPENSATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
ITEM  12.

SECURITY OWNERSHIP  OF CERTAIN  BENEFICIAL OWNERS AND

MANAGEMENT AND RELATED  STOCKHOLDER  MATTERS . . . . . . . . . . .
ITEM  13. CERTAIN RELATIONSHIPS  AND  RELATED TRANSACTIONS . . . . . . . . . . . .
ITEM  14. CONTROLS AND PROCEDURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

PART IV
ITEM  15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND  REPORTS ON

FORM 8-K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
SIGNATURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CERTIFICATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Page

1
12
16
17
17

17
18

21

34
34

34

35
35

35
35
35

36
37
38

All references to ‘‘we, ‘‘us,’’ ‘‘our,’’ or ‘‘Cross Country’’ in this Report on Form 10-K  means Cross

Country, Inc.

i

Forward-Looking Statements

In addition to historical information, this Annual Report on Form 10-K contains forward-looking
statements. These forward-looking statements are  subject to  certain risks and uncertainties  that  could
cause  actual results to differ materially from those reflected in these forward-looking  statements.
Factors that might cause such a difference include, but are not  limited  to; those  discussed in the  section
entitled ‘‘Business-Risk Factors.’’ Readers are cautioned  not  to  place undue  reliance on these forward-
looking statements, which reflect management’s opinions only as  of  the date hereof. The Company
undertakes no obligation to revise or  publicly release the  results of any revision  to  these forward-
looking statements. Readers should carefully review the Risk Factors described in other documents the
Company files from time to time with the  Securities and  Exchange Commission,  including the
Quarterly Reports on Form 10-Q to  be  filed  by the  Company in  fiscal year  2003.

ITEM 1. BUSINESS

Overview of Our Company

PART I

We  are one of the  largest providers of healthcare staffing  services in the United States. Our
healthcare staffing business segment,  which represents approximately 92% of our revenue, is comprised
of travel nurse and allied health staffing, per diem  nurse staffing and clinical research trials  staffing.
Approximately 80% of our revenue is derived from travel nurse  staffing  services.  Our other staffing
services include the placement of allied  healthcare professionals, such as radiology technicians,
rehabilitation therapists and respiratory  therapists, and  the placement of clinical research professionals.
Our other human capital management  services business  segment, which  represents approximately  8% of
our  revenues, consists of education and  training, healthcare consulting, and physician  and executive
search services.

Our active client base includes more  than 3,000  hospitals, pharmaceutical companies and other

healthcare providers across all 50 states.  Our  fees  are paid directly by our clients rather than by
government or other third-party payors. As a  result, we  have no  direct exposure to Medicare or
Medicaid reimbursements. We are well positioned to take advantage of current industry dynamics,
including the growing shortage of nurses  in the United  States, the growing demand for healthcare
services due to an aging population and  the secular  trend among healthcare providers toward
outsourcing staffing services. For the year  ended December 31, 2002,  our revenue was $640.0 million
and our net income was $29.8 million,  or $0.88  per  diluted  share.

Overview of Our Industry

The Staffing Industry Report, an independent staffing industry publication, estimates that the

healthcare segment of the temporary  staffing industry was $8.5 billion in 2001, an increase of 18% from
$7.2 billion in 2000. Nurse staffing represents over 70% of the revenue  generated in the temporary
medical staffing industry.

The most common temporary nurse staffing alternatives available to hospital administrators are

travel nurses and per diem nurses.

• Travel nurse staffing involves placement of registered  nurses on a contracted, fixed-term basis.
Assignments may range from several  weeks to one year,  but are typically 13  weeks long and
involve temporary relocation to the geographic area of  the assignment. Travel nurses provide a
long-term solution to a nurse shortage, provide hospitals and other healthcare facilities with the
flexibility to manage changes in their staffing  needs due  to shifts in demand, represent a pool of
potential full-time job candidates and enable  healthcare facilities to provide their patients with

1

continuity of care. The staffing company generally is  responsible for providing travel nurses with
customary employment benefits and for coordinating travel and  housing arrangements.

• Per diem staffing comprises the majority of temporary  healthcare staffing and involves placement

of locally based healthcare professionals on  very short-term assignments, often  for daily shift
work, with little advance notice of assignments  by the  client.

Industry Dynamics

Shortage of Nurses. There is  a pronounced shortage of registered nurses,  especially experienced

acute care specialty nurses, which staff operating rooms,  emergency  rooms,  intensive care  units and
pediatric wards. The American Hospital  Association currently estimates the shortage of nurses  to  be
approximately 126,000. The nurse shortage  is expected  to  grow  over the coming decades  to  an
estimated 20% below requirements by  the year  2015 and 29% below requirements by the year 2020,
according to a report by the U.S. Department  of  Health and Human  Services (July  2002).  Similarly,  a
2002 report to the Joint Commission on Accreditation  of  Healthcare  Organizations (JCAHO) titled
‘‘Health Care at the Crossroads—Strategies for Addressing  the Evolving  Nursing Shortage,’’ quantified
this  shortage stating that by the year 2020  there will be at least 400,000 fewer nurses available  to
provide care than will be needed.

According to the July 2002 report mentioned above, the national shortage of registered  nurses is
not evenly distributed across the U.S.  In  2000, 30 states were estimated to have shortages.  By the  year
2020, 44 states and the District of Columbia are  projected to have shortages.

Several factors have contributed to the decline in the  supply of nurses:

• The nurse pool is getting older and approaching retirement age. Several factors contribute to the
aging of the registered nurse workforce:  (1) the  decline  in number of nursing school graduates,
(2) the higher age of recent graduates, and  (3)  the aging of  the  existing pool of  licensed nurses.
The largest source of new registered nurses,  associate-degreed nurses, are on average 33 years
old when they graduate and considerably  older than  in 1980 when the average age  was  28. The
JCAHO report outlined the average  age  of  a working registered nurse at 43.3 and increasing at
a rate more than twice that of other  workforces in this country. In contrast, 12% of registered
nurses are under age 30, a 41% decline compared to a  1% decline for other occupations since
1983. The slowing of new, young entrants combined with  an accelerating retirement rate for
older registered nurses is expected to result in a national  supply of nurses in  the year 2020 that
will not only be older, but no larger in number than  the supply projected for the year 2005. By
the year 2010, it is projected that the  average age of working registered nurses  will be 50.

• Approximately 60% of nurses work in  hospitals. Many registered nurses are leaving the hospital
workforce through retirement, death or  by choosing careers outside  of acute care  hospitals or in
professions other than nursing. There are  currently more than  500,000 licensed nurses  not
employed in nursing. According to a Peter  D. Hart Research Associates study  (April  2001),  the
top reasons nurses leave patient care, besides retirement, is  to  seek a job that is less stressful
and less physically demanding (56%), seek more regular hours (22%) and  desire more
compensation (18%). Among working hospital  nurses, understaffing (39%) and  the stress and
physical demands of the job (38%) were cited as  the biggest problems with  nursing.

• Enrollment levels in nursing schools declined in the  last half of the 1990s, resulting in 26%
fewer registered nurse graduates in 2000 than in 1995.  Declines were seen across all degree
programs—diploma, associate degrees and baccalaureate. Similarly, the  numbers of  domestically
educated candidates taking the registered  nurse licensing examination (NCLEX) for the first
time has declined at an average of 5.5% for each of  the past six  years,  as reported by the
National Council of State Boards of Nursing, Inc.  While  the American Association of Colleges

2

of Nursing (AACN) reported a 3.7%  increase in baccalaureate enrollment between 2000 and
2001, there are approximately 21,000 fewer  nursing students than in 1995.  In  addition, the
relatively longer educational time frame required to complete baccalaureate  studies increases the
length of time before students can take the NCLEX  test and emerge as  licensed  nurses.

• The shortage of nurses is mirrored  by a  corresponding  shortage of nursing faculty. As a result of

the faculty shortage, nursing schools turned away 5,000  qualified baccalaureate program
applicants in 2001. Nursing school faculty members average age 51—eight  years  older than the
average age of all registered nurses. Doctorally prepared faculty members are even older with an
average age of 56 for professors, 54 for  associate professors  and 50 for  assistant  professors.  As
the supplier of a majority of the pool of nurse educators,  the American Association of Colleges
of Nurses reports that doctoral nursing enrollments grew  by only  1.5%  from 2001 to 2002. The
shortage of nurses drives demand for our services because hospitals turn to temporary nurses  as
a flexible way to manage changes in demand  of  their permanent staff and  make  up for budgeted
shortfalls in staffing.

Increasing Utilization of Healthcare Services. There are a number of factors driving an increase in

the utilization of healthcare services, including:

• A projected 18% increase in population between the year 2000 and  2020, resulting in  an

additional 50 million people who will require  health  care—19  million of which will be in the
65-and-over age group (Report by US. Department  of  Health and Human  Services—July  2002).

• The aging of Americans. Baby boomers are  just entering  the 55 to 64  age group,  where inpatient
days per thousand are 58% higher than in  the 45 to 54  age  group, and 121% higher than in the
35 to 44 age group. National spending on hospital services  increased $83.6  billion between 1997
and 2001. Of this increase, the most significant  source  of  growth (55.4%) was volume—more
people using hospital services. For the period 2001 to 2003,  labor costs, pushed  up by the
nursing shortage, are projected to account for 38.8%  of  the increase  in spending  on hospital  care
and volume (population) growth is associated with 20% of the  increase (Cost of Caring: Key
Drivers of Growth in Spending on Hospital  Care  by PriceWaterhouseCoopers—February 2003).

• Advances in medical technology and healthcare  treatment methods  that  attract a greater number

of patients with complex medical conditions requiring higher intensity  of care.

Spending on hospital services has grown  61% over the  past  10 years. The Centers for Medicare
and Medicaid Services project that annual  growth in  spending  on hospital services  will remain relatively
constant at about 6% throughout the  next decade while  total healthcare expenditures are  expected to
grow by an average of 7.1% annually from 2001 through 2010. During the  past few years, growth in
spending on hospital services has moderated—from 8.3% in 2001 to 7.4%  in 2002, and is  expected to
be 5.5% in 2003.

Increased Outsourcing of Staffing Services. The use of temporary personnel enables healthcare
providers the flexibility to vary their  staffing levels to match the  changes  in demand  of  their  permanent
staff  caused by both planned and unplanned  vacancies. Healthcare  providers  also use  temporary
personnel to address budgeted shortfalls due to vacancy rates and are increasingly using temporary
staffing to manage seasonal fluctuations in  demand  for their services. The following factors have
created seasonal fluctuations in demand  for healthcare personnel:

• Seasonal population swings, in the  sun-belt states of Florida, Arizona and California  in the

winter months and the northeast in the summer  months.

• Seasonal changes in occupancy rates that tend to increase during the  winter months and

decrease during the summer months.

3

From 1997 to 2001, the growth in the number of agency nurses  was  46%  compared to 7%  for
hospital nurses, according to the PriceWaterhouseCoopers 2003 report. The  healthcare staffing industry
also includes the temporary staffing of doctors  and  dentists,  allied  health personnel  and professionals,
and advanced practice professionals,  but  excludes home healthcare  services.

Temporary Decrease in Demand. We believe that hospitals have taken nurse-staffing actions that
have decreased demand for travel nurse staffing,  which we believe has temporarily slowed our  rate of
revenue growth during the later part  of 2002. We believe these decisions have  resulted in increased
reliance on staff nurse overtime, increased patient-to-nurse ratios and high wage and compensation
increases, including sign-on bonuses,  by the hospitals. We  also believe that due to present economic
conditions, where many nurse’s spouses have been laid off and severance  and unemployment benefits
have ended, many part-time nurses employed directly  by hospitals who would have  typically worked two
shifts or less per week have increased  the number  of  shifts worked at their  hospitals and are doing so
at the prevailing hospital wage. Other factors that affect  the demand for our services  are patient
occupancy rates. As occupancy increases,  temporary  employees  are often added before full-time
employees are hired. As occupancy decreases, clients tend to reduce their  use of temporary employees
before undertaking layoffs of their regular  employees.  Additionally, we may experience more
competitive pricing pressure during these  periods of decreased demand.

Legislation Change that will Increase Demand.

In response to concerns by consumer groups  over

the quality of care provided in healthcare  facilities and concerns by nursing  organizations about  the
increased workloads and pressures on nurses,  a number of states have either passed or introduced
legislation related to prohibiting mandatory overtime and addressing nurse-to-patient ratios. The
passage of such legislation is expected  to  increase the demand for nurses. California, in  particular, has
passed legislation requiring minimum  nurse-to-patient ratios at all hospitals. Maine, New Jersey and
Oregon have passed legislation limiting  mandatory overtime for nurses. Several  states are considering,
or have already introduced, similar legislation.

Our Competitive Strengths

Our competitive strengths include:

• Leader in Rapidly Growing Nurse Staffing Industry. We have operated in the travel nurse  staffing

industry since the 1970s and have the  leading brand  name based on revenue. Our Cross Country
TravCorps brand is well recognized among leading healthcare providers and professionals. We
believe that through our existing relationships with  travel nurse staffing  clients, we are positioned
to effectively market our complementary services,  which include staffing  of allied health and
clinical trial professionals, search and recruitment, consulting, and education and training to our
existing client base.

• Strong and Diverse Client Relationships. We provide staffing solutions to an active client  base  of
over 3,000 hospitals, pharmaceutical companies and other healthcare  providers  across all 50
states. No single client accounted for more than 3% of  our revenue in 2002. In 2002, we worked
with over 70% of the nation’s top hospitals, as identified  by ‘‘U.S.  News & World Reports’’. We
provide temporary staffing to our clients  through assignments  that typically have terms of 13
weeks or longer.

• Fees Paid Directly by Clients. Our fees are paid directly by our clients rather than by  government

or other third-party payors. As a result, we have no exposure to Medicare or  Medicaid
reimbursements.

• Leader  in Recruiting and Employee Retention. We are a leader in the recruitment and the

retention of highly qualified healthcare professionals. We  recruit  healthcare professionals from
all 50 states and Canada. We also recruit registered  nurses  from English-speaking foreign

4

countries, assist them in obtaining U.S. nursing  licenses, sponsor  them for U.S. permanent
residency visas and then place them in domestic acute care  hospitals. In 2002, approximately
15,700 field staff completed applications were added to our database. Employee referrals
generated a majority of our new candidates. We believe we offer appealing  assignments,
competitive compensation packages, attractive  housing options and other valuable  benefits. In
2002, approximately 70% of our nurses  accepted a new assignment with us  within 35 days of
completing a previous assignment with  us. In  1996, we established  Cross Country University, the
first educational program in the travel nurse industry to be accredited by  the  American Nurse
Credentialing Center. Cross Country University provides accreditation and  continuing  education
to our nurses and other healthcare professionals.

• Scalable  and Efficient Operating Structure. We have an efficient centralized operating  structure
that at year-end 2002 included a database of more than 170,000  nurses  and  other healthcare
professionals who completed job applications  with us. Our size and centralized structure  provide
us with operating efficiencies in key areas  such as  recruiting, advertising, marketing, training,
housing and insurance benefits. Our integrated proprietary  information  system enables us to
manage virtually all aspects of our travel staffing operations.  This system  is designed to
accommodate significant future growth of  our business.

• Quality Assurance. Our quality assurance department is structured to ensure that our healthcare
clients receive professionals that are qualified to meet their needs.  Each new candidate that
submits an application with us is screened  before  being placed at a healthcare facility. Our
internal screening process requires that each new candidate has the experience, skills,
credentials, education and licensing required generally of all  of our candidates.  Our quality
assurance department also verifies the work history and references  of each candidate  and
ensures that each candidate meets the  specific requirements of each  hospital client regarding,
among other things, background checks,  health records, drug screening, continuing education
and certifications. In addition, our quality  assurance department evaluates our candidates on a
continual basis through a written evaluation process. Our healthcare clients deliver evaluations
to us after each candidate completes an assignment so  that  we  have direct  feedback from them.

• Strong Management Team with Extensive Healthcare Staffing and Acquisition Experience. Our

management team has played a key role in  the development of the  travel nurse staffing industry.
Our management team, which averages  more  than  10 years of experience in  the healthcare
industry, has consistently demonstrated the  ability to successfully identify and integrate  strategic
acquisitions.

Our Business

Healthcare Staffing Services

Nurse  Staffing

We  are a leading provider of travel nurse staffing  services  in the U.S. In 2002, we reorganized the

delivery of our healthcare staffing services  under the  Cross Country Staffing umbrella to provide
fixed-term, flexible-term and permanent staffing  solutions on an  integrated basis.  Cross  Country
Staffing  provides hospital clients with  a  single point of  access to our differentiated nurse  recruitment
brands consisting of Cross Country TravCorps,  NovaPro, Cross Country Local and  Assignment
America, which allows us to recruit nurses and allied healthcare professionals on a domestic and
international basis, and deliver an array  of  high quality  staffing  services. Nurse staffing services
represented approximately 87% of this segment’s revenue in 2002.

We  provide credentialed nurses for contracted fixed-term and flexible-term assignments at public
and private, and for-profit and not-for-profit facilities throughout the U.S., Canada, Bermuda  and the

5

U.S. Virgin Islands. The majority of our  assignments are  at acute  care hospitals, including  teaching
institutions, trauma centers and community  hospitals located in  major metropolitan  areas. We also
provide other healthcare professionals,  which include  operating room technicians, therapists and  other
allied health and advanced practice professionals, such  as radiology technicians, rehabilitation therapists
and respiratory therapists, in a wide  range of specialties.  We also fill staffing assignments in non-acute
care settings, including nursing homes,  skilled nursing facilities and  sports medicine clinics, and, to a
lesser degree, in non-clinical settings,  such as  schools.

In addition, we provide contractual per diem nurse staffing services to healthcare facilities as a

staffing solution to fill the immediate needs in  managing both  their day-to-day  shift coverage and
varying-length local shift coverage. We operate our per diem  nurse staffing  services under a  centralized
model that leverages the quality of recruitment  and credentialing  associated with the  reputation and
brand recognition  of our travel nurse  staffing  business  while providing our hospital clients with 24x7
centralized call center service from our headquarters in Boca Raton, Florida.  We also operate 5  local
offices, which only conduct recruitment  and  credentialing.  In  contrast, traditional per diem staffing
businesses operate fully staffed, full-service branches in the cities they serve. In 2002, we provided
flexible-term per diem nurse staffing services to healthcare facilities in 25 states.  While  per  diem
services accounted for less than 1% of our revenue in 2002,  we believe  this  market presents  a
significant growth opportunity.

Sales and Marketing

During  2002, we reorganized our sales and marketing efforts  to  respond  to changing industry

dynamics. To accomplish this task, Cross  Country Staffing  markets all the Company’s  differentiated
nurse and allied recruitment brands to  hospitals  on an  integrated basis.

The Cross Country Staffing sales and marketing organization is  focused on  obtaining  preferred

provider relationships with existing and new hospital clients  and healthcare purchasing organizations.
The organizational structure includes  a National Accounts Team,  Territory Sales Team, Account
Managers, and Product Specialists who  provide a  support function.

Brand Marketing. Our brand marketing initiatives help develop and  foster Cross Country’s image
in the markets we  serve. Our brand is  reinforced by our  professionally designed website, brochures and
pamphlets, direct mail and advertising  materials. We  believe that our branding  initiatives,  coupled  with
our  high-quality client service, differentiate us from our  competitors  and establish us as a  leader, in
terms of brand recognition, in temporary nurse  staffing.

Trade and Association Relationship Management. We actively manage trade and association
relationships through attendance at numerous national, regional and local  conferences and meetings,
including National Association of Health  Care  Recruiters, Association  of  Critical Care  Nurses,
American Organization of Nurse Executives, American Society for Healthcare Human Resource
Administration, American College of  Healthcare Executives and Medical Group  Management
Association.

Nurse  Recruiting

We  operate differentiated nurse recruitment brands consisting  of  Cross Country TravCorps,
NovaPro, Cross Country Local and Assignment  America,  which allow us to recruit nurses and allied
healthcare professionals on a domestic  and international  basis, and  deliver  an array of high quality
staffing services. We believe that these  professionals  are attracted to us because we  offer them high
levels of customer service, as well as  a wide range of diverse assignments at attractive locations
primarily throughout the United States  as well as in Canada, Bermuda and the  U.S. Virgin Islands.

6

Our nurse recruiters are a vital component of our  business, responsible  for establishing  and
maintaining key relationships with candidates from  their  introduction  to  the Company. Our recruiters
work with the candidates throughout the  placement  process on their  first assignment as well  as
subsequent assignments. We believe our strong  retention rate  is a direct result  of these  relationships.
During  2002, we substantially increased  the number  of  our  nurse recruiters from 75 to 121 at year-end,
thus  increasing our internal capacity  to match the  supply of qualified  nurse  candidates in  our database
with the demand of positions from our  hospital  clients. We believe we have an adequate number of
nurse recruiters to support the present level of demand.

Our Cross Country TravCorps and NovaPro brands  recruit credentialed nurses  and other

healthcare professionals, including operating  room  technicians, therapists  and other allied health and
advanced practice  professionals such as  radiology technicians, rehabilitation therapists and  respiratory
therapists, for placement on fixed-term  and flexible-term travel  assignments away  from their homes  and
local travel assignments. Our purchase  of  NovaPro in January of  2002 was our first step towards
segmenting the nurse population. The working nurses  of  Cross Country Travcorps and NovaPro  each fit
a different demographic. Our Cross Country TravCorps brand offers nurses a  more standardized
benefits package while our NovaPro  brand targets nurses seeking more customized benefits packages.

Our Cross Country Local brand recruits credentialed nurses and other healthcare  professionals for

flexible-term local per diem assignments  at healthcare facilities  made  on short-notice to fill day-to-day
shift  coverage and varying-length shift coverage. We operate our flexible-term per diem staffing  on a
24x7 basis from a centralized call center  at our headquarters  in Boca Raton, Florida. In 2002, we
provided flexible-term per diem nurse staffing services to healthcare  facilities  in 25 states. We  also
operated  five local offices that only conduct recruitment and credentialing in  Florida (two  offices),
Arizona,  Illinois and Washington.

In 2001, we initiated Assignment America, our international recruitment brand designed to address
the present shortage of nurses in the U.S. by attracting  foreign-trained nurses and supplementing  nurse
recruiting activities in the U.S. and Canada by our Cross Country TravCorps and NovaPro brands.
Assignment America currently recruits experienced acute-care  nurses  from English-speaking foreign
countries (the United Kingdom, Ireland,  New Zealand and Australia), executes  their licensure and
immigration requirements, and prepares  them personally and professionally  for their transition into the
U.S.  prior  to  placing  them  on  long-term  domestic  assignments  in  acute  care  facilities.  In  January  2003,
due  to  the  current  demand  environment,  Assignment  America  altered  its  recruitment  model  to  focus
on certain specialties. These specialties continue to have increases in demand year over  year and
include nurses that have completed their  Commission  on Graduates of Foreign Nursing Schools
Certificate Program to better meet efficiencies  of the U.S Boards of  Nursing  and current immigration
procedures. Assignment America currently has 342  nurses in its pipeline at various stages of the
licensure and immigration process.

Recruiting and Retention

In 2002, approximately 15,700 completed  field staff applications  were added to our database. More

than half of our field employees have  been referred by current or former  employees, with  the
remainder attracted by advertisements  in  trade publications and our internet website.  Our internet site
allows potential applicants to review  our  business profile,  apply on-line, view our company-provided
housing and participate in on-line forums. We offer appealing assignments, attractive compensation
packages, housing and other benefits, as  well as substantial training opportunities  through Cross
Country University.

Our recruiters are responsible for recruiting applicants, handling  placements,  maintaining  a regular
dialogue with nurses on assignment, making  themselves available to address  nurses’ concerns  regarding
current assignments and future opportunities, and other significant job support and  guidance.

7

Recognizing that a nurse’s relationship with the  recruiter  is the key to retaining qualified applicants,
our  recruiters establish lasting partnerships with  the nurses. As  part of  the screening process, we
conduct in-depth telephone interviews with  our applicants and verify  references to determine
qualifications. Along with our hospital  clients, we typically review  our travel  nurses’ performance  after
each  assignment and use this information to maintain the high  quality of our staffing.

Our recruiters utilize our sophisticated  database of positions, which is kept up-to-date by our

account managers, to match assignment opportunities  with the  experience,  skills  and geographic
preferences of their candidates. Once  an  assignment is selected,  the  account manager  reviews the
candidate’s resume package before submitting it  to  the client for review. Our educational and  training
services give us a competitive advantage by enhancing both the quality of our nurses and the
effectiveness of our recruitment efforts. We typically monitor the quality of  our  workforce in the field
through performance reviews after each assignment  and  further  develop the  capabilities  of  our  recruits
through our Cross Country University  brand.  These  services offer  substantial benefits, such as:

• Improving the quality of our nurses by offering them substantial training opportunities;

• Enabling our nurses to easily complete  state licensing  requirements;

• Providing professional development opportunities  to  our  nurses; and

• Enhancing our image within the industry.

Contracts With Field Employees and Clients

Each  of our traveling field employees works for  us  under a contract.  These contracts typically last

13 weeks. Our traveling field employees  that are payroll  contract employees  are hourly employees
whose contract specifies the hourly rate they  will be paid, including applicable overtime, and  any other
benefits they are entitled to receive during  the contract  period. For payroll  contract employees, we bill
clients  at an hourly rate and assume all  employee  costs, including payroll,  withholding taxes, benefits
and professional liability insurance and  OSHA requirements, as well  as any travel and  housing
arrangements. Mobile contract employees are hourly employees  of the hospital client and  receive an
agreement that specifies the hourly rates  they will be paid  by the  hospital employer, as well as  any
benefits they are entitled to receive from us.  For mobile contract  employees, we  provide recruitment,
housing in apartments we lease and travel  services.  Our contract with the healthcare professional
obligates us to provide these services  to  the healthcare professional. We are compensated for the
services we provide at a predetermined rate  negotiated with our  hospital client, without  regard to our
cost of providing these services. Currently  approximately 99%  of  our employees work  for us  under
payroll  contracts. Our fees are paid directly by  our  clients rather  than  by  government or other  third-
party payors. In 2002, we completed approximately 18,700 individual assignments, typically lasting 13
weeks. In 2001, we completed approximately 17,000 individual  assignments.

Operations

We  operate from a centralized business model servicing  all of the assignment needs of our field
employees and client facilities through  operations centers  located  in Boca Raton and Tampa, FL and
Malden, MA. These centers perform key support activities such as coordinating assignment
accommodations, payroll processing, benefits administration, billing  and collections, contract  processing,
client care, and risk management.

Hours worked by field employees are  recorded  by our operations system,  which then transmits  the

data directly to Automated Data Processing  (ADP)  for payroll processing. As  a result, biweekly  client
billings are generated automatically once the payroll information is  complete,  enabling real  time
management reporting capabilities as to hours worked,  billings  and payroll  costs. Our payroll
department also provides customer support services  for field  employees who have questions.

8

We  have approximately 3,100 apartments on lease  throughout the U.S. Our client housing
department secures leases and arranges  for furniture rental and  utilities for field  employees at their
assignment locations. Typically, we provide for  shared  accommodations at no  cost to the healthcare
professional on assignment with us, with  lease terms that generally correspond to the length of the
assignment. We believe that our economies  of scale help us secure preferred pricing  and favorable lease
terms.

We  have also developed expertise in  insurance, benefits administration and  risk management.

These programs are partially self-insured  and  are offered at no cost  to  our  healthcare professionals.

Clinical Research and Trials Staffing

Through our ClinForce brand, we provide  clinical research professionals for  both fixed-term
contract assignments and permanent placement to many of  the world’s leading companies in the
pharmaceutical, biotechnology, medical  device and  related industries.  We provide  an array of
professionals in such areas as clinical research and clinical data sciences, medical  review and  writing,
and pharmacoeconomics and regulatory  affairs.  Our understanding of the clinical research process
enables us to provide responsive service  to our clients  and to offer greater opportunities  to  our
research professionals.

Other  Human Capital Management Services

We  provide an array of healthcare-oriented human capital management services, which

complement our core travel nurse staffing business.  These  services include:

Search and Recruitment. We provide both retained and contingency search and recruitment

services to healthcare organizations throughout  the U.S.,  including hospitals,  pharmaceutical companies,
insurance companies and physician groups.  Our search services include the placement of physicians,
healthcare executives and nurses.

Healthcare Consulting Services. We provide healthcare-oriented consulting services, including

consulting related to physician compensation, strategy, operations, facilities planning, workforce
management and merger integration.

Education and Training Services. Cross Country University (CCU) provides  continuing  education
programs to the healthcare industry.  CCU  holds  national  conferences, as  well as one-day seminars,  on
topics relevant to nurses and other healthcare professionals. In 2002, CCU produced 4,623  seminars
and conferences that were attended by approximately  143,700 registrants in 265 cities across the U.S.
This compares to more than 3,300 CCU  seminars  and conferences that were attended by over 92,000
registrants in more than 200 cities across  the U.S. in 2001. In  addition, we extend these educational
services to our field employees on favorable terms as  a recruitment and retention tool.

Systems

Our placement and support operations are supported by sophisticated information systems that

facilitate smooth interaction between our recruitment and support  functions. Our fully integrated
proprietary information system enables  us to manage virtually all aspects of our travel staffing
operations. The system is designed to  accommodate  significant future growth  of our  business.  In
addition, its parallel process design allows  for  the addition of further capacity to its existing hardware
platform. We have proprietary software  that handles  most facets of our  business, including contract
pricing and profitability, contract processing, job posting, housing management, billing/payroll and
insurance. Our systems provide reliable support  to  our facility clients and field  employees and enable
us to efficiently fulfill and renew job assignments.  Our systems also provide detailed information on the
status and skill set of each registered field  employee.

Our financial and management reporting is managed  on  the PeopleSoft  Financial Suite. PeopleSoft

is a leading enterprise resource planning software suite that provides modules used to manage our

9

accounts receivable, accounts payable,  general ledger  and billing.  This  system  is designed  to
accommodate significant future growth of  our business.

Growth Strategy

Despite the reduction in overall demand  for outsourced healthcare staffing,  there still  remains  a
level  of  unmet demand for our fixed- and flexible-term healthcare  staffing  services.  We are  striving  to
meet a greater portion of this demand by recruiting additional licensed nurses  and other  healthcare
professionals, establishing preferred provider relationships with  hospital clients,  and managing our
internal capacity to maximize the changing supply and demand  requirements of the healthcare staffing
marketplace. We intend to continue to grow our businesses by:

• Enhancing Our Recruitment Efforts to  Increase the Supply  of  Licensed Nurses and  Other  Healthcare

Professionals. Our recruitment strategy is focused on:

• Utilizing a segmented brand approach to recruit nurses  and other healthcare professionals

on a domestic and international basis while segmenting the nurse marketplace  with
differentiated brand offerings.

• Increasing the number of referrals from existing field employees by providing them  with

superior service.

• Expanding our advertising presence to reach more  nursing professionals.

• Using  the internet to accelerate the recruitment-to-placement cycle.

• Improving the productivity of staff dedicated to the recruitment of new nurses.

• Expanding the Range of Services We Offer  our Clients. We plan to utilize Cross Country Staffing
as a vehicle to provide hospital clients  with a single point of access to our  integrated delivery of
fixed-term, flexible-term and permanent healthcare staffing solutions.

• Preferred Provider Relationships. We plan to focus on establishing preferred provider relationships
with our existing hospital clients and  healthcare organizations that we do  not presently  provide
staffing services for. We also plan to utilize our relationships with existing travel staffing clients
to more  effectively market our complementary services, including staffing of clinical trials and
allied health professionals, search and  recruitment, consulting, and education and training.

• Increasing Our Market Presence in the Flexible-Term Per  Diem Staffing  Market. We intend to use
our  existing brand recognition, client relationships  and  database of  nurses who have expressed
an interest in flexible-term assignments  to  expand our  per  diem services to the  acute care
hospital market. While we have not historically had a significant presence  in per diem staffing
services, we believe that this market  presents  a substantial growth opportunity.

• Acquiring Complementary Businesses. We continually evaluate opportunities to acquire

complementary businesses to strengthen and broaden our market  presence.

• Increasing Operating Efficiencies. We seek to increase our operating margins  by increasing the
productivity of our administrative personnel, using our  purchasing power  to achieve greater
savings in key areas such as housing and benefits and continuing to invest in our information
systems.

Competitive Environment

The fixed- and flexible-term travel and per diem nurse staffing industry is highly competitive, with

limited barriers to entry. Our principal competitor in the  fixed-term travel  nurse staffing  industry is
AMN  Healthcare Services, Inc. We also compete with a  number of nationally and regionally focused
temporary nurse staffing companies that  have the capabilities to relocate nurses geographically and, to
a lesser extent, with local temporary  nurse agencies. In addition, the  markets for our clinical trials and
allied staffing services and for our healthcare-oriented  human capital management services are highly
competitive and highly fragmented, with limited barriers to  entry.

10

The principal competitive factors in attracting  qualified candidates for temporary employment are

salaries and benefits, quality of accommodations, quality and breadth of assignments,  speed of
placements, quality of recruitment teams and reputation. We believe  that persons  seeking  temporary
employment through us are also pursuing  employment through  other  means, including other temporary
staffing firms, and that multiple staffing companies have the opportunity to place employees  with many
of our clients. Therefore, the ability to respond to candidate inquiries and submit candidates to clients
more quickly than our competitors is  an important factor in our ability  to fill  assignments.  In addition,
because of the large overlap of assignments, we focus  on retaining field employees by providing
long-term benefits, such as 401(k) plans and cash bonuses. Although  we believe  that  the relative size of
our  database and economies of scale derived from the size of our  operations make  us an attractive
employer for nurses seeking travel opportunities, we expect competition for candidates to continue to
increase.

The principal competitive factors in attracting  and  retaining temporary  healthcare staffing  clients

include the ability to fill client needs, price,  quality assurance and screening capabilities, compliance
with regulatory requirements, an understanding  of  the client’s work environment, risk management
policies and coverages, and general industry reputation. In  addition,  the level of  demand for  outsourced
nurse staffing is influenced by national healthcare spending and spending  on hospital  care;  general
economic conditions and its impact on national, regional and local  labor markets, and; the
corresponding supply of full- and part-time hospital-based nurses  willing to work at  prevailing hospital
wages.

Regulatory Issues

In order to service our client facilities and to comply with  OSHA and JCAHO standards,  we have
a risk management program. The program is  designed to protect against the risk of negligent hiring by
requiring a detailed skills assessment from each healthcare professional.  In addition,  we have  a claims-
based professional liability insurance policy pursuant  to  which we  provide primary coverage of
$2 million for each occurrence through  a self-insured retention program that is guaranteed  by  a
$2 million irrevocable letter of credit  held by our excess insurance provider. We also provide up  to
$10 million in umbrella liability insurance  coverage after the $2 million primary coverage has  been
exhausted.

Professional Licensure. Nurses and most other healthcare professionals  employed by  us are
required to be individually licensed or certified under applicable state law. In addition, the healthcare
professionals that we staff frequently  are  required to have been certified to provide certain  medical
care, such as CPR and ACLS, depending  on  the positions  in which they are placed. Our  comprehensive
compliance program is designed to ensure that our employees possess all necessary licenses and
certifications, and we believe that our employees,  including  nurses  and therapists,  comply with all
applicable state laws.

Business Licenses. A number of states require state licensure  for businesses that, for a fee, employ
and assign personnel, including healthcare personnel,  to  provide services on-site at hospitals  and other
healthcare facilities to support or supplement  the hospitals’ or healthcare facilities’ work force. A
number of states also require state licensure for  businesses that operate placement services for
individuals attempting to secure employment.  Failure to obtain the necessary licenses can  result in
injunctions against operating, cease and desist orders, and/or fines. We endeavor to maintain in effect
all required state licenses.

Regulations Affecting Our Clients. Many of our clients are reimbursed under the  federal Medicare

program and state Medicaid programs  for the services they provide. In recent years, federal and state
governments have  made significant changes in these programs that have reduced reimbursement rates.
In addition, insurance companies and  managed care organizations seek  to control  costs by requiring
that healthcare providers, such as hospitals, discount  their services in exchange for exclusive or
preferred participation in their benefit  plans.  Future federal and state legislation or  evolving

11

commercial reimbursement trends may further  reduce, or  change conditions for, our  clients’
reimbursement. Such limitations on reimbursement  could reduce our clients’  cash flows, hampering
their ability to pay us.

Immigration. Changes in immigration law and procedures following September 11, 2001 have
slowed down our ability to recruit foreign nurses to meet demand, and  changes  to  such procedures in
the future could further hamper our  overseas recruiting efforts.  In  addition, our use of foreign nurses
may entail greater difficulty in ensuring that each  professional has the proper  credentials and  licensure.

Employees

As  of  February  21,  2003,  we  had  approximately  820  corporate  employees  and  approximately  5,500

field employees. None of our employees is subject to a  collective bargaining agreement. We consider
our  relationship with employees to be  good.

Available  Information

Financial reports and filings with the Securities and Exchange Commission  (SEC) are  available

free of charge as soon as reasonably  practicable after  filing  such material with,  or furnishing it to, the
SEC, via the internet at our website, www.crosscountry.com.

Risk Factors

In addition to the other information  included  in this Report on  Form 10-K, you should consider

the following risk factors.

Although demand for outsourced nurse  staffing has declined from higher  than  average levels during
the past several years, industry dynamics are  such that  we  are still unable to  recruit  enough nurses to
meet our clients’ demands for our nurse  staffing services, limiting the potential growth of our  staffing
business.

We  rely  significantly on our ability to  attract, develop and retain nurses and other healthcare
personnel who possess the skills, experience and, as required, licensure necessary to meet the  specified
requirements of our healthcare staffing clients.  We compete for healthcare staffing  personnel with other
temporary healthcare staffing companies, as well as actual and potential clients, some  of which seek to
fill positions with either regular or temporary employees.  Currently, there is  a shortage of qualified
nurses in most areas of the United States  and  competition for nursing  personnel is  increasing.  Although
demand has slowed down, at this time we still do not have enough nurses to meet  our  clients’ demands
for our  nurse staffing services. This shortage of nurses limits our ability  to  grow  our staffing business.
Furthermore, we believe that the aging  of the  existing nurse population and declining enrollments in
nursing schools will further exacerbate  the existing  nurse shortage. In addition, in the aftermath of  the
terrorist attacks on New York and Washington, we experienced a temporary  interruption of normal
business activity. Similar events in the future  could  result in additional temporary or longer-term
interruptions  of our normal business activity.

The costs of attracting and retaining  qualified nurses and  other  healthcare  personnel may raise more
than we anticipate.

We  compete with other healthcare staffing  companies for qualified nurses  and other healthcare

personnel. Because there is currently a  shortage of qualified  healthcare personnel, competition for
these employees is intense. To induce healthcare  personnel to sign on with them, our  competitors may
increase hourly wages or other benefits.  If we do not raise  wages in response to such increases by our
competitors, we could face difficulties attracting and retaining qualified healthcare  personnel. In
addition, if we raise wages in response  to  our  competitors’ wage increases and  are unable to pass such
cost increases on to our clients, our margins  could decline.

12

Our costs of providing housing for nurses and other  healthcare personnel may be  higher  than  we
anticipate and, as a result, our margins could decline.

We  currently have approximately 3,100 apartments on lease  throughout the U.S. If  the costs of
renting  apartments and furniture for our nurses and other healthcare personnel  increase more than we
anticipate and we are unable to pass such  increases on  to  our clients, our margins  may decline. To  the
extent the length of a nurse’s housing lease exceeds  the term of the nurse’s staffing contract,  we bear
the risk that we will be obligated to pay rent for housing  we do not use.  To limit the  costs of unutilized
housing, we try to secure leases with  term  lengths that match the term  lengths of our staffing  contracts,
typically 13 weeks. In some housing markets we have had, and  believe we will continue to have,
difficulty identifying short-term leases. If  we cannot identify a  sufficient number  of  appropriate
short-term leases in regional markets,  or, if  for any reason, we  are  unable to efficiently utilize  the
apartments we do lease, we may be required to pay  rent  for unutilized  housing or,  to  avoid such  risk,
we may forego otherwise profitable opportunities.

Decreases in patient occupancy at our  clients’ facilities may adversely affect the profitability of our
business.

The general level of patient occupancy at our clients’ facilities significantly affects  demand for  our
temporary healthcare staffing services. When a  hospital’s occupancy  increases, temporary employees  are
often added before full-time employees  are hired. As occupancy  decreases, clients may reduce  their  use
of temporary employees before undertaking layoffs of their regular employees. We also may experience
more competitive pricing pressure during  periods of occupancy  downturn. In addition, if  a trend
emerges toward providing healthcare in  alternative settings, as opposed to acute care hospitals,
occupancy at our clients’ facilities could  decline. This reduction  in occupancy could adversely  affect the
demand for our services and our profitability.

We are dependent on the proper functioning of our information systems.

Our company is dependent on the proper functioning  of our information  systems in  operating our
business. Critical information systems used in daily operations identify and match staffing resources and
client assignments and perform billing  and accounts receivable  functions.  Our information  systems are
protected through physical and software  safeguards and we have backup  remote processing capabilities.
However, they are still vulnerable to fire, storm, flood, power loss, telecommunications failures, physical
or software break-ins and similar events. In the event  that  critical information  systems fail or are
otherwise unavailable, these functions would  have to be accomplished manually,  which could
temporarily impact our ability to identify business opportunities quickly, to maintain billing and clinical
records reliably and to bill for services  efficiently.

If regulations that apply to us change, we  may  face increased costs that  reduce our revenue and
profitability.

The temporary healthcare staffing industry is regulated in  many states. In some states, firms such

as our company must be registered to establish  and  advertise as a nurse-staffing agency  or must qualify
for an exemption from registration in those  states. If we were to lose any required state licenses, we
could be required to cease operating  in those  states. The introduction of new regulatory  provisions
could substantially raise the costs associated with hiring temporary employees.  For example,  some states
could impose sales taxes or increase  sales  tax rates on temporary healthcare  staffing services. These
increased costs may not be able to be passed on  to  clients without a decrease  in demand for temporary
employees. In addition, if government  regulations were implemented that limited the  amounts  we could
charge  for our services, our profitability could  be  adversely affected.

Future changes in reimbursement trends could hamper  our clients’  ability to  pay us.

Many of our clients are reimbursed under the federal Medicare program  and state Medicaid
programs for the services they provide. In recent  years,  federal  and  state governments have made

13

significant changes in these programs that have reduced reimbursement  rates. In addition, insurance
companies and managed care organizations seek to control costs by  requiring that healthcare providers,
such as hospitals, discount their services  in exchange for exclusive or preferred participation  in their
benefit plans. Future federal and state legislation  or evolving commercial reimbursement trends may
further reduce, or change conditions for,  our  clients’ reimbursement. Limitations on reimbursement
could reduce our clients’ cash flows, hampering  their ability to pay us.

Competition for acquisition opportunities may restrict our future growth  by  limiting our ability to
make acquisitions at reasonable valuations.

Our business strategy includes increasing our market share  and presence in the  temporary
healthcare staffing industry through strategic acquisitions of companies  that complement  or enhance
our  business. We have historically faced competition  for  acquisitions. In  the future, this could limit our
ability to grow by acquisitions or could  raise the prices  of  acquisitions and  make them less accretive  to
us. In addition, restrictive covenants  in our credit facility,  including a covenant that requires us to
obtain bank approval for any acquisition over $25.0  million,  may limit our  ability to complete desirable
acquisitions. If we are unable to secure necessary  financing under  our credit facility or  otherwise, we
may be unable to complete desirable acquisitions.

We may face difficulties integrating our acquisitions  into our operations and our acquisitions may be
unsuccessful, involve significant cash  expenditures or expose us to unforeseen  liabilities.

We  continually evaluate opportunities to acquire  healthcare staffing companies and other human

capital management services companies that complement  or  enhance  our  business  and frequently have
preliminary acquisition discussions with  some of these companies.

These acquisitions involve numerous risks, including:

• potential loss of key employees or  clients of acquired companies;

• difficulties integrating acquired personnel and distinct cultures  into  our business;

• difficulties integrating acquired companies into our operating,  financial  planning and financial

reporting systems;

• diversion of management attention  from existing operations;  and

• assumption of liabilities and exposure to unforeseen liabilities of  acquired companies, including

liabilities for their  failure to comply with healthcare  regulations.

These acquisitions may also involve significant cash expenditures, debt incurrence and integration
expenses that could have a material adverse effect on our financial condition and results  of  operations.
Any acquisition may ultimately have  a  negative  impact  on our business and financial  condition.

Significant legal actions could subject  us to substantial  uninsured liabilities.

In recent years, healthcare providers  have become  subject to an increasing number of legal actions
alleging  malpractice, product liability or related legal theories. Our Company may  be  subject to liability
in such cases  even if the contribution  to  the alleged injury  was  minimal.  Many of  these actions involve
large claims and significant defense costs.  In addition, we  may  be  subject to claims related to torts or
crimes committed by our employees or temporary  staffing personnel. In some instances,  we are
required to indemnify clients against  some or  all  of  these risks. A failure  of  any of  our employees or
personnel to observe our policies and guidelines  intended to reduce  these risks, relevant client policies
and guidelines or applicable federal, state  or  local laws, rules and regulations could result  in negative
publicity, payment of fines or other damages.

A key component of our business is the credentialing process. Ultimately, any hospital or  other
health care provider is responsible for its own internal credentialing process, and  the provider makes
the hiring decision. Nevertheless, in many  situations, the provider  will be relying upon the reputation
and screening process of the Company.  Errors  in this  process, or failure  to detect a  poor  or incorrect

14

history, could have a material effect on our reputation. In addition,  we  do not have  access to all of  the
resources that are available to hospitals  to  check credentials, such as the National Practitioner Data
Bank.

To protect ourselves from the cost of  these types of claims, we maintain professional malpractice

liability insurance and general liability insurance coverage  in amounts and with deductibles that we
believe are appropriate for our operations. Our coverage is, in part,  self-insured. However, our
insurance coverage may not cover all claims against us or  continue to be available to us at  a reasonable
cost. If we are unable to maintain adequate insurance coverage, we may be exposed to substantial
liabilities.

If our insurance costs increase significantly, these incremental costs could negatively affect our
financial results.

The costs related to obtaining and maintaining professional and general liability insurance and
health insurance for healthcare providers  has been  increasing.  The  cost of our professional and general
liability insurance per FTE increased by  approximately  64%  in 2002.  The cost of our healthcare
insurance per FTE increased by approximately  21% in 2002.  If the cost  of carrying this insurance
continues to increase significantly, we  will  recognize an associated increase in costs, which  may
negatively affect our margins. This could  have an adverse impact on our  financial condition.

If we become subject to material liabilities under our  self-insured programs, our financial results may
be adversely affected.

We  provide workers compensation coverage  through a program that is  partially  self-insured. In

addition, we provide medical coverage  to  our employees through a partially self-insured preferred
provider organization. If we become  subject to substantial uninsured workers compensation or  medical
coverage liabilities, our financial results may be adversely affected.

Our clients may terminate or not renew their staffing  contracts  with us.

Our travel staffing arrangements with  clients are generally terminable upon 30 or 90 days’ notice.

We  may have fixed costs, including housing costs, associated with  terminated arrangements  that  we will
be obligated to pay post-termination.

Our clinical trials staffing business is conducted under long-term contracts with  individual clients

that may conduct numerous clinical trials.  Some  of  these long-term contracts are terminable by the
clients  without cause upon 30 to 60 days’ notice.

Our indemnity from W. R. Grace, in connection with our acquisition  of the assets of  Cross  Country
Staffing, may be materially impaired by  Grace’s  financial condition.

In connection with our acquisition from W.  R. Grace & Co. of  the assets of Cross Country
Staffing,  our predecessor, Grace agreed to indemnify  us  against damages arising out of the breach of
certain representations or warranties  of Grace, as  well as  against any liabilities retained by Grace.  In
March 2001, Grace filed a voluntary petition under Chapter 11 of the United  States Bankruptcy  Code.
This bankruptcy filing could materially  impair Grace’s obligations to indemnify us.

Our principal stockholders will be able  to  substantially influence the outcome of  all matters submitted
to our stockholders for approval, regardless  of the preferences of  other  stockholders.

Charterhouse Equity Partners III (CEP III) and investment  funds  managed by Morgan Stanley
Private Equity together own approximately 35% of our  outstanding common stock.  Accordingly, acting
together, they will be able to substantially  influence:

• the election of directors;

• management and policies; and

15

• the outcome of any corporate transaction or  other matter  submitted to our stockholders for

approval, including mergers, consolidations and the sale of  all or substantially all of our assets.

Currently, our board of directors is comprised of nine  members,  two of  whom  are designees  of

CEP III and two of whom are designees of investment funds managed by Morgan Stanley Private
Equity.  Under our stockholders’ agreement,  CEP III and the funds managed by Morgan Stanley Private
Equity each have the right to designate  two directors  for nomination to our board of directors.  This
number decreases if either CEP III or the funds  managed by Morgan Stanley Private Equity  reduce
their respective ownership by more than  50%  of  their holdings prior to our initial  public offering. Their
interests may conflict with the interests of  the other  holders of common stock.

CEP III and investment funds managed  by  Morgan Stanley Private Equity each have demand  rights  to
cause us to file a registration statement under the Securities  Act covering resales of their  stock and
sales of this stock could cause our stock price to decline.

CEP III and investment funds managed by Morgan Stanley Private Equity each have  demand
rights to cause us to file, at our expense, a registration statement under the Securities Act covering
resales of their shares. These shares represent approximately  35% of  our outstanding common stock.
These shares may also be sold under Rule  144 of the Securities  Act, depending on  their  holding  period
and subject to significant restrictions  in  the case of shares held by persons  deemed to be our affiliates.

In addition, we registered 4,398,001 shares of common  stock  for  issuance  under our stock option

plans. Options to purchase 2,937,043 shares of common stock were issued and outstanding  as of
February 28, 2003, of which, as of February 28, 2003, options  to  purchase 1,832,522 shares were vested.
Common stock issued upon exercise of stock  options, under our  benefit  plans are eligible  for resale in
the public market without restriction.

We  cannot predict what effect, if any,  market sales of shares held by any stockholder  or the

availability of these shares for future sale  will have on the market price  of our  common stock.

If provisions in our corporate documents and Delaware law delay or  prevent a change in control of our
Company, we may be unable to consummate a transaction  that our stockholders consider favorable.

Our certificate of incorporation and by-laws may discourage,  delay or prevent a merger or
acquisition involving us that our stockholders  may  consider  favorable. For  example, our certificate  of
incorporation authorizes our board of  directors  to  issue up  to  10,000,000 shares  of  ‘‘blank  check’’
preferred stock. Without stockholder  approval,  the board of directors has the authority to attach  special
rights, including voting and dividend rights, to this  preferred  stock. With  these rights, preferred
stockholders could make it more difficult for  a third party to acquire us.  Delaware law may also
discourage, delay or prevent someone  from acquiring or merging with us.

ITEM 2. PROPERTIES

We  do not own any real property. Our principal leases are listed below.

Location

Function

Square Feet

Lease Expiration

Boca Raton, Florida . . . . . . . . . . . Headquarters
Malden, Massachusetts . . . . . . . . .

Clayton, Missouri . . . . . . . . . . . . .

Tampa, Florida . . . . . . . . . . . . . . .

Staffing administration and
general office use
Search and recruitment
headquarters
Staffing administration and
general office use

70,406
30,462

April 30, 2008
June  30, 2005

20,539

November 30,  2008

17,880

December 31, 2007

Atlanta, Georgia . . . . . . . . . . . . . . Consulting headquarters
Durham, North Carolina . . . . . . . . Clinical research and trials

13,348
12,744

August 31, 2005
December 31, 2004

staffing headquarters

16

ITEM 3. LEGAL PROCEEDINGS

We  are not presently a party to any material legal proceedings.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

There were no matters submitted to a vote of security holders  during the fourth quarter of 2002.

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY AND  RELATED  STOCKHOLDER

MATTERS

Our common stock commenced trading on the Nasdaq National  Market under the symbol
‘‘CCRN’’ on October 25, 2001. The following  table  sets forth, for the  periods indicated, the high  and
low closing sale prices per share of common stock on the Nasdaq National Market. (Such  prices reflect
inter-dealer prices, without retail mark-up,  mark-down or  commission and may not represent actual
transactions.)

Calendar Period

Closing
Sale Prices

High

Low

2001
Quarter Ended December 31, 2001 (from October 25, 2001) . . . . . . . . . . . .

$28.00

$20.00

2002
Quarter Ended March 31, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Quarter Ended June 30, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Quarter Ended September 30, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Quarter Ended December 31, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$30.97
$38.86
$36.51
$16.80

$21.13
$27.50
$12.31
$10.40

2003
Quarter  Ended  March  31,  2003  (through  March  25,  2003) . . . . . . . . . . . . . .

$12.00

$ 9.98

As of March 7, 2003, there were approximately 132 stockholders of record  of  our  common stock.
In addition, there are approximately 5,100  beneficial owners  of our  common stock held by brokers or
other institutions on behalf of stockholders.

We  have never paid or declared cash dividends on our  common stock. We currently intend to use

available cash from operations for use in  the operation  and expansion of our business or  to  retire  debt,
to repurchase our common stock or  to  possibly pay cash dividends. Covenants  in our credit  facility  limit
our  ability to repurchase our common  stock and declare  and pay  cash dividends on our common stock.

During  2002, we granted options to purchase a total of  53,279  shares of  common stock to
employees, including certain senior managers, at  a weighted average exercise  price of approximately
$17.89 per share. Such grants were deemed exempt from registration under the Securities Act in
reliance on either: (1) Rule 701 promulgated under the Securities Act  as offers  and sales of securities
pursuant to certain compensatory benefit  plans and contracts relating to compensation in compliance
with Rule 701; or (2) Section 4(2) of  the Securities Act, including Regulation  D thereunder, as
transactions by an issuer not involving  any public offering.

17

With respect to equity compensation plans as of December 31, 2002, see table  below:

Number of securities to be
issued upon exercise of
outstanding options,
warrants and rights
(a)

Weighted-average
exercise  price of
outstanding options,
warrants and  rights
(b)

Number of securities
remaining available for
future issuance under
equity compensation  plans
(excluding securities
reflected in column (a))
(c)

Plan Category

Equity compensation plans

approved by security holders . . .

2,974,983

Equity compensation plans not

approved by security holders . . .

None

Total

. . . . . . . . . . . . . . . . . . . .

2,974,983

$13.50

N/A

$13.50

948,025

N/A

948,025

ITEM 6. SELECTED FINANCIAL  DATA

The selected consolidated financial data as  of December  31, 2002 and 2001 and for the years

ended December 31, 2002, 2001 and 2000 are derived from the audited consolidated financial
statements of Cross Country, Inc. included elsewhere in this report. The  selected consolidated financial
data as of December 31, 2000, and for the  five-month period July 30, 1999  to  December 31, 1999, are
derived from the audited consolidated financial  statements of  Cross Country, Inc. that have been
audited but not included in this report.  The selected consolidated financial data as  of December 31,
1998 and July 29, 1999 and for the year ended December  31, 1998 and for the seven-month  period
January 1, 1999 to July 29, 1999 have  been  derived from the audited  financial statements of Cross
Country Staffing, our predecessor, that  have been audited but not included in this report.

The following selected financial data should  be  read in conjunction with the consolidated financial

statements and related notes of Cross Country, Inc., and  Cross Country Staffing, ‘‘Management’s
Discussion and Analysis of Financial Condition and Results  of  Operations’’  and other financial
information included elsewhere in this  report.

18

Years Ended December 31,

Predecessor (a)

Period from Period from
January 1
through
July  29,

July 30
through
December 31,

Year Ended
December  31,

2002

2001

2000

1999(b)

1999

1998

(Dollars in thousands, except share and per  share data)

Consolidated Statement of Operations Data
Revenue  from  services
Operating expenses:

. . . . . . . . . . . . . . . . . $ 639,953 $ 504,364 $ 368,332

$

87,727

$106,047

$158,592

273,094
49,594
433
1,324
13,624
—
1,289

339,358

28,974

15,435
—

13,539
(6,807)

6,732

(1,680)
(454)

4,598

Direct  operating expenses . . . . . . . . . . . . . .
Selling,  general and administrative expenses (c)
Bad debt  expense . . . . . . . . . . . . . . . . . . .
Depreciation . . . . . . . . . . . . . . . . . . . . . .
Amortization . . . . . . . . . . . . . . . . . . . . . .
Non-recurring secondary offering costs (d) . . .
Non-recurring indirect transaction costs (e) . . .

Total operating expenses . . . . . . . . . . . . . . .

Income from operations
Other expense:

. . . . . . . . . . . . . . . .

Interest  expense, net
. . . . . . . . . . . . . . . . .
Other expense . . . . . . . . . . . . . . . . . . . . .

Income from continuing operations before

478,550
94,930
242
3,524
3,148
886
—

581,280

58,673

3,753
—

377,291
68,560
1,274
2,700
14,851
—
—

464,676

39,688

14,422
—

income taxes . . . . . . . . . . . . . . . . . . . . . .
Income tax expense (f) . . . . . . . . . . . . . . . . .

54,920
(21,254)

25,266
(10,862)

Income (loss) from continuing operations
Discontinued operations, net of income tax

. . . . .

33,666

14,404

benefit:
Loss from discontinued operations (g) . . . . . .
. . . . . . . . . . . . . . . . .
Loss on disposal (g)

Net income  (loss) before extraordinary item . . . .
Extraordinary loss on early extinguishment of

debt,  net of  income tax benefit (h) . . . . . . . .

(3,883)
—

29,783

(741)
(207)

13,456

—

(4,784)

—

Net income  (loss)

. . . . . . . . . . . . . . . . . . . . $

29,783 $

8,672 $

4,598

Net income  (loss) per common share—basic (i):

Income (loss) from continuing operations . . . . $
Discontinued operations . . . . . . . . . . . . . . .

1.04 $
(0.12)

Net income  (loss) before extraordinary item . . . .
Extraordinary loss on early extinguishments of

debt . . . . . . . . . . . . . . . . . . . . . . . . . . . .

0.92

—

0.58 $
(0.04)

0.54

(0.19)

Net income  (loss)

. . . . . . . . . . . . . . . . . . . . $

0.92 $

0.35 $

0.29
(0.09)

0.20

—

0.20

Net income  (loss) per common share—diluted (i):

Income (loss) from continuing operations . . . . $
Discontinued operations . . . . . . . . . . . . . . .

1.00 $
(0.12)

0.57 $
(0.04)

0.29
(0.09)

Net income  (loss) before extraordinary item . . . . $
Extraordinary loss on early extinguishments of

debt . . . . . . . . . . . . . . . . . . . . . . . . . . . .

0.88 $

0.53 $

—

(0.19)

Net income  (loss)

. . . . . . . . . . . . . . . . . . . . $

0.88 $

0.34 $

0.20

—

0.20

$

$

$

$

$

$

68,036
9,257
511
155
4,422
—
—

82,381

5,346

4,821
—

525
(672)

(147)

(195)
—

(342)

—

80,187
12,688
157
212
496
—
—

93,740

12,307

230
190

11,887
—

11,887

—
—

121,951
19,070
722
264
859
—
—

142,866

15,726

850
183

14,693
—

14,693

—
—

11,887

14,693

—

—

(342)

$ 11,887

$ 14,693

(0.01)
(0.01)

(0.02)

—

(0.02)

(0.01)
(0.01)

(0.02)

—

(0.02)

Weighted-average common shares outstanding:

Basic . . . . . . . . . . . . . . . . . . . . . . . . . . . 32,432,026 24,881,218 23,205,388
Diluted . . . . . . . . . . . . . . . . . . . . . . . . . . 33,653,433 25,222,936 23,205,388

15,291,749
15,291,749

Other Operating Data
Adjusted EBITDA (j) . . . . . . . . . . . . . . . . . . $
Adjusted EBITDA as % of revenue . . . . . . . . .
FTE’s  (k) . . . . . . . . . . . . . . . . . . . . . . . . . .
Weeks worked  (l) . . . . . . . . . . . . . . . . . . . . .
Average  healthcare staffing revenue per FTE per

week (m)

. . . . . . . . . . . . . . . . . . . . . . . . $
Net cash flow provided by operating activities . . . $
Net cash flow (used in) provided by investing

66,231 $
10.3%
5,535
287,820

57,239 $
11.3%
4,816
250,432

45,211

$

12.3%
4,167
216,684

9,923
11.3%
2,789
61,358

$ 13,015

$ 16,849

12.3%
2,466
73,980

10.6%

2,264
117,728

2,046 $
41,421 $

1,865 $
19,795 $

1,619
11,594

$
$

$

$

1,417
6,301

$
1,429
$ 12,178

$
1,347
$ 14,434

1,370

$

(202)

$

(977)

(3,101)

$ (11,977)

$ (13,458)

activities . . . . . . . . . . . . . . . . . . . . . . . . . $ (18,566) $ (42,321) $ (10,781)

Net cash flow (used in) provided by financing

activities . . . . . . . . . . . . . . . . . . . . . . . . . $

(8,381) $

25,262 $

(5,641)

19

As of December 31,

As of

As of

July 29, December  31,

2002

2001

2000

1999

1999

1998

(Dollars in thousands)

Consolidated Balance Sheet Data
Working capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 78,148 $ 72,732 $ 36,436 $ 33,998 $ 9,752
Cash and  cash  equivalents . . . . . . . . . . . . . . . . . . . . . . . .
—
44,464
Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Total debt
7,874
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
19,466
Stockholders’  equity (n) . . . . . . . . . . . . . . . . . . . . . . . . . .

2,736
361,980
48,865
269,927

17,210
390,600
42,815
300,832

—
317,626
157,272
123,340

4,828
309,695
159,074
118,742

$12,871
—
41,901
13,173
13,451

(a) On July 29,  1999, we acquired the assets of Cross Country Staffing, which, for accounting and reporting purposes, is our

predecessor. Financial data for the period prior to July 30,  1999 is that of Cross Country Staffing.

(b) Includes TravCorps results from December 16, 1999, the date of  its acquisition, through December 31, 1999.

(c)

Includes expenses related to a discontinued management incentive  compensation plan of $2.1 million for the seven-month
period  January 1-July 29, 1999. The management incentive  compensation plan was discontinued on July 30, 1999.

(d) Non-recurring secondary offering costs were $0.9 million, all relating to expenses incurred as a result of our secondary

offering in March 2002. We did not receive any proceeds  from this offering and, accordingly, did not capitalize any of the
associated costs.

(e) Non-recurring indirect transaction costs consist of non-capitalizable transition bonuses and integration costs related to the

TravCorps acquisition and expenses related to this transaction.

(f) Prior to July 30, 1999, our predecessor, Cross Country Staffing, operated as a partnership under the applicable provisions of
the Internal Revenue Code, and, accordingly, income  related to the operations of Cross Country Staffing was taxed directly
to its  partners.

(g) Reflects the operating results of HospitalHub, Inc. and E-Staff, Inc. HospitalHub began operations in 1999. We completed
the divestiture of HospitalHub, Inc. during the second  quarter of 2001. In March, 2002, we committed to a formal plan to
dispose  of E-Staff, Inc.

(h) Extraordinary loss on early extinguishment of debt consists  of a  $1.6 million prepayment penalty from the early redemption
of  the subordinated pay-in-kind notes and the write-off of  $6.4 million of debt issuance costs related to the repayment of
borrowings  under our credit facility, net of applicable  taxes.

(i) The  financial data contained herein for periods prior  to  July 30, 1999, is that of our predecessor, Cross Country Staffing, a

partnership, for which share and per share amounts were  not applicable.

(j) We define Adjusted EBITDA as income before interest, income  taxes, depreciation, amortization, non-recurring secondary
offering costs and non-recurring indirect transaction costs. Adjusted  EBITDA should not be considered a measure of
financial performance under generally accepted accounting principles. Items excluded from Adjusted EBITDA are significant
components in understanding and assessing financial  performance. Adjusted EBITDA is a key measure used by management
to evaluate  our operations and provide useful information to investors. Adjusted EBITDA should not be considered in
isolation or as an alternative to net income, cash flows  generated from operating, investing or financing activities, or other
financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity.
Because  Adjusted EBITDA is not a measurement determined  in accordance with generally accepted accounting principles
and is thus susceptible to varying calculations, Adjusted  EBITDA as presented may not be comparable to other similarly
titled measures of other companies.

(k) FTE’s represent the average number of contract staffing personnel on a full-time equivalent basis.

(l) Weeks worked is calculated by multiplying the FTE’s by the number of weeks during the respective period.

(m) Average healthcare staffing revenue per FTE per week is  calculated by dividing the healthcare staffing revenue by the

number of weeks worked in the respective periods.  Healthcare staffing revenue includes revenue from permanent placement
of  nurses.

(n) Consists of partners’ capital for periods prior to July 30, 1999, since our predecessor, Cross Country Staffing, was a

partnership.

20

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION  AND

RESULTS OF OPERATIONS

The following discussion and analysis  of our financial condition and results  of operations  should  be
read in conjunction with Selected Financial and Other Data and our  consolidated financial statements  and
the accompanying notes that appear elsewhere in  this annual report on Form 10-K.

Certain prior year information has been reclassified to conform  to the current  year’s  presentation.

Overview

We are one of the largest providers of healthcare staffing services in the United States. Our
healthcare staffing business segment, which represents approximately 92% of our revenue, is comprised
of travel  nurse and allied health staffing, per diem nurse staffing and clinical research trials  staffing.
Approximately 80% of our revenue is derived from travel nurse  staffing  services.  Our other staffing
services include the placement of allied healthcare professionals, such as radiology technicians,
rehabilitation therapists and respiratory therapists, and  the placement of clinical research professionals.
Our other human capital management services business segment, which  represents approximately  8% of
our revenues, consists of education and training, healthcare consulting, and physician  search  services.
For the year ended December 31, 2002, our revenue and  income before interest, income taxes,
depreciation, amortization, non-recurring secondary offering costs and non-recurring indirect
transaction  costs  as  shown  on  the  consolidated  statement  of  operations  (Adjusted  EBITDA)  were
$640.0 million and $66.2 million, respectively.

History

In July 1999, an affiliate of Charterhouse Group  International, Inc. and certain members  of
management acquired the assets of Cross Country Staffing, our  predecessor, from W.  R. Grace & Co.
Upon the closing of this transaction, we changed from a partnership to a C corporation  form of
ownership. In December 1999, we acquired TravCorps Corporation  (TravCorps), which  was  owned by
investment funds managed by Morgan Stanley  Private Equity and certain members  of  TravCorps’
management and subsequently changed  our name to Cross Country  TravCorps, Inc.  In May 2001,  we
changed our name to Cross Country, Inc.

Revenue

Our travel and per diem nurse staffing revenue  is received primarily from  acute care  hospitals. Our

clinical trials staffing revenue is received  primarily from pharmaceutical  and  biotechnology  companies,
as well as medical device manufacturers.  Revenue  from allied  health  staffing services  is received from
numerous sources, including providers of radiation, rehabilitation  and respiratory services at  hospitals,
nursing homes, sports medicine clinics and schools. Revenue from our search and recruitment,
consulting and education and training  services is received  from  numerous sources, including hospitals,
physician group practices, insurance companies and individual healthcare  professionals.  Our fees are
paid directly by our clients rather than by government or  other third-party  payors.

During 2002, we adopted the provisions of the Financial Accounting  Standard Board’s (FASB)

Emerging Issues Task Force (EITF) Issue  No. 01-14, Income Statement Characterization of
Reimbursements Received for ‘‘Out-of-Pocket’’ Expenses  Incurred. This EITF requires that
reimbursements  received  for  out-of-pocket  expenses  should  be  characterized  as  revenue  and  a
corresponding expense in the consolidated statements of operations. Prior to the adoption of this EITF,
we reflected the reimbursement of out-of-pocket expenses as an offsetting reduction to direct  operating
expenses and selling, general, and administrative expenses.  Accordingly, we have  adjusted all periods
reported to reflect an increase in revenue, and an equal and offsetting increase  in expenses, related to

21

reimbursable expenses. This change in  classification has not had an effect  on current  or previously
reported net income, or net income per share.

Revenue is recognized when services  are rendered. Accordingly, accounts  receivable includes an

accrual  for employees’ time worked but  not yet  invoiced. Similarly,  accrued  compensation includes an
accrual  for employees’ time worked but  not yet  paid. Each  of  our field  employees on travel assignment
works for us under a contract. These contracts  typically last 13  weeks. Payroll  contract employees are
hourly employees whose contract specifies  the hourly  rate they will be paid, including applicable
overtime, and any other benefits they are entitled to receive  during the contract period.  For payroll
contract employees, we bill clients at an hourly  rate and assume all employee  costs, including payroll,
withholding taxes, benefits and professional  liability  insurance and Occupational  Safety and Health
Administration, or OSHA, requirements,  as well as any travel  and  housing arrangements. Mobile
contract employees are hourly employees of the hospital  client and receive  an agreement that specifies
the hourly rates they will be paid by  the  hospital employer,  as well  as any benefits they are  entitled to
receive from us. For mobile contract  employees, we provide  recruitment, housing  in apartments leased
by us and travel reimbursement. Our  contract with the healthcare professional obligates us  to  provide
these services to the healthcare professional.  We are  compensated for the services  we provide at a
predetermined rate negotiated with our  hospital client,  without regard to the our cost  of providing
these services. Currently, approximately 99%  of our employees work under  payroll contracts.

Our healthcare staffing revenue and  earnings are impacted by the relative supply  of and  demand
for nurses at healthcare facilities. We  rely significantly on  our ability to recruit and retain  nurses and
other healthcare personnel who possess the  skills, experience  and, as  required,  licensure  necessary  to
meet the specified requirements of our clients. Shortages  of  qualified nurses and other healthcare
personnel could limit our ability to fill  open assignments  and grow our  revenue and net income.

The relative demand for our services  at client’s facilities may also affect the  profitability of our
business. Of late, many hospitals have  taken nurse  staffing  actions that have decreased demand,  which
we believe has temporarily slowed our  rate of revenue growth  during  the later  part of 2002. We believe
these decisions have resulted in increased reliance on  staff  nurse overtime, increased patient-to-nurse
ratios and high wage and compensation increases, including sign-on  bonuses, by the hospitals.  We also
believe that, due to present economic  conditions, where many nurse’s spouses have been laid off and
severance and unemployment benefits  have ended, many  part-time  nurses employed directly by
hospitals who would have typically worked two shifts or less per week  have increased  the number  of
shifts worked at their hospitals; and are doing  so at the prevailing  hospital wage. Other factors that
affect the demand for our services are  patient occupancy  rates. As occupancy increases,  temporary
employees are often added before full-time employees are hired. As occupancy  decreases, clients tend
to reduce their use of temporary employees  before  undertaking layoffs of their regular employees.
Additionally, we may experience more  competitive pricing pressure during these periods of decreased
demand.

22

Acquisitions

The following table provides certain information relating to our acquisitions to date:

Acquired Business

Acquisition Date Primary  Services

Purchase Price(a)

Potential
Earnout

Earnout Earned
to date

Jennings, Ryan  & Kolb,

March 2002

Inc. . . . . . . . . . . . . . .

Healthcare management
consulting services

$ 2.1 million

$1.8 million
over  34 months

$0.5 million

NovaPro . . . . . . . . . . . . January 2002

Nurse staffing

$ 7.6 million

—

—

Gill/Balsano Consulting,

May 2001

LLC. . . . . . . . . . . . . .

Healthcare management
consulting services

$ 1.8 million

$2.0 million
over  3 years

$1.2 million

ClinForce, Inc.

. . . . . . . . March 2001

Clinical trials staffing

$32.8 million

—

—

Heritage  Professional

Education, LLC . . . . . . December 2000 Continuing education for

$ 6.6 million

E-Staff  (Discontinued

in  2002) . . . . . . . . . . . July 2000

healthcare professionals

Internet subscription based
communication, scheduling,
credentialing and training
services

$6.5  million
over  3 years

$3.5 million

$ 1.5 million

$3.8  million(b)
over 3 years

$0.5 million

TravCorps Corporation . . . December 1999 Healthcare staffing- allied

$77.1 million

—

—

and nurse professionals

(a) Acquisition purchase price includes cash paid, the assumption of  debt and post-closing adjustments. The Travcorps

acquisition  price represents the approximate value of  our common stock that was exchanged for all the outstanding shares  of
Travcorps—$32.1 million, plus the assumption of $45.0  million of  debt.

(b) Due to the discontinuance of the E-Staff business we do not expect additional earnout payments to be made.

Discontinued Operations

In March 2002, we committed to a formal plan to dispose of our subsidiary, E-Staff,  through a sale

of this business. E-Staff was previously included in  our other  human capital  management services
segment. E-Staff is an application service provider  that has developed an  internet subscription based
communication, scheduling, credentialing  and training service  business  for  healthcare providers. As  an
application service provider, E-Staff maintains a database of the client’s  employees on E-Staff’s servers,
and prospective E-Staff clients were concerned about  placing  their health care  employees names  and
credentials on servers owned or controlled  by one of the nation’s  largest healthcare  staffing companies.
Accordingly, we decided to sell this subsidiary. Pursuant to FASB Statement No. 144,  our consolidated
financial statements have been reclassified to reflect the discontinuance of E-Staff. The costs  and
expenses, assets and liabilities of E-Staff  have been  segregated and  reported as  discontinued operations
in the consolidated balance sheets and  statements of operations.

In December 2000, we committed to  a formal plan to divest  HospitalHub, Inc., or  HospitalHub,

our  electronic job  board business, which began operations  in 1999.  The  operating results of
HospitalHub have been accounted for  as discontinued operations in our  consolidated financial
statements and notes thereto and in the  other financial information included  herein.  We completed the
divestiture of HospitalHub in the second  quarter of 2001.

Goodwill and Other Identifiable Intangible Assets

Goodwill and other identifiable intangible assets from the acquisition of the assets of  our

predecessor, Cross Country Staffing, a Partnership, and from subsequent acquisitions were

23

$226.1 million and $22.9 million, respectively,  at December 31, 2002. We  adopted the provisions of
FASB No. 142, Goodwill and Other Intangible Assets, as of January 1, 2002. Accordingly,  goodwill  and
certain other identifiable intangible assets  are no longer subject to amortization.  Instead, we  review
impairment annually. Other identifiable intangible assets, which are subject to amortization, are being
amortized using the straight-line method over their estimated useful lives  ranging from  3 to 15 years.
Goodwill and other intangible assets represented  82.8% of our  stockholders’  equity as of December 31,
2002. The amount of definite-lived intangible assets  amortized  equaled  4.6% of our income from
operations for the year ended December  31, 2002.

Results of Operations

The following table summarizes, for  the periods indicated, selected statement of operations data

expressed as a percentage of revenue:

Year Ended December 31,

2002

2001

2000

Revenue from services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Direct  operating expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Selling, general and administrative expenses . . . . . . . . . . . . . . . . .
Bad debt expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

100.0% 100.0% 100.0%
74.8
74.8
13.6
14.8
0.3
0.1

74.1
13.5
0.1

Adjusted EBITDA (a) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Depreciation and amortization . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-recurring secondary offering and indirect transaction  costs . . .

Income from operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Income from continuing operations before  income  taxes . . . . . . . .
Income tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Income from continuing operations . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations, net of income taxes . . . . . . . .
Loss on disposal of discontinued operations, net of  income taxes . .

Net income before extraordinary item . . . . . . . . . . . . . . . . . . . . .
Extraordinary loss on early extinguishment of  debt . . . . . . . . . . . .

10.3
1.0
0.1

9.2
0.6

8.6
(3.3)

5.3
(0.6)
—

4.7
—

11.3
3.4
—

7.9
2.9

5.0
(2.1)

2.9
(0.2)
(0.0)

2.7
(1.0)

12.3
4.1
0.3

7.9
4.2

3.7
(1.9)

1.8
(0.4)
(0.1)

1.3
—

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

4.7% 1.7% 1.3%

(a) We define Adjusted EBITDA as income before interest, income taxes, depreciation, amortization,
non-recurring secondary offering costs and non-recurring indirect transaction costs. Adjusted
EBITDA should not be considered a  measure of financial performance under generally accepted
accounting principles. Items excluded from Adjusted EBITDA are significant components in
understanding and assessing financial performance. Adjusted  EBITDA is  a key measure used by
management to evaluate our operations and provide useful information to investors. Adjusted
EBITDA should not be considered in isolation or as an alternative to net  income,  cash flows
generated by operations, investing or financing activities, or other financial  statement  data
presented in the consolidated financial statements as  indicators of financial  performance or
liquidity. Because Adjusted EBITDA is  not  a measurement determined in accordance with
generally accepted accounting principles and is thus susceptible to varying calculations, Adjusted
EBITDA as presented may not be comparable to other similarly  titled measures of other
companies.

24

Segment Information

The following table presents, for the periods indicated, selected  statement of operations data by

segment:

Revenue (a):

Year Ended December 31,

2002

2001

2000

(dollars in thousands)

Healthcare staffing . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other  human capital management services . . . . . . . . . . . .

$588,743
51,210

$466,986
37,378

$350,856
17,476

$639,953

$504,364

$368,332

Contribution income (b):

Healthcare staffing . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other  human capital management services . . . . . . . . . . . .
Unallocated corporate overhead . . . . . . . . . . . . . . . . . . . . .

$ 81,160
6,521
(21,450)

$ 70,853
4,701
(18,315)

$ 61,937
1,315
(18,041)

Adjusted EBITDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 66,231

$ 57,239

$ 45,211

(a) We adopted EITF Issue No. 01-14,  which states  that reimbursements received for  out-of-pocket
expenses should be characterized as revenue in the income  statement. This required certain
reclassifications of our revenue, cost  of  sales  and selling, general and administrative expenses. This
change has been reflected in all periods presented.

(b) We define contribution income as  earnings before interest, income taxes, depreciation,

amortization and corporate expenses not specifically identified to a reporting segment. During the
year ended December 31, 2002 we refined our methodology for allocating corporate overhead
expenses to our segments to more accurately reflect  the profitability  of  each  segment. Certain prior
year segment data has been reclassified to reflect this improvement in the allocation  methodology.
Segment information for 2000 was not  reclassified as  it would not  have provided meaningful
comparisons. This change in the allocation  of  overhead expenses  does not impact prior  year
consolidated financial statements. Additionally, E-Staff, which was previously included  in other
human capital management services,  has been included in discontinued operations.

Year Ended December 31, 2002 Compared  to  Year Ended December 31, 2001

Revenue for the year ended December  31, 2002 totaled $640.0 million  as compared  to
$504.4 million for the year ended December 31, 2001.  Comparisons include revenue  from the
acquisitions in 2002 and 2001. Excluding  the effects of these acquisitions,  revenue  for 2002 increased
19.1% as compared with the year ended December  31, 2001.

Revenue from our healthcare staffing  segment for the year  ended  December 31, 2002 totaled

$588.7 million as compared to $467.0  million for the year ended December 31, 2001. Revenue  from
NovaPro, acquired in January 2002, and a full  year’s  revenue,  rather than 91⁄2 months of revenue from
ClinForce in 2001 (as ClinForce was  acquired on March  16, 2001) was included in 2002.  Excluding  the
effects of these acquisitions, revenue increased $88.6, million or  19.0%,  as compared  with 2001 revenue.
The increase was attributable to a higher  average hourly bill  rate in all  businesses and an increase in
the numbers of field employees in our  nurse staffing  and  allied health  staffing businesses, offset  in part
by a modest reduction in the hours billed per FTE per week. The average number of hours worked per
week per FTE continued to decrease in  2002 primarily as  a result of  an increase in the number of
nurses working three 12-hour shifts rather than five 8-hour shifts. For the year ended  December 31,
2002, 86.8% of our healthcare staffing revenue  was generated by nurse staffing operations and 13.2%
was generated by other operations. For  the year ended December 31, 2001, 86.5% of our healthcare

25

staffing revenue was generated by nurse staffing operations and 13.5% was generated by other
operations.

Revenue from our other human capital management services segment  for the  year  ended

December 31, 2002 totaled $51.2 million as compared to $37.4 million for the  year ended
December 31, 2001. Revenue in 2002  included JRK, which was acquired March 1,  2002, and  3 months
more of Gill/Balsano, which was acquired  on April  1, 2001. Excluding the  effects of these acquisitions,
revenue increased $7.8 million, or 20.8%, as  compared with  the year ended December 31, 2001.  This
increase is primarily due to an increase  in  revenues from  our educational seminars business. Revenue
from the educational seminars business increased due  to  an increase in number  of seminars conducted
and the number of attendees, partially  offset by a lower average price per seminar.

Direct  operating expenses are comprised  primarily of  field employee compensation  expenses,
housing expenses, travel expenses and  field insurance  expenses. Direct operating expenses totaled
$478.6 million for the year ended December 31, 2002  as compared  to  $377.3 million for  the year  ended
December 31, 2001. As a percentage of revenue,  direct operating expenses  represented  74.8% of
revenue for the years ended December 31, 2002 and 2001.

Selling, general and administrative expenses  for the  year ended December  31, 2002 totaled
$94.9 million as compared to $68.6 million for the year ended December  31, 2001. As a  percentage of
revenue, selling, general and administrative expenses represented 14.8% of revenue for the year ended
December 31, 2002 compared with 13.6% for the  year  ended December 31, 2001. This increase  is
primarily due to increased expenses in our healthcare staffing business. In  2002, we  invested  in our
centralized per diem and international  recruitment business and  hired additional  recruiters for our core
travel nurse staffing business.

Bad debt expense for the year ended December  31, 2002  totaled $0.2 million as compared  to
$1.3 million for the year ended December 31, 2001.  As a percentage  of  revenue, bad debt expense
represented 0.1% of revenue for 2002 compared  with 0.3% for 2001.  This  decrease was due to
improved collections coupled with a decrease in write-offs.

Adjusted EBITDA, as a result of the  above, totaled $66.2 million for the year ended  December 31,

2002 as compared to $57.2 million for  the year ended  2001. As a percentage of  revenue, Adjusted
EBITDA represented 10.3% of revenue  for  the year  ended December  31, 2002  compared with  11.3%
for the year ended December 31, 2001.

Depreciation and amortization expense for the year ended December 31,  2002 totaled $6.7 million

as compared to $17.6 million for the year ended December 31,  2001. As a  percentage of revenue,
depreciation and amortization expense declined to 1.0% for the year ended December 31,  2002 from
3.4% for the year ended December 31, 2001. This  decrease  was primarily due to a decrease  in
amortization of intangibles as a result  of  the adoption of FASB  Statement No.  142 in January  2002 and
the write-off of $6.4 million of debt issuance costs  in October 2001 as  a  result of  our initial public
offering. FASB Statement No. 142 promulgates  that  goodwill and  certain  intangible assets that have
indefinite lives should not be amortized.  Instead, goodwill and certain intangible assets are reviewed
annually for impairment. No impairment  charges were  necessary as  of December 31, 2002.

Non-recurring secondary offering costs for the year ended  December 31,  2002 were $0.9 million,

all relating to expenses incurred as a result of our secondary offering in  March 2002. We did not
receive any proceeds from this offering  and,  accordingly, did not  capitalize any  of the associated costs.

Income from operations for the year  ended December 31, 2002  totaled $58.7 million  as compared

to $39.7 million for the year ended December 31, 2001. As  a  percentage of  revenue, income from
operations represented 9.2% of revenue for the year ended December 31,  2002 compared with 7.9%
for the year ended December 31, 2001.

26

Net interest expense for the year ended December  31, 2002 totaled  $3.8 million as compared  to
$14.4 million for the year ended December 31, 2001.  The decrease in  2002 was primarily due to the
repayment of approximately $134.5 million  of  debt  with the proceeds received from our initial  public
offering of common stock in October 2001.

Income from continuing operations before  income  taxes for the year ended December 31, 2002

totaled $54.9 million as compared to $25.3 million for the year ended December 31,  2001.

Income tax expense for the year ended December  31, 2002 was $21.3 million as compared  to
$10.9 million for the year ended December 31, 2001.  The Company’s effective  tax rate was 38.7%  for
the year ended December 31, 2002 and 43.0%  for  the year ended December 31, 2001.  The  tax rate has
been impacted by our adoption of FASB  Statement No. 142. Certain  non-tax deductible intangible
assets, which were being amortized for  financial reporting purposes  during the year ended
December 31, 2001, were not amortized during the year ended December 31, 2002. The tax  treatment
of these  intangible assets remained the same.  Accordingly, the effective tax  rate was lower during the
year ended December 31, 2002.

As a result of the above, income from continuing  operations totaled $33.7 million, or $1.00  per
diluted share, for the year ended December 31, 2002  as compared  to  $14.4 million, or $0.57 per diluted
share for the year ended December 31,  2001.

Losses from discontinued operations, net  of income tax  benefits, for the years ended  December 31,
2002 and December 31, 2001, were $3.9 million and $0.9  million, respectively. Losses from discontinued
operations in the year ended December  31, 2002 include E-Staff’s results of  operations and an
impairment charge of $2.5 million after-taxes relating to the development  of  our  E-Staff technology, a
web-enabling scheduling business. Losses  in the year ended  December  31, 2001 include the  results of
operations of E-Staff and adjustments  to  the estimated loss  on disposal of the HospitalHub  business,
which  was sold in June 2001.

Net income for the year ended December 31,  2002 totaled $29.8 million, or  $0.88 per diluted
share, as compared to $8.7 million, or $0.34 per diluted share for the year ended  December 31,  2001.

Year Ended December 31, 2001 Compared  to  Year Ended December 31, 2000

Revenue for the year ended December  31, 2001 totaled $504.4 million  as compared  to

$368.3 million for the year ended December 31, 2000.  Revenue included from  ClinForce and Heritage,
which  were acquired on March 16, 2001  and  December 26,  2000, respectively, totaled $43.7 million for
the year ended December 31, 2001. Excluding  the effects of these acquisitions, revenue increased
25.1%, as compared with the year ended December  31, 2000.

Revenue from our healthcare staffing  segment for the year  ended  December 31, 2001 totaled
$467.0 million as compared to $350.9  million for the year ended December 31, 2000. Revenue  included
from ClinForce totaled $28.8 million for  the year  ended December  31, 2001.  Excluding the  effect of
this  acquisition, revenue increased $87.3  million or  24.9%, as compared  with 2000 revenue. The
increase was attributable to a higher average hourly bill rate in  all businesses and increased numbers of
field employees in both the travel nursing  and  allied  health  staffing  businesses, offset in part by a
modest reduction in the hours billed  per  FTE  per  week. The  average number of hours worked  per
week per FTE decreased primarily as  a  result of an  increase in the  number of nurses working three
12-hour shifts rather than five 8-hour shifts. For the year ended December 31,  2001, 86.5% of our
healthcare staffing revenue was generated  by nurse staffing operations and 13.5% was  generated by
other operations. For the year ended  December 31,  2000, 92.7% of our  healthcare staffing  revenue was
generated by  nurse staffing operations and  7.3% was generated by  other operations.  This shift is
primarily a result of our expansion of healthcare staffing services into the clinical trials sector through
our  acquisition of ClinForce.

27

Revenue from our other human capital management services segment  for the  year  ended

December 31, 2001 totaled $37.4 million as compared to $17.5 million for the  year ended
December 31, 2000. Revenue included from Heritage totaled $14.9 million  for the  year  ended
December 31, 2001. Excluding the effect  of  this  acquisition, revenue increased $5.0 million, or  28.5%,
as compared with the year ended December 31,  2000. This increase is  primarily  due  to  more favorable
pricing in our physician search and existing consulting businesses, as well as our acquisition of Gill/
Balsano.

Direct  operating expenses are comprised  primarily of  field employee compensation  expenses,
housing expenses, travel expenses and  field insurance  expenses. Direct operating expenses totaled
$377.3 million for the year ended December 31, 2001  as compared  to  $273.1 million for  the year  ended
December 31, 2000. As a percentage of revenue,  direct operating expenses  represented  74.8% of
revenue for the year ended December  31, 2001 compared  with 74.1% for the  year  ended December  31,
2000. The increase in direct operating expenses as a  percent of revenue was mostly attributable to an
increase in field salaries, housing costs, and health  and professional  liability insurance, along with an
increase in the percentage of nurses  working under  staffing rather than mobile contracts. These
increases were partly offset by the relatively lower  direct operating expenses as a percent  of revenue for
each  of ClinForce and Heritage.

Selling, general and administrative expenses  for the  year ended December  31, 2001 totaled
$68.6 million as compared to $49.6 million for the year ended December  31, 2000. As a  percentage of
revenue, selling, general and administrative expenses represented 13.6% of revenue for the year ended
December 31, 2001 compared with 13.5% for the  year  ended December 31, 2000.

Bad debt expense for the year ended December  31, 2001  totaled $1.3 million as compared  to
$0.4 million for the year ended December 31, 2000.  As a percentage  of  revenue, bad debt expense
represented 0.3% of revenue for 2001 compared  with 0.1% for 2000.  This  increase is  primarily due to
an increase in the percentage of accounts receivable greater  than  90 days.

Adjusted EBITDA, as a result of the  above, totaled $57.2 million for the year ended  December 31,
2001 as compared to $45.2 million for  the year ended  December  31, 2000. As  a percentage  of  revenue,
Adjusted EBITDA represented 11.3% of revenue for the year ended December 31,  2001 compared
with 12.3% for the year ended December  31, 2000.

Depreciation and amortization expense for the year ended December 31,  2001 totaled

$17.6 million as compared to $14.9 million for the year ended December  31, 2000. The increase in
depreciation and amortization expense in  2001 was due primarily to increased amortization of goodwill
and other intangibles resulting from  the  Heritage  and  ClinForce acquisitions.  As a  percentage of
revenue, depreciation and amortization expense represented 3.4% of revenue for 2001 compared with
4.1% for the year ended December 31, 2000.

Non-recurring indirect transaction costs totaled $1.3 million  for  the year ended December 31, 2000,

which  consisted primarily of transition bonuses related to the TravCorps acquisition.

Income from operations for the year  ended December 31, 2001  totaled $39.7 million  as compared

to $29.0 million for the year ended December 31, 2000. As  a  percentage of  revenue, income from
operations represented 7.9% of revenue for the years ended December 31,  2001 and  2000.

Net interest expense for the year ended December  31, 2001 totaled  $14.4 million as compared  to

$15.4 million for the year ended December 31, 2000.  The decrease in  2001 was primarily due to the
repayment of approximately $134.5 million  debt with the proceeds received from our initial public
offering of common stock in October 2001  and  a decrease in  interest rates.

Income from continuing operations before  income  taxes for the year ended December 31, 2001

totaled $25.3 million as compared to $13.5 million for the year ended December 31,  2000.

28

Income tax expense for the year ended December  31, 2001 was $10.9 million as compared  to
$6.8 million for the year ended December 31, 2000.  The Company’s effective  tax rate was 43.0%  for
the year ended December 31, 2001 and 50.3%  for  the year ended December 31, 2000.  This decline in
our  effective tax rate was primarily a result of  non-deductible amortization expenses representing a
smaller proportion of our income from  continuing operations before income taxes. For the  year ended
December 31, 2001 and 2000, amortization  of  non-deductible intangibles resulting from  the TravCorps
acquisition was $2.0 million and $2.8 million, respectively.

As a result of the above, income from continuing  operations totaled $14.4 million, or $0.57  per
diluted share, for the year ended December 31, 2001  as compared  to  $6.7 million, or $0.29 per diluted
share for the year ended December 31,  2000.

Losses from discontinued operations, net  of income tax  benefits, for the years ended  December 31,
2001 and December 31, 2000, were $0.9 million and $2.1  million, respectively. Losses in  the year  ended
December 31, 2001 include the results of operations of E-Staff and an  adjustment  to  the estimated loss
on disposal of the HospitalHub business,  which was  sold  in June 2001. Losses in  the year ended
December 31, 2000 include an estimated  loss on disposal of  HospitalHub and the 2000  results of
operations of the HospitalHub and E-Staff  businesses.

Extraordinary loss on the early extinguishment  of  debt  totaled  $4.8 million, after tax, for  the year
ended December 31, 2001. This amount  represents the  write off of  $6.4 million  in loan fees due to the
repayment of $134.5 million of debt  and  a prepayment penalty of $1.6 million on the early termination
of $38.8 million of subordinated debt, less  applicable taxes. The debt was repaid  with proceeds from
our  initial public offering of common stock  in October  2001.

Net income for the year ended December 31,  2001 totaled $8.7 million, or  $0.34 per diluted  share,

as compared to $4.6 million, or $0.20 per diluted share,  for  the year ended December 31, 2000.

Liquidity and Capital Resources

As of December 31, 2002, we had a current ratio, the amount of  current assets  divided by current
liabilities, of 2.6 to 1.0. Working capital  increased by $5.4  million to $78.1  million  as of December 31,
2002, compared to $72.7 million as of December 31,  2001. The increase in working  capital was
primarily attributable to an increase in cash  and accounts  receivable partially offset by an increase in
the current portion of long-term debt and a decrease in our deferred tax  asset and  net assets of
discontinued operations. Part of the  increase in  accounts receivable  was related to acquisitions.
Excluding acquisitions, accounts receivable increased $6.9  million,  however, days  sales outstanding was
56 days at December 31, 2002, down from  63 days at December 31, 2001.  This reduction was due to
improved collections.

Our operating cash flows constitute our primary source of liquidity and  historically have been

sufficient to fund our working capital,  capital  expenditures, internal business expansion, and  debt
service. We believe that our capital resources are sufficient to meet our working  capital needs for  the
next twelve months. We expect to meet  our  future needs for working capital, capital  expenditures,
internal business expansion, debt service, and any additional stock repurchases from  a combination of
operating cash flows and funds available under our credit facility. We also continue to evaluate
acquisition opportunities that may require  additional funding.

On October 30, 2001, we completed  our  initial public offering of 7,812,500  shares of common  stock

at $17.00 share. Additionally, the underwriters exercised  the over-allotment  option of 1,171,875 shares,
bringing the total number of shares issued to 8,984,375. Total proceeds received  by  the Company, net of
expenses related to the initial public  offering  were $138.8 million.  The proceeds  were used to repay
$89.6 million of our outstanding balance  under the term loan portion  of  our senior  secured credit
facility, $6.1 million of our outstanding  balance  under the  revolver  portion of our senior secured credit

29

facility, and $40.3 million to redeem  our outstanding senior  subordinated pay-in-kind notes,  including
the associated redemption premium.  The remainder  of  the proceeds  was  used for  general corporate
purposes.

On March 20, 2002, an aggregate of  9,000,000 shares of our common stock were sold by existing

shareholders pursuant to a registration  statement  filed by us with the Securities and Exchange
Commission. We did not sell any shares  nor receive  any of the  proceeds from  the sale  of  these  shares
but paid $0.9 million of expenses for such registration in 2002.

On November 5, 2002, our Board of  Directors  authorized  a  stock repurchase program, whereby,

we may purchase up to 1,500,000 of our  common  shares at an aggregate price not to exceed
$25.0 million. In November 2002, we amended our credit facility  to  increase our limitation  on
repurchases of capital stock in order to allow us to proceed with this program.  As of December 31,
2002, we purchased and retired 435,000  shares of  our  common  stock at an average cost  of  $13.83 per
share pursuant to the current authorization. The cost of  such purchases was $6.0  million.  Under this
program, the shares may be purchased  from time to time  on the  open market. The repurchase program
may be discontinued at any time at the  discretion  of the Company.

Credit Facility

The credit facility is provided by a lending syndicate  comprised of Citicorp USA, GE Capital,
Wachovia Bank, Deutsche Bank, SunTrust Bank, Fleet  Bank, Highland Capital Management, L.P., ING
US Capital, Sovereign Bank, Bank of America and Provident Bank of Maryland. We amended our
credit facility in February and November, 2002.  As of December 31,  2002, the  amended credit facility
was comprised of (i) a revolving credit  facility of up to $30.0 million, including a swing-line sub-facility
of $7.0 million and a letter of credit  sub-facility of $15.0  million,  and  (ii)  a $42.6  million  term loan
facility (which was reduced by $15.3 million after a 2003  repayment). The revolving facility  matures  on
July 29, 2005 and the term loan facility has staggered maturities  through 2005.

Borrowings under the amended credit facility bear  interest at variable rates based,  at our option,

on LIBOR or the prime rate plus various applicable margins  that are determined by the  amended
credit facility. As of December 31, 2002, the weighted average effective interest  rate under the
amended credit facility, including the effects of our interest rate swap, was 8.63%. We are required  to
pay a quarterly commitment fee at a rate  of 0.50%  per  annum  on  unused commitments under  the
revolving loan facility. As of December 31,  2002, we  had  no borrowings outstanding under  our
revolving credit facility and $9.8 million  of outstanding letters  of credit, leaving  availability under our
revolving credit facility of $20.2 million.

The terms of the credit facility include customary covenants and events  of default.  Our investments

covenant requires us to obtain the consent of our lenders  to complete any acquisition, the  costs of
which  exceeds $25.0 million. In the event of an event  of default,  our lenders may terminate their
lending commitments to us and declare  our outstanding  indebtedness under  the credit  facility  due  and
payable, together with accrued but unpaid interests and fees. Borrowings  under  the amended  credit
facility are collateralized by substantially  all  our  assets and the assets of our subsidiaries.

Year Ended December 31, 2002 Compared  to  Year Ended December 31, 2001

Net cash provided by operating activities  during  2002 more than doubled  to  $41.4 million

compared to $19.8 million during 2001. Investing activities  used $18.6 million during 2002 compared to
$42.3 million during 2001. Investing activities in 2002 were primarily attributable to current  year
acquisitions and capital expenditures  relating to upgrading  our information systems. NovaPro and JRK
were acquired in the first quarter of 2002 using cash  of approximately  $9.8 million during the year
ended December 31, 2002. The remainder of cash used in  2002 was primarily for  earnout payments
relating to previous acquisitions. Investing activities in 2001 included approximately $32.8  million  for

30

the acquisition of ClinForce and $2.1 million for the acquisitions  of  Heritage and Gill/Balsano. Net
cash used in financing activities during 2002 totaled $8.4 million  compared to cash provided  by
financing activities of $25.3 million in 2001. In  2002, we  used $6.4 million to repay debt and
$6.0 million to repurchase shares of our common stock in  accordance with the  approved program
described above. These uses were offset by  cash  received  from the exercise of stock options in  2002. In
2001, cash provided by financing activities came from our initial public  offering and the proceeds from
issuance of debt for acquisitions; offset by  repayments  of  debt using  the offering  proceeds and funds
generated by  operations.

Year Ended December 31, 2001 Compared  to  Year Ended December 31, 2000

Net cash provided by operating activities  during  2001 increased $8.2 million to $19.8  million
compared to $11.6 million during 2000. Investing activities  totaled  $42.3 million during 2001  compared
to a use of $10.8 million during 2000. Investing activities in 2001 included approximately  $32.8 million
for the acquisition of ClinForce and $2.1 million  for  the acquisitions  of Heritage  and Gill/Balsano.
Investing activities during 2000 included $6.2 million for the acquisition of Heritage and  $2.6 million
relating to our investment in E-Staff,  now  a discontinued business. Net cash provided by financing
activities during 2001 totaled $25.3 million compared  to  cash used in  financing activities of  $5.6 million
in 2000. The increase in cash provided  by financing activities  in 2001  was  due to our  initial public
offering and the proceeds from issuance  of debt  for  acquisitions; offset by  repayments  of  debt  using  the
offering proceeds and funds generated by operations.

Commitments

The following table reflects our significant contractual obligations and  other  commitments as of

December 31, 2002:

Contractual Obligations

Total

2003

2004

2005

2006

2007

Thereafter

(Dollars in thousands)

Term Loan . . . . . . . . . . . . . . . . . . . . . . . . $42,575 $14,289 $18,297 $ 9,989 $ — $ — $ —
3,361
Operating Leases . . . . . . . . . . . . . . . . . . .

17,348

3,341

2,033

2,377

2,830

3,406

$59,923 $17,630 $21,703 $12,819 $2,377 $2,033

$3,361

Since December 31, 2002, we have repaid $15.3 million of our  borrowings under  the term loan

portion of our credit facility, which have adjusted our  scheduled maturities in  accordance with the
provisions of our credit facility. Subsequent to the repayment, the scheduled maturities of the term
loan, in thousands, are: 2003-$5,981; 2004-$14,031; and 2005-$7,274.

Critical Accounting Principles and Estimates

In response to the Securities and Exchange Commission’s Release Number 33-8040  ‘‘Cautionary
Advice Regarding Disclosure About Critical  Accounting Policies’’ and Number  33-8056 ‘‘Commission
Statement about Management’s Discussion and Analysis of Financial Condition and Results  of
Operations,’’  we have identified the following critical accounting policies that affect the more significant
judgments and estimates used in the preparation of our consolidated financial statements. The
preparation of our financial statements  in conformity with accounting principles  generally accepted in
the United States of America requires  us to make  estimates and judgments that affect our reported
amounts of assets and liabilities, revenues  and  expenses, and related disclosures of contingent  assets
and liabilities. On an on-going basis,  we  evaluate our estimates, including those related  to  asset
impairment, accruals for insurance, allowance for doubtful  accounts, and contingencies and litigation.
We  state our accounting policies in the  notes to the audited consolidated financial statements and
related notes for the year ended December 31, 2002, contained herein. These estimates are based on

31

the information that is currently available  to  us  and on various  other assumptions  that  we believe  to  be
reasonable under the circumstances.  Actual results  could  vary from those estimates under  different
assumptions or conditions.

We  believe that the following critical  accounting policies affect the more significant judgments  and

estimates used in the preparation of our consolidated  financial  statements:

• We have recorded goodwill and intangibles  resulting from  our acquisitions through

December 31, 2002. Through December 31,  2001, goodwill and other intangibles were amortized
on a straight-line basis over their estimated  useful lives  of  3 to 25 years. Upon the  adoption of
FASB Statement No. 142 on January 1, 2002, we  ceased  amortizing goodwill and certain other
intangible assets with indefinite lives and performed  a transitional impairment analysis as of
January 1, 2002, to assess the recoverability of these intangibles, in  accordance with the
provisions of FASB Statement No. 142.  We also completed the annual impairment test of
goodwill and indefinite lived intangible assets during  the fourth  quarter of 2002. Based  on the
results of these tests, we determined that there was no impairment  of  goodwill or indefinite lived
intangible assets as of January 1, or December  31, 2002.  The  calculation  of fair value used in
these impairment assessments included a number of estimates  and assumptions, including
projections of future income and cash flows, the  identification of appropriate market multiples
and the choice of an appropriate discount  rate.  If we  are required to record an  impairment
charge in the future, it could have an adverse impact on our  results of operations. We
periodically evaluate the recovery of the carrying amount of net assets from discontinued
operations to determine if the net assets are impaired.  This evaluation can  also be triggered  by
various  indicators of impairment, including factors,  which could cause the estimated discounted
cash flows to be less than the carrying amount of net assets.  During  the year ended
December 31, 2002, an impairment charge  of  approximately  $2.5 million net of income tax
benefit of $1.6 million, was taken on the  net assets of E-Staff and is  included in our  consolidated
statement of operations as loss from discontinued  operations. At December 31, 2002,  fair value
was based on the latest offer received  for the  sale of E-Staff  and included the estimated  cash
flows from the sale to a potential buyer, adjusted for  the estimated probability  of  the sale.  Any
further impairment would be immaterial.

• We maintain accruals for our health, workers compensation and professional liability policies

that are partially self-insured and are classified in accrued employee compensation and  benefits
in our consolidated balance sheets. We determine  the adequacy of  these accruals  by  periodically
evaluating our historical experience and trends related  to  health,  workers compensation, and
professional liability claims and payments, based on actuarial computations and  industry
experience and trends. If such information indicates that our accruals are  overstated  or
understated, we will reduce or provide  for additional accruals  as appropriate.

• We maintain an allowance for doubtful accounts for  estimated losses resulting from  the inability
of our customers to make required payments, which  results in  a  provision  for bad debt expense.
We  determine the adequacy of this allowance by  continually evaluating individual customer
receivables, considering the customer’s financial condition, credit history and current economic
conditions. If the financial condition of our customers  were to deteriorate, resulting  in an
impairment of their ability to make payments, additional  allowances may  be  required.

• We are subject to various claims and legal actions in  the ordinary course  of our  business.  Some
of these matters include professional  liability  and  employee-related  matters.  Our hospital  and
healthcare facility clients may also become subject to claims, governmental inquiries and
investigations and legal actions to which  we may become a party  relating to services provided by
our  professionals. From time to time, and  depending  upon the  particular  facts and
circumstances, we may be subject to  indemnification obligations under our contracts with our

32

hospital and healthcare facility clients relating  to  these matters. Although we are currently  not
aware of any such pending or threatened litigation that we believe is reasonably likely to have a
material adverse effect on us, if we become aware of such claims  against  us,  we will evaluate  the
probability of an adverse outcome and provide accruals for such  contingencies  as necessary.

Recently Issued Accounting Standards

In June 2001, the FASB issued FASB Statement No.  142, Goodwill and Other Intangible Assets. We

adopted the provisions of FASB Statement No.  142, as of  January  1, 2002. FASB Statement No. 142
further clarifies the criteria to recognize intangible assets separately from goodwill and promulgates
that goodwill and certain intangible assets with indefinite lives not be amortized. Instead,  these  assets
are reviewed for impairment annually  with  any related losses recognized in earnings when incurred.
Other identifiable intangible assets continue to be amortized, under  the provisions  of this  Statement,
using the straight-line method over their estimated useful lives ranging from 3  to  15 years.

In August 2001, the FASB issued FASB  Statement No.  144, Accounting for the Impairment or
Disposal of Long-Lived Assets. We adopted the provisions of FASB Statement No.  144 as of January 1,
2002. In accordance with this Statement, long-lived assets are reviewed for  impairment whenever  events
or changes in circumstances indicate that  the carrying amount may not be recoverable. We periodically
review long-lived assets, including identifiable intangible assets, to determine if any  impairment exists
based upon projected, undiscounted net  cash flows of the  Company. Recoverability of intangible assets
is measured by comparison of the carrying amount of the  asset  to  net  future cash flows expected to be
generated from the asset. At December  31, 2002 and 2001, we believe that no impairment of long-lived
assets or identifiable intangible assets exists.

In April 2002, the FASB issued FASB  Statement No.  145, Rescission of Statements 4, 44, and 64,

Amendment of FASB Statement No. 13, and Technical Corrections. This Statement rescinds FASB
Statement No. 4, Reporting Gains and Losses from Extinguishment of Debt, and an amendment of that
Statement, FASB Statement No. 64, Extinguishments of Debt Made to Satisfy Sinking-Fund  Requirements.
This Statement also rescinds FASB Statement No. 44, Accounting for Intangible Assets of Motor Carriers.
This Statement amends FASB Statement  No. 13, Accounting for Leases, to eliminate an inconsistency
between the required accounting for  sale-leaseback transactions and the required accounting for certain
lease modifications that have economic effects that are  similar  to  sale-leaseback transactions. This
Statement also amends other existing  authoritative  pronouncements to make various technical
corrections, clarify meanings, or describe  their applicability under changed conditions. We  have not
adopted the provisions of this statement  as of December 31, 2002.  The provisions  of  this  Statement
related to the rescission of Statement 4  are effective for fiscal  years  beginning after May 15, 2002.  Any
gain or loss on extinguishment of debt  that was classified as an extraordinary item  in prior periods
presented that does not meet the criteria in  Opinion 30 for  classification as an extraordinary  item shall
be  reclassified.  Accordingly,  our  extraordinary  loss  on  early  extinguishment  of  debt  will  be  reclassified
upon adoption of this standard in the  year ending December 31, 2003.

In July 2002, the FASB issued FASB  Statement No. 146, Accounting for Costs Associated with Exit
or Disposal Activities. FASB Statement No. 146 requires that a liability for a cost that  is associated  with
an exit  or disposal  activity be recognized when  the liability is incurred. It nullifies  the guidance in  EITF
Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other  Costs to Exit an
Activity (including Certain Costs Incurred in a  Restructuring). Under EITF 94-3, an entity recognized  a
liability for an exit cost on the date that the entity committed itself to an exit plan. Under FASB
Statement No. 146, an entity’s commitment to a plan does not, by  itself, create a  present  obligation  to
other parties that meets the definition  of  a  liability.  FASB  Statement No. 146 will be effective for exit
or disposal activities that are initiated after  December 31,  2002. We  have not adopted  the provisions  of
FASB Statement No. 146 in the December 31, 2002 financial statements, or for  any prior  periods.  The

33

adoption of FASB Statement No. 146  is  expected to impact the timing  of  recognition of  costs associated
with future exit and disposal activities.

In December 2002, the FASB issued FASB Statement No. 148, Accounting for Stock Based
Compensation—Transition and Disclosure. FASB Statement  No.148 amends FASB Statement No. 123,
Accounting for Stock-Based Compensation, to provide alternative methods of transition for a  voluntary
change to the fair value based method of  accounting for stock-based employee compensation. Further,
the Statement requires disclosure of  comparable information for all companies regardless  of  whether,
when, or how an entity adopts the preferable, fair  value based  method of accounting.  These disclosures
are now required for interim periods in addition  to  the traditional annual disclosure. FASB  Statement
No. 148 is effective for fiscal periods ending after December 15, 2002. We have adopted the additional
disclosure requirements as of December  31, 2002.

Inflation

During  the last several years, the rate of inflation  in healthcare  related  services has exceeded  that

of the economy as a whole. This inflation  has increased our direct operating costs.  We  are also
impacted by fluctuations in housing costs and recently by increases  in costs  of professional, general  and
healthcare insurance. Historically, we have been able to recoup  the negative impact of  such fluctuations
by increasing our billing rates. We may not be able to continue  increasing  our billing  rates  and
increases in our direct operating costs  may  adversely affect us in the future. In addition, our  clients are
impacted by payments of healthcare benefits by federal and  state governments as well as  private
insurers.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES  ABOUT MARKET  RISK

We  are exposed to interest rate changes, primarily as a result of our  credit facility, which  bears

interest based on floating rates. We are party to an interest rate  swap agreement,  which fixes the
interest rate paid on $45.0 million of  borrowings under  our credit  facility at 6.705% plus the applicable
margin. The last swap payment was made in February 2003.  Prior to January 2001, we accounted  for
the swap agreement as a hedge, which means changes in the fair  value of the swap were  not  required
to be recognized in earnings. Effective January  1, 2001,  we adopted FASB Statement No. 133,
Accounting for Derivative Instruments and Hedging Activities. Upon adopting FASB Statement No. 133,
we recorded a liability for the fair value of  the swap, which reduced consolidated stockholders’ equity
by $0.9  million. We recognized changes in the fair value  of  the swap  in earnings to the  extent such
changes were greater or less than the  corresponding change in the fair value of  the future variable
interest payments on the portion of the  debt underlying the swap. During the year ended December 31,
2002, other comprehensive income increased by $0.8 million as a result of this interest rate swap.  The
fair value of our interest rate swap at  December 31, 2002  was $0.6 million and is separately  stated  in
our  consolidated balance sheets. Changes in interest rates, which  result in  a yield  curve  that  is different
from those projected, may cause changes in the  fair value of the swap.

A 1% change in interest rates on variable  rate debt would have resulted in interest expense

fluctuating approximately $0.5 million  for  2002 and  $1.2 million for 2001 and 2000.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

See Item 15 of Part IV of this Report.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON  ACCOUNTING AND

FINANCIAL DISCLOSURE

Not applicable.

34

PART III

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE  REGISTRANT

Information with respect to directors  and  executive officers is included in Cross Country’s  Proxy

Statement (the ‘‘Proxy Statement’’) to  be  filed pursuant to Regulation 14A with the SEC and such
information is incorporated herein by reference.

ITEM 11. EXECUTIVE COMPENSATION

Information with respect to executive compensation is included in the  Proxy Statement  to  be  filed

with the SEC and such information is  incorporated herein by reference.

ITEM 12. SECURITY OWNERSHIP  OF CERTAIN  BENEFICIAL  OWNERS AND MANAGEMENT

AND RELATED STOCKHOLDER MATTERS

Information with respect to the Company’s common stock  is included in  the Proxy Statement to be

filed  with the SEC and such information is  incorporated herein by reference.

ITEM 13. CERTAIN RELATIONSHIPS  AND RELATED  TRANSACTIONS

Information with respect to certain relationships and  related transactions  is included in the  Proxy

Statement to be filed with the SEC and  such information  is incorporated  herein by reference.

ITEM 14. CONTROLS AND PROCEDURES

Within 90 days prior to the date of this report, the  Company carried out  an evaluation,  under the

supervision and with the participation  of  the  Company’s  Chief Executive Officer and Chief Financial
Officer, of the effectiveness of the design  and operation of  the Company’s  disclosure controls and
procedures (as defined in Rules 13a-14(c) and 15d-14(c) under the Securities Exchange Act of 1934, as
amended (the ‘‘Exchange Act’’)). Based upon the evaluation, the  Company’s Chief Executive  Officer
and  Chief Financial Officer concluded  that the Company’s disclosure controls  and procedures are
effective. Disclosure controls and procedures are designed  to  ensure  that information  required to be
disclosed in Company reports filed or submitted under the  Exchange Act  is recorded, processed,
summarized and reported within the time periods specified  in the Securities and Exchange
Commission’s rules and forms.

There have been no significant changes  in the Company’s internal controls or in  other  factors that

could significantly affect the Company’s internal controls subsequent to the  date of the  evaluation.

35

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES  AND REPORTS ON FORM 8-K

(a) See Index to Financial Statements  immediately following Exhibit Index.

(b) Form 8-Ks have been filed pursuant to Item  5, Other Events  and Required FD  Disclosure  on

October 18, 2002 and November 6, 2002.

(c) Exhibits

See Exhibit Index immediately following certifications

36

Pursuant to the requirements of Section 13  or 15(d) of the Securities Exchange Act of  1934, the

Registrant has duly caused this report to be signed on its  behalf  by the undersigned,  thereunto duly
authorized.

Signatures

CROSS COUNTRY, INC.

By: /s/ JOSEPH A. BOSHART

Name: Joseph A. Boshart
Title: Chief Executive Officer and President

Dated:  March  26,  2003

Pursuant to the requirements of the Securities Exchange  Act of 1934, this report has been signed

by the following persons in the capacities indicated and on the dates indicated:

Signature

Title

Date

/s/ JOSEPH A. BOSHART

Joseph A. Boshart

/s/ EMIL HENSEL

Emil Hensel

/s/ DANIEL J. LEWIS

Daniel J. Lewis

/s/ KAREN H. BECHTEL

Karen H. Bechtel

/s/ W. LARRY CASH

W. Larry Cash

/s/ THOMAS C. DIRCKS

Thomas C. Dircks

/s/ A. LAWRENCE FAGAN

A. Lawrence Fagan

/s/ FAZLE HUSAIN

Fazle Husain

/s/ JOSEPH SWEDISH

Joseph Swedish

/s/ JOSEPH TRUNFIO

Joseph Trunfio

President, Chief Executive Officer,
Director (Principal Executive
Officer)

March 26,  2003

Chief Financial Officer and Director

(Principal Financial Officer)

March 26, 2003

Chief Accounting Officer

March  26, 2003

Director

Director

Director

Director

Director

Director

Director

37

March 26, 2003

March 26, 2003

March 26, 2003

March 26, 2003

March 26, 2003

March 26, 2003

March 26, 2003

CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Joseph A. Boshart, certify that:

1.

I have reviewed this annual report  on  Form 10K  of Cross  Country, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement  of  a material fact or

omit to state a material fact necessary  to  make the statements made,  in light  of the circumstances
under which such statements were made, not misleading  with respect to the period  covered by this
annual report;

3. Based on my knowledge, the financial statements, and  other financial  information included in  this

annual report, fairly present in all material respects the  financial  condition, results  of operations
and cash flows of the registrant as of, and for,  the periods presented in this annual  report;

4. The registrant’s other certifying  officers and I  am responsible for establishing and maintaining

disclosure controls and procedures (as defined  in Exchange  Act Rules 13a-14 and 15d-14) for the
registrant and have:

a)

b)

c)

designed such disclosure controls and  procedures  to  ensure that material information relating
to the registrant, including its consolidated  subsidiaries, is made  known to us by others within
those entities, particularly during the period in  which this annual report is  being  prepared;

evaluated the effectiveness of the registrant’s  disclosure controls and  procedures as of a  date
within 90 days prior to the filing date of this annual report (the ‘‘Evaluation Date’’);  and

presented in this annual report our conclusions about the effectiveness of the  disclosure
controls and procedures based on our  evaluation as  of  the Evaluation Date;

5. The registrant’s other certifying  officer  and  I have disclosed, based on our most recent  evaluation,

to the registrant’s auditors and the audit  committee of registrant’s board of directors (or persons
performing the equivalent functions):

a)

b)

all significant deficiencies in the design or  operation of internal  controls  which could adversely
affect the registrant’s ability to record, process, summarize and report  financial  data  and have
identified for the registrant’s auditors any material  weaknesses in  internal controls; and

any fraud, whether or not material,  that involves management  or other employees who have a
significant role in the registrant’s  internal controls; and

6. The registrant’s other certifying  officer  and  I have indicated in  this annual report whether  or not

there were significant changes in internal controls or  in other  factors that could significantly affect
internal controls subsequent to the date of our most  recent evaluation, including  any corrective
actions with regard to significant deficiencies  and  material weaknesses.

Date:  March  26,  2003

/s/ Joseph A. Boshart
Joseph  A. Boshart
President and Chief Executive Officer

38

I, Emil Hensel, certify that:

1.

I have reviewed this annual report  on  Form 10K  of Cross  Country,Inc.;

2. Based on my knowledge, this report does not contain any untrue statement  of  a material fact or

omit to state a material fact necessary  to  make the statements made,  in light  of the circumstances
under which such statements were made, not misleading  with respect to the period  covered by this
annual report;

3. Based on my knowledge, the financial statements, and  other financial  information included in  this

annual report, fairly present in all material respects the  financial  condition, results  of operations
and cash flows of the registrant as of, and for,  the periods presented in this annual  report;

4. The registrant’s other certifying  officers and I  are responsible  for establishing and maintaining

disclosure controls and procedures (as defined  in Exchange  Act Rules 13a-14 and 15d-14) for the
registrant and have:

a)

b)

c)

designed such disclosure controls and  procedures  to  ensure that material information relating
to the registrant, including its consolidated  subsidiaries, is made  known to us by others within
those entities, particularly during the period in  which this annual report is  being  prepared;

evaluated the effectiveness of the registrant’s  disclosure controls and  procedures as of a  date
within 90 days prior to the filing date of this annual report (the ‘‘Evaluation Date’’);  and

presented in this annual report our conclusions about the effectiveness of the  disclosure
controls and procedures based on our  evaluation as  of  the Evaluation Date;

5. The registrant’s other certifying  officer  and  I have disclosed, based on our most recent  evaluation,

to the registrant’s auditors and the audit  committee of registrant’s board of directors (or persons
performing the equivalent functions):

a)

b)

all significant deficiencies in the design or  operation of internal  controls  which could adversely
affect the registrant’s ability to record, process, summarize and report  financial  data  and have
identified for the registrant’s auditors any material  weaknesses in  internal controls; and

any fraud, whether or not material,  that involves management  or other employees who have a
significant role in the registrant’s  internal controls; and

6. The registrant’s other certifying  officer  and  I have indicated in  this annual report whether  or not

there were significant changes in internal controls or  in other  factors that could significantly affect
internal controls subsequent to the date of our most  recent evaluation, including  any corrective
actions with regard to significant deficiencies  and  material weaknesses.

Date:  March  26,  2003

/s/ Emil Hensel
Emil Hensel
Chief Financial Officer

39

Exhibit Index

No.

Description

2.1+ Cross Country Staffing Asset Purchase Agreement,  dated June  24, 1999, by and among W. R.

Grace & Co.-Conn., a Connecticut corporation, Cross Country Staffing,  a Delaware  general
partnership, and the Registrant, a Delaware corporation

2.2+ Agreement and Plan of Merger, dated as of  October 29,  1999, by and among the Registrant,
CCTC Acquisition, Inc. and Certain Stockholders of Cross Country Staffing,  Inc and
TravCorps Corporation and the Stockholders of TravCorps Corporation

2.3+ Stock Purchase Agreement, dated as  of  December  15,  2000, by and between Edgewater

Technology, Inc. and the Registrant

3.1+ Amended and Restated Certificate of Incorporation of the Registrant

3.2+ Amended and Restated By-laws of the Registrant

4.1+ Form of specimen common stock  certificate

4.2+ Amended and Restated Stockholders Agreement, dated  August 23,  2001, among the

Registrant, a Delaware corporation, the  CEP Investors and the Investors

4.3+ Registration Rights Agreement,  dated as of October 29, 1999,  among  the Registrant, a

Delaware corporation, and the CEP  Investors and the MSDWCP  Investors

4.4+ Amendment to the Registration Rights Agreement, dated as  of  August 23, 2001, among the

Registrant, a Delaware corporation, and the CEP Investors  and  the  MSDWCP  Investors

4.5+ Stockholders Agreement, dated as of August 23, 2001, among the Registrant, Joseph  Boshart

and Emil Hensel and the Financial Investors

10.1+ Employment Agreement, dated  as of June 24, 1999, between Joseph Boshart  and the

Registrant

10.2+ Employment Agreement, dated  as of June 24, 1999, between Emil Hensel and the Registrant

10.3+ Employment Agreement termination,  dated as of December 21,  2000, between Bruce Cerullo

and the Registrant

10.4+ Lease Agreement, dated April  28, 1997,  between  Meridian  Properties and the Registrant

10.5+ Lease Agreement, dated October 31, 2000,  by  and between  Trustees of the Goldberg  Brothers

Trust, a Massachusetts Nominee Trust and TVCM, Inc.

10.6+ 222 Building Standard Office Lease between Clayton Investors  Associates, LLC and Cejka &

Company

10.7* Amended and Restated 1999  Stock  Option Plan of the Registrant

10.8* Amended and Restated Equity  Participation Plan of the  Registrant

10.9+ Second Amended and Restated Credit  Agreement, dated  as of March 16,  2001 (the ‘‘Credit
Agreement’’), among the Registrant, the  Lenders Party thereto, Salomon  Smith Barney, Inc.,
as Arranger, Citicorp USA, Inc. as Administrative  Agent, Collateral Agent,  Issuing Bank and
Swingline Lender, Bankers Trust Company, as Syndication  Agent, and  Wachovia Bank,  N.A.,
as Documentation Agent

40

No.

Description

10.10* Amendment No. 3, dated as  of  February  11, 2002, to the Credit  Agreement, among the

Registrant, the Lenders Party thereto, Salomon Smith Barney, Inc.,  as Arranger,  Citicorp
USA, Inc. as Administrative Agent, Collateral  Agent, Issuing  Bank and Swingline Lender,
Bankers Trust Company, as Syndication Agent, and Wachovia Bank, N.A.,  as Documentation
Agent

10.11+ Form of Subsidiary Guarantee  Agreement, dated as of  December 16, 1999, among the

Registrant’s subsidiary guarantors and Citicorp USA, Inc., as collateral  agent for the Obligees

10.12+ Form of Security Agreement, dated as of July 29, 1999,  as amended and restated as of

December 16, 1999 among the Registrant and Citicorp USA,  Inc. as  collateral agent  for the
Obligees

10.13+ Form of Pledge Agreement, dated as of July  29, 1999, as amended  and restated  as of

December 16, 1999, among the Registrant and Citicorp USA,  Inc., as  collateral agent  for the
Obligees

10.14+ Form of Indemnity, Subrogation  and  Contribution Agreement,  dated as of December 16,
1999, among the Registrant, the subsidiaries of the Registrant and Citicorp USA,  Inc., as
collateral agent for the Obligees

10.15^ Amendment No. 4 to the Amended and Restated Credit  Agreement, dated as of  November 4,
2002, among the Registrant, the Lenders  Party thereto, Salomon  Smith Barney, Inc., as
Arranger, Citicorp USA, Inc. as Administrative  Agent, Collateral Agent,  Issuing Bank and
Swingline Lender, Bankers Trust Company, as Syndication  Agent, and  Wachovia Bank,  N.A.,
and Fleet National Bank, as Documentation Agents

10.16^ Amendment to Lease by and  between Meridian Commercial  Properties Limited Partnership

and Cross Country, Inc. dated May 1, 2002

10.17^ Employment Agreement between  Kevin Conlin and the Company

10.18^ Employment Agreement between  Annette Gardner and  the  Company

10.19

10.20

10.21

10.22

10.23

21.1

23.1

99.1

Cross Country, Inc. Deferred compensation plan

Restricted Stock Agreement between Company  and Joseph A. Boshart

Restricted Stock Agreement between Company  and Emil Hensel

Restricted Stock Agreement between Company  and Vickie Anenberg

Restricted Stock Agreement between Company  and Jonathan  Ward

List of subsidiaries of the Registrant

Consent of Independent Certified  Public Accountants

Certification Pursuant to 18 U.S.C. Section  1350 by Joseph A.  Boshart, Chief Executive
Officer

99.2

Certification Pursuant to 18 U.S.C. Section  1350 by Emil Hensel, Chief Financial  Officer

+ Previously filed as an exhibit to the Company’s Registration Statement on Form S-1, Commission

File No.  333-74403, and incorporated by reference herein.

*

Previously filed as an exhibit to  the Company’s Registration Statement  on Form S-1, Commission
File No.  333-83450, and incorporated by reference herein.

^ Previously filed as exhibits in the Company’s Quarterly Reports on Form 10Q filings  during the

year ended December 31, 2002, and incorporated by reference herein.

41

[THIS PAGE INTENTIONALLY LEFT BLANK]

INDEX TO FINANCIAL STATEMENTS

Cross Country, Inc.

Report of Independent Certified Public Accountants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Balance Sheets as of December 31,  2002 and 2001 . . . . . . . . . . . . . . . . . . . . . . .
Consolidated Statements of Operations  for the Years Ended December 31, 2002,

Page

F-2
F-3

2001 and 2000 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F-4

Consolidated Statement of Stockholders’ Equity for the  Years  Ended December 31, 2002,

2001 and 2000 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F-5

Consolidated Statements of Cash Flows  for  the Years Ended December 31, 2002,

2001 and 2000 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Notes to the Consolidated Financial  Statements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

F-6
F-7

Financial Statements Schedule

Schedule II—Valuation and Qualifying Accounts for the Years Ended December 31, 2002,

2001 and 2000 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

II-1

Schedules not filed herewith are either not applicable, the information is  not material or  the

information is set forth in the financial  statements or notes thereto.

F-1

Report of Independent Certified Public  Accountants

The Board of Directors and Stockholders
Cross Country, Inc.

We  have audited the accompanying consolidated balance sheets of Cross  Country, Inc.  as of

December 31, 2002 and 2001, and the related consolidated statements of operations, stockholders’
equity and cash flows for each of the three years in the period ended December 31, 2002.  Our audits
also included the financial statement schedule listed  in the index at Item 15(a). These financial
statements and schedule are the responsibility of the  Company’s management.  Our responsibility  is to
express an opinion on these financial statements based on our  audits.

We  conducted our audits in accordance with auditing  standards  generally  accepted in the United

States. Those standards require that we plan and perform the audit to obtain reasonable assurance
about whether the financial statements  are  free of material misstatement. An audit includes  examining,
on a test basis, evidence supporting the amounts and disclosures in the  financial  statements.  An audit
also includes assessing the accounting  principles used and  significant estimates made by management,
as well as evaluating the overall financial  statement presentation. We believe  that  our audits provide  a
reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects,

the consolidated financial position of  Cross Country, Inc. at December 31, 2002  and 2001, and  the
consolidated results of their operations  and their cash flows for each of the three  years  in the period
ended December 31, 2002, in conformity with accounting  principles generally accepted in the United
States. Also, in our opinion, the related financial statement schedule, when  considered in relation  to
the basic financial statements taken as a whole, present fairly, in  all material  respects, the information
set forth therein.

As discussed in Note 2 to the financial statements, in  2002 the Company  changed its method  of

accounting for goodwill.

West  Palm Beach,  Florida
February 5, 2003

/s/ Ernst & Young LLP

F-2

Cross Country, Inc.

Consolidated Balance Sheets

December 31,

2002

2001

Assets
Current assets:

Cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accounts receivable, less allowance for doubtful  accounts  of  $2,250,047  in 2002

and $2,424,865 in 2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income taxes receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid rent on employees’ apartments . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deposits on employees’ apartments, net  of allowance  of $261,782  in  2002 and

$512,562 in 2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Assets from discontinued operations, net
. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Total current assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Property and equipment, net of accumulated depreciation  and amortization  of

$12,928,611 in 2002 and $8,785,801 in 2001 . . . . . . . . . . . . . . . . . . . . . . . . . . .
Trademark, net of accumulated amortization of $1,401,169  in  2002  and  2001 . . . . . .
Goodwill, net of accumulated amortization of $20,873,294 in 2002  and  2001 . . . . . .
Other identifiable intangible assets, net of accumulated amortization  of $8,824,087

$ 17,209,946

$ 2,735,960

97,641,426
645,177
1,815,458
4,038,736

1,051,191
247,789
5,428,138

87,414,713
4,398,198
1,512,155
3,992,775

1,138,173
3,483,615
3,954,507

128,077,861

108,630,096

12,394,162
15,748,831
226,115,646

8,501,933
15,398,831
218,748,858

in 2002 and $6,114,775 in 2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

7,112,663

9,308,225

Debt issuance costs, net of accumulated  amortization  of $1,236,562  in  2002  and

$797,921 in 2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1,105,470
45,180

1,390,364
1,200

Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$390,599,813

$361,979,507

Liabilities and stockholders’ equity
Current liabilities:

Accounts payable and accrued expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrued employee compensation and  benefits . . . . . . . . . . . . . . . . . . . . . . . . .
Current portion of long-term  debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Notes payable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Net liabilities from discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Total current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest rate swap . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred income taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 3,296,638
29,663,232
14,311,336
50,581
185,889
2,422,642

49,930,318
606,356
10,778,749
28,452,603

$

3,172,152
26,699,668
2,424,594
1,365,009
173,697
2,062,674

35,897,794
2,508,877
8,570,361
45,075,406

Total  liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

89,768,026

92,052,438

Commitments and contingencies
Stockholders’ equity:

Common stock—$.0001 par value; 100,000,000  shares  authorized;  32,229,666 and

32,211,745 shares issued and outstanding at  December  31,  2002 and  2001,
respectively . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Additional paid-in capital . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accumulated other comprehensive loss . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Retained earnings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3,223
258,488,773
(371,687)
42,711,478

3,221
258,151,811
(1,156,736)
12,928,773

Total stockholders’  equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

300,831,787

269,927,069

Total liabilities and stockholders’ equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$390,599,813

$361,979,507

See accompanying notes.

F-3

Cross Country, Inc.

Consolidated Statements of Operations

Revenue from services . . . . . . . . . . . . . . . . . . . . . . . . . .
Operating expenses:

Direct  operating expenses . . . . . . . . . . . . . . . . . . . . . .
Selling, general and administrative expenses . . . . . . . . .
Bad debt expense . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-recurring secondary offering costs . . . . . . . . . . . .
Non-recurring indirect transaction costs . . . . . . . . . . . .
Total operating expenses . . . . . . . . . . . . . . . . . . . . .
Income from operations . . . . . . . . . . . . . . . . . . . . . . . . .
Other expenses:

Interest expense, net . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from continuing operations before  income  taxes .
Income tax expense . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Income from continuing operations . . . . . . . . . . . . . . . . .
Discontinued operations, net of income  tax benefit:

Loss from discontinued operations . . . . . . . . . . . . . . .
Loss on disposal of HospitalHub . . . . . . . . . . . . . . . . .

Net income before extraordinary item,  net of income tax

benefit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Extraordinary loss on early extinguishment of debt, net
. . . . . . . . . . . . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

of income tax benefit

Net income (loss) per common share—basic:

Income from continuing operations . . . . . . . . . . . . . . .
Discontinued operations . . . . . . . . . . . . . . . . . . . . . . .
Net income before extraordinary item . . . . . . . . . . . . . . .
Extraordinary loss on early extinguishment of debt . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Net income (loss) per common share—diluted:

Income from continuing operations . . . . . . . . . . . . . . .
Discontinued operations . . . . . . . . . . . . . . . . . . . . . . .
Net income before extraordinary item . . . . . . . . . . . . . . .
Extraordinary loss on early extinguishment of debt . . . .
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$

$

$

$

1.04
(0.12)
0.92
—
0.92

1.00
(0.12)
0.88
—
0.88

Year ended December 31,

2002

2001

2000

$639,952,915

$504,363,637

$368,332,184

478,549,635
94,930,045
242,230
3,524,004
3,147,952
886,036
—
581,279,902
58,673,013

377,291,122
68,559,671
1,273,656
2,699,916
14,851,382
—
—
464,675,747
39,687,890

273,094,434
49,594,082
432,973
1,323,397
13,624,161
—
1,289,217
339,358,264
28,973,920

3,752,718
54,920,295
(21,254,154)
33,666,141

14,422,170
25,265,720
(10,862,257)
14,403,463

15,435,236
13,538,684
(6,806,882)
6,731,802

(3,883,436)
—

(741,006)
(206,710)

(1,679,774)
(453,832)

29,782,705

13,455,747

4,598,196

—
$ 29,782,705

(4,783,705)
8,672,042

0.58
(0.04)
0.54
(0.19)
0.35

0.57
(0.04)
0.53
(0.19)
0.34

$

$

$

$

$

—
4,598,196

0.29
(0.09)
0.20
—
0.20

0.29
(0.09)
0.20
—
0.20

$

$

$

$

$

Weighted average common shares outstanding—basic . . .

32,432,026

24,881,218

23,205,388

Weighted average common shares outstanding—diluted . .

33,653,433

25,222,936

23,205,388

See accompanying notes.

F-4

Cross Country, Inc.

Consolidated Statement of Stockholders’ Equity

Common Stock

Shares

Dollars

Additional
Paid-In
Capital

Other
Comprehensive
(Loss) Gain

Deficit)
Retained
Earnings

Total
Stockholders’
Equity

Accumulated (Accumulated

Balance at December 31, 1999 . . . . . . . . 23,205,298 $2,321 $119,080,880 $

Net income . . . . . . . . . . . . . . . . . . .

—

—

—

Balance at December 31, 2000 . . . . . . . . 23,205,298 2,321 119,080,880
898 138,765,700
305,231
—

Initial public offering . . . . . . . . . . . . . 8,984,375
22,072
Exercise of stock options . . . . . . . . . .
—
Net income . . . . . . . . . . . . . . . . . . .
Comprehensive loss:

2
—

— $ (341,465) $118,741,736
4,598,196
—

4,598,196

—
—
—
—

4,256,731

123,339,932
— 138,766,598
305,233
—
8,672,042
8,672,042

FASB Statement No. 133  (derivative)
transition adjustment . . . . . . . . . .
Net change  in hedging transaction . .

Total comprehensive loss . . . . . . . . . .

—
—

—

—
—

—

—
—

(910,009)
(246,727)

—
—

(910,009)
(246,727)

— (1,156,736)

— (1,156,736)

Balance at December 31, 2001 . . . . . . . . 32,211,745 3,221 258,151,811
45
4,401,717
— 2,158,863
(6,014,790)
(43)
(208,828)
—
—
—

Exercise of stock options . . . . . . . . . .
Tax benefit of stock option exercises . .
Stock repurchase and retirement . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . .
Net income . . . . . . . . . . . . . . . . . . .
Comprehensive gain:

452,921
—
(435,000)
—
—

269,927,069
12,928,773
(1,156,736)
4,401,762
—
—
2,158,863
—
—
— (6,014,833)
—
(208,828)
—
—
29,782,705
— 29,782,705

Net change in hedging transaction . .

—

—

—

785,049

—

785,049

Balance at December 31, 2002 . . . . . . . . 32,229,666 $3,223 $258,488,773 $ (371,687) $42,711,478 $300,831,787

See accompanying notes.

F-5

Cross Country, Inc.

Consolidated Statements of Cash Flows

Operating  activities
Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Adjustments to  reconcile net income to net cash provided  by operating activities:

Amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Depreciation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Bad debt  expense . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Deferred income taxes expense (benefit) . . . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Estimated  loss on disposal of discontinued operations
. . . . . . . . . . . . . . . . . .
Cumulative interest due at maturity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Extraordinary loss on early extinguishment of debt
. . . . . . . . . . . . . . . . . . . .
Changes in operating assets and liabilities:

Accounts receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Prepaid  rent, deposits, and other current assets . . . . . . . . . . . . . . . . . . . . .
Accounts payable and accrued  expenses . . . . . . . . . . . . . . . . . . . . . . . . . .
Other current liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Net cash provided by continuing operations . . . . . . . . . . . . . . . . . . . . . . . . .
Loss from discontinued operations, net
. . . . . . . . . . . . . . . . . . . . . . . . . .
Loss on impairment of discontinued operations . . . . . . . . . . . . . . . . . . . . .
Change in net assets from discontinued operations . . . . . . . . . . . . . . . . . . .

Year Ended December 31,

2002

2001

2000

$29,782,705

$ 8,672,042

$ 4,598,196

3,147,952
3,524,004
242,230
3,978,365
3,883,436
—
—
—

(6,870,488)
4,559,599
2,283,599
359,968

44,891,370
(3,883,436)
4,142,750
(3,729,804)

14,851,382
2,699,916
1,273,656
(169,137)
741,006
206,710
4,321,000
4,783,705

13,624,161
1,323,397
432,973
(164,055)
1,679,774
453,832
3,839,000
—

(17,627,379)
(125,959)
1,242,312
832,835

(15,096,272)
1,215,833
2,344,984
79,621

21,702,089
(741,006)
—
(1,166,224)

14,331,444
(1,679,774)
—
(1,057,774)

Net cash used in discontinued operations

. . . . . . . . . . . . . . . . . . . . . . .

(3,470,490)

(1,907,230)

(2,737,548)

Net cash provided by operating activities . . . . . . . . . . . . . . . . . . . . . . . . . . . .

41,420,880

19,794,859

11,593,896

Investing activities
Acquisition  of Heritage Professional Education, LLC . . . . . . . . . . . . . . . . . . . .
Acquisition  of Clinforce, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition  of Gill/Balsano Consulting, L.L.C. . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition  of NovaPro . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Acquisition  of Jennings, Ryan & Kolb, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . .
Purchases of property and equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Investing activities of discontinued operations . . . . . . . . . . . . . . . . . . . . . . . . .

(1,500,000)
—
(498,750)
(7,906,527)
(1,876,008)
(7,240,897)
72,266
384,375

(241,145)
(32,824,592)
(1,881,000)
—
—
(5,783,283)
99,949
(1,691,093)

(6,200,000)
—
—
—
—
(1,992,109)
—
(2,588,800)

Net cash used in investing activities

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(18,565,541)

(42,321,164)

(10,780,909)

Financing activities
Debt issuance costs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Exercise of stock options . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Initial public offering . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock repurchase and retirement
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Repayment of  debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Proceeds from issuance of debt . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Net cash (used in) provided by financing activities . . . . . . . . . . . . . . . . . . . . . .
Change in cash and cash equivalents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Cash and  cash  equivalents at beginning of year . . . . . . . . . . . . . . . . . . . . . . . .

(153,747)
4,401,762
(208,828)
(6,014,833)
(30,155,707)
23,750,000

(8,381,353)
14,473,986
2,735,960

(981,833)
205,598
138,766,598
—
(320,193,108)
207,465,010

25,262,265
2,735,960
—

—
—
—
—
(65,258,097)
59,617,233

(5,640,864)
(4,827,877)
4,827,877

Cash and  cash  equivalents at end of year . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$17,209,946

$ 2,735,960

Supplemental  disclosure of noncash investing and financing activities
Issuance  of common stock in exchange for employee  services . . . . . . . . . . . . . . .

$

— $

99,635

$

$

Tax benefit on  stock option exercises . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 2,158,863

$

— $

—

—

—

Supplemental  disclosure of cash flow information
Interest  paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 3,785,670

$ 11,779,213

$10,711,873

Income taxes  paid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$11,683,839

$ 5,972,007

$

221,467

See accompanying notes.

F-6

Cross Country, Inc.

Notes to Consolidated Financial Statements

December 31, 2002

1. Organization and Basis of Presentation

On July 29, 1999, Cross Country Staffing, Inc. (CCS), a  Delaware corporation, was established
through an acquisition of certain assets and liabilities of Cross Country Staffing, a Delaware general
partnership (the Partnership). The acquisition  included certain identifiable intangible assets primarily
related to proprietary databases and contracts. The Partnership was engaged  in the business of
providing nurses and other allied health personnel to health  care providers primarily on a contract
basis. CCS recorded the assets and certain assumed liabilities, as  defined in the asset purchase
agreement, at fair market value. The  purchase  price of approximately $189,000,000 exceeded  the fair
market value of the assets less the assumed liabilities by  approximately  $167,537,000, which, was
recorded  as goodwill and other identifiable intangible assets.

On December 16, 1999, CCS entered  into  a Plan of Merger with TravCorps Corporation

(TravCorps). TravCorps and its wholly-owned  subsidiary, Cejka & Company (Cejka), provide flexible
staffing, search, consulting, and related outsourced services to health  care providers throughout the
United States. Pursuant to the Plan of  Merger on  December 16,  1999, all outstanding shares of
TravCorps’ common stock were exchanged for common  stock in CCS and TravCorps became  a wholly-
owned subsidiary of CCS. As a result of the transaction, there were approximately $1,300,000 of
non-capitalizable transaction costs for the  year ended December 31, 2000, which consisted primarily of
transition bonuses related to the TravCorps  acquisition,  which  are included in non-recurring indirect
transaction costs in the consolidated statements of operations. The  fair value of the shares of common
stock issued to the stockholders of TravCorps, as determined by a valuation  of the common stock as of
December 16, 1999, was $32,102,000.  The  purchase  price  exceeded the fair value of the  net tangible
assets acquired by approximately $66,575,000,  of  which $10,243,000 was allocated to certain identifiable
intangible assets ($5,800,000—trademark, $2,910,000—databases, $630,000—workforce, $900,000—
hospital relations, and $3,000—covenant  not to compete). The remaining $56,332,000  was allocated  to
goodwill. Subsequent to the adoption of Financial  Accounting Standards Board (FASB) Statement
No. 142, the amount originally recorded  as workforce was reclassified  to goodwill.

Effective October 1, 2000, TravCorps  changed its name to TVCM, Inc.  (TVCM). Effective
October 10, 2000, CCS changed its name  to  Cross Country TravCorps, Inc. (CCT).  Subsequent to
December 31, 2000, CCT changed its  name to Cross Country,  Inc. (the Company). The Company  is
primarily engaged in the business of  providing temporary health care staffing  services to acute and
subacute care facilities nationwide.

The consolidated financial statements include the accounts  of the Company  and its wholly-owned

direct and indirect subsidiaries: CC Staffing, Inc., Cross Country TravCorps,  Inc., Cross Country
TravCorps, Inc. Ltd., TVCM, Inc. (f/k/a  TravCorps), Cross  Country Local, Inc. (f/k/a Flexstaff, Inc.),
Cejka & Company, E-Staff, Inc. (E-Staff),  CFRC,  Inc., HospitalHub, Inc. (f/k/a Ashley
One, Inc.)(HospitalHub), NovaPro, Inc.,  Cross Country Consulting, Inc.,  Cross  Country Seminars, Inc.
(f/k/a CCS/Heritage Acquisition Corp.)  (Cross Country Seminars), Clinforce,  Inc. (ClinForce),
Assignment America, Inc, and Vendor Management Solutions,  Inc. At December 31, 2002, CFRC, Inc.
and HospitalHub were dissolved. All material intercompany transactions and balances have been
eliminated in consolidation.

F-7

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

2. Summary of Significant Accounting Policies

Use of Estimates

The preparation of the consolidated  financial statements in conformity with accounting principles
generally accepted in the United States requires management to make estimates and  assumptions that
affect the reported amounts in the consolidated financial statements and accompanying notes. Actual
results could differ from those estimates.

Accounts Receivable and Concentration of  Credit Risk

Financial instruments that potentially subject  the Company to concentrations of credit risk  as

defined by FASB Statement No. 105, Disclosure of Information About Financial Instruments  With
Off-Balance-Sheet Risk and Financial Instruments With Concentrations of Credit Risk, consist principally
of accounts receivable. The Company’s  customers are health  care providers and accounts  receivable
represent amounts due from these providers. The Company performs ongoing  credit evaluations  of its
customers’ financial conditions and, generally,  does not require collateral. The allowance  for doubtful
accounts represents the Company’s estimate for  uncollectible  receivables based  on a  review of specific
accounts and the Company’s historical collection experience. The Company  writes-off specific accounts
based on an ongoing review of collectibility  as well as  management’s past experience with the customer.
The Company’s contract terms are typically between 30 to 60 days and will be considered past due
based on the particular negotiated contract terms.

Overall, based on the large number of customers in differing geographic areas throughout the
United States and its territories, the Company believes  the concentration  of  credit risk is  limited. As of
December 31, 2002, an aggregate of  approximately 9% of the Company’s outstanding accounts
receivable were due from five customers. As  of  December 31,  2001, an  aggregate  of approximately  8%
of the outstanding accounts receivable were due from  four customers.

Cash and Cash Equivalents

The Company considers all investments with original maturities of  less  than three  months to be

cash and cash equivalents.

Prepaid Rent and Deposits

The Company leases a number of apartments for its  employees under  short-term agreements
(typically three to six months), which generally coincide with  each employee’s staffing contract.  As a
condition of these agreements, the Company places  security deposits on the leased apartments. Prepaid
rent and deposits relate to these short-term agreements.

Property and Equipment

Property and equipment are stated at  cost, less accumulated  depreciation. Depreciation is

determined on a straight-line basis over the estimated useful lives of  the  assets, which  generally range
from three to seven years. Leasehold improvements are depreciated over  the lives of the  related leases
or the useful life of an individual lease, whichever is shorter.

F-8

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

2. Summary of Significant Accounting Policies (Continued)

Certain software development costs are capitalized in accordance with the provisions of Statement
of Position 98-1, Accounting for the Costs of Computer Software Developed or Obtained  for Internal Use.
Such costs include charges for consulting services  and  costs for  personnel associated with programming,
coding, and testing such software. Amortization  of capitalized software costs begins  when the software
is placed into service and is included  in depreciation expense  in the  accompanying consolidated
statements of operations. Software development costs are being amortized  using  the straight-line
method over five years. Certain software development  costs related  to  the development  of  the E-Staff
technology were capitalized in accordance with the provisions of FASB Statement No.  86, Accounting
for Costs of Computer Software to Be  Sold, Leased, or Otherwise Marketed. Such costs include charges for
consulting services and costs for personnel associated  with programming, coding, and testing such
software. These costs are included in  assets from discontinued operations, net, at December 31, 2002
and 2001. See Note 16 for a further  discussion on discontinued  operations. Through December  31,
2002, the Company has not recognized any revenue from the sale of software.

Reserves for Claims

Workers’ compensation, professional liability and  health care benefits are provided under  partially
self-insured plans. The Company records  its estimate  of  the  ultimate cost  of,  and reserves for, workers’
compensation and professional liability  benefits  based on  actuarial computations using the Company’s
loss history as well as industry statistics. Furthermore, in  determining  its  reserves, the  Company
includes reserves for estimated claims  incurred but  not  reported.

The ultimate cost of workers’ compensation  and  professional liability costs  will depend on actual

costs incurred to settle the claims and may differ from the  amounts reserved by the  Company for those
claims.

In August 2001, the Company changed its professional liability coverage  from an occurrence to a
claims made basis. The professional liability  policy  provides for coverage in the amount of $1,000,000
per  claim and $3,000,000 in the aggregate  as  well as excess  coverage in the  amount  of $10,000,000 per
claim and $10,000,000 in the aggregate.  In addition, there  is a $100,000 deductible  per  occurrence.

In August 2002, the Company changed its professional and general liability policy to include a
self-insured limit of $2,000,000 per claim  through  a self-insured  retention, as well  as excess coverage in
the amount of $10,000,000 in the aggregate. There is no deductible  per  occurrence.

Accruals for workers’ compensation claims, health care benefits and professional liability insurance

are included in accrued employee compensation and benefits in  the consolidated balance sheets.

Goodwill and Other Identifiable Intangible  Assets

Goodwill represents the excess of purchase price over  the fair  value of net assets  acquired.  The

Company adopted the provisions of FASB  Statement No. 142, Goodwill and Other Intangible Assets, as
of January 1, 2002. FASB Statement No.  142  further clarifies the criteria to recognize intangible assets
separately from goodwill and promulgates  that goodwill and certain intangible  assets with  indefinite
lives not be amortized. Instead, these  assets are reviewed for  impairment annually with  any related
losses recognized in earnings when incurred. Other identifiable intangible assets  continue to be

F-9

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

2. Summary of Significant Accounting Policies (Continued)

amortized, under the provisions of this Statement, using the straight-line method over their estimated
useful lives ranging from 3 to 15 years.

In accordance with FASB Statement No. 142, the Company completed the transitional impairment

test of goodwill and indefinite-lived intangible assets during the first quarter of 2002. The transitional
impairment test required the Company  to  determine the  fair value of  each reporting unit, as defined,
and compare it to the reporting unit’s carrying amount. The Company estimated the  fair value of its
reporting units using a discounted cash  flow  methodology. Based on the results of the initial test  and a
subsequent annual impairment test during  the fourth quarter of 2002, the Company determined  that
there was no impairment of goodwill  or  indefinite-lived intangible  assets as of January 1 or
December 31, 2002.

Long-lived assets and identifiable intangible  assets with  definite lives are  evaluated  for impairment

in accordance with FASB Statement No.  144, Accounting for the Impairment or Disposal  of  Long-Lived
Assets, adopted as of January 1, 2002. In accordance  with this Statement, long-lived assets  are reviewed
for impairment whenever events or changes in circumstances indicate  that  the carrying amount may not
be recoverable. The Company periodically reviews  long-lived assets, including identifiable  intangible
assets, to determine if any impairment  exists based upon projected,  undiscounted  net cash  flows  of  the
Company. Recoverability of intangible  assets is measured by comparison of the carrying  amount  of the
asset to net future cash flows expected to be generated from the asset. At  December 31,  2002 and
2001, the Company believes that no impairment  of long-lived assets or identifiable intangible assets
exists.

Debt Issuance Costs

Deferred costs related to the issuance of debt are being  amortized on a straight-line  basis, which

approximates the effective interest method, over the six-year  term of the  debt. Subsequent to the
Company’s initial public offering in 2001,  the Company  repaid  $89,580,000 of its outstanding balance
under the term loan portion of its senior secured credit  facility, and  paid $38,779,000 to redeem its
outstanding senior subordinated pay-in-kind notes. Related  debt issuance costs of $6,433,000, net,  were
written off and included in extraordinary  loss on  early extinguishment of debt  in the 2001  consolidated
statement of operations. At December  31, 2002 and 2001, debt issuance costs of  approximately
$1,105,000 and $1,390,000, net of accumulated amortization  of  approximately  $1,237,000 and $798,000,
respectively, are included in the consolidated  balance  sheets.

Revenue Recognition

Revenue from services consists primarily of temporary staffing  revenues. Revenue  is recognized
when services are rendered. Accordingly,  accounts receivable includes an  accrual  for employees’ time
worked but not yet invoiced. At December  31, 2002 and 2001,  the amounts accrued  are approximately
$17,982,000 and $15,051,000, respectively.

Revenues on permanent and temporary placements  are recognized when services provided are
substantially completed. The Company does not, in the  ordinary  course of business, give refunds.  If a
candidate leaves a permanent placement  within a  short period of time (i.e., one month), it is customary
for the Company to seek a replacement  at no  additional cost. Allowances are established as  considered

F-10

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

2. Summary of Significant Accounting Policies (Continued)

necessary to estimate significant losses  due to placed candidates not remaining employed for  the
Company’s guarantee period. During  2002, 2001 and 2000, such losses were not material and,
accordingly, related allowances were  not  recorded.

Revenue from the Company’s education and  training  services is recognized as the  instructor-led

seminars are performed and the related  learning  materials  are delivered.

During  2002, the Company adopted the  provisions of FASB’s Emerging Issues Task Force (EITF)

Issue No. 01-14, Income Statement Characterization of Reimbursements Received for ‘‘Out-of-Pocket’’
Expenses Incurred.  This  EITF  requires  that  reimbursements  received  for  out-of-pocket  expenses  should
be characterized as revenue and a corresponding expense in the consolidated statements of operations.
Prior to  the adoption of this EITF, the Company reflected  the reimbursement of out-of-pocket
expenses  as an offsetting reduction to  direct operating  expenses  and selling, general, and  administrative
expenses. Accordingly, the Company has adjusted all periods reported to reflect  an increase in  revenue,
and  an equal and offsetting increase in  expenses, related to  reimbursable expenses.  The  associated
amount of reimbursable expenses that are included  in revenue  for  the years ending December 31, 2002,
2001 and 2000 was approximately $10,963,000, $3,861,000, and $642,000, respectively. The
corresponding effect on selling, general  and administrative  expenses of the other human capital
management services business segment  in 2002, 2001 and 2000  was approximately $1,635,000,
$1,221,000, and $642,000, respectively.  The effect on direct  costs of the  healthcare staffing  business
segment for the years ending December 31, 2002  and 2001 was approximately $9,328,000  and
$2,640,000,  respectively.  This  change  in  classification  has  not  had  an  affect  on  current  or  previously
reported net income, or net income per share.

Stock-Based Compensation

The Company, from time to time, grants stock options for  a  fixed  number of common  shares to
employees. The Company accounts for employee  stock option grants in accordance with  Accounting
Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and accordingly,
recognizes no compensation expense for stock option grants when the  exercise  price of the options
equals, or is greater than, the market  value  of  the underlying stock on the close  of  business  on the  date
immediately preceding the date of grant.

In December 2002, the FASB issued FASB Statement No. 148, Accounting for Stock Based
Compensation—Transition and Disclosure. FASB Statement  No. 148 provides two additional transition
methods for entities that adopt the preferable  method of accounting  for  stock  based compensation.
Further, the Statement requires disclosure of comparable information for  all  companies regardless of
whether, when, or how an entity adopts  the preferable, fair value  based method  of  accounting. These
disclosures are now required for interim periods  in addition to the traditional annual disclosure. FASB
Statement No. 148 is effective for fiscal  periods ending after December 15, 2002. The pro-forma
disclosure  of  stock  based  compensation  required  by  this  Statement  is  shown  below.

The Company’s consolidated net income  would have changed to the pro forma amounts set  forth

below had compensation cost for stock options  granted during 2002,  2001 and 2000 been  measured

F-11

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

2. Summary of Significant Accounting Policies (Continued)

under the fair value based method prescribed by FASB Statement No. 123, Accounting for Stock-Based
Compensation.

Net income as reported . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock based employee compensation  included  in as reported

net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Stock based employee compensation,  net of  tax, applying FASB
Statement No. 123 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Year ended December 31,

2002

2001

2000

$29,782,705

$8,672,042

$4,598,196

—

—

—

(2,774,445)

(1,934,711)

(1,779,467)

Pro forma net income applying FAS Statement No. 123 . . . . . .

$27,008,260

$6,737,331

$2,818,729

Basic and diluted earnings per share as  reported:
Net income per common share—basic . . . . . . . . . . . . . . . . . . .

Net income per common share—diluted . . . . . . . . . . . . . . . . .

Pro forma basic and diluted earnings  per  share:
Pro forma net income—basic . . . . . . . . . . . . . . . . . . . . . . . . .

Pro forma net income—diluted . . . . . . . . . . . . . . . . . . . . . . . .

$

$

$

$

0.92

0.88

0.83

0.81

$

$

$

$

0.35

0.34

0.27

0.27

$

$

$

$

0.20

0.20

0.12

0.12

Advertising

The Company’s advertising expense consists  primarily of  print media, online advertising, direct
mail  marketing, and promotional material. Advertising costs  that are not considered direct  response  are
expensed as incurred and were approximately $5,918,000, $3,735,000 and $2,450,000 for  the years ended
December 31, 2002, 2001 and 2000, respectively. Direct response  advertising costs associated with the
Company’s education and training services are capitalized  and expensed when the related event takes
place. At December 31, 2002 and 2001  approximately $1,264,000 and $1,143,000, respectively, of these
costs are included in other current assets  in the  consolidated  balance  sheets.

Derivative Financial Instruments

The Company is exposed to market risks arising from  changes in  interest rates. To protect  against

such risks, the Company has one derivative financial instrument, an interest rate swap  agreement, which
is more fully disclosed in Note 14, Interest Rate Swap.

Comprehensive Income

FASB Statement No. 130,  Comprehensive Income, requires that an enterprise: (a) classify items of

other comprehensive income by their nature in  the financial statements; and (b) display  the
accumulated balance of other comprehensive  income separately from retained earnings and additional
paid-in capital in the equity section of the balance  sheet. The  items of other  comprehensive income
that are typically required to be displayed  are foreign currency items, minimum  pension liability
adjustments and unrealized gains and  losses on certain investments in debt and  equity securities.  There

F-12

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

2. Summary of Significant Accounting Policies (Continued)

are no other components of comprehensive income or loss other than the Company’s consolidated net
income for the years ended December 31,  2002, 2001 and 2000, and  the accumulated derivative gain or
loss for the years ended December 31, 2002 and 2001.

During  1998, the FASB issued Statement No.  133, Accounting for Derivative Instruments and
Hedging Activities, which was effective beginning January 1, 2001.  FASB Statement  No. 133 requires
companies to recognize all of its derivative  instruments as either assets  or  liabilities in the statement of
financial position at fair value. The accounting  for changes  in the fair value (i.e., gains or  losses)  of  a
derivative instrument depends on whether it  has been designated and  qualifies  as part of a hedging
relationship and further, on the type of  hedging relationship. For  those derivative  instruments that are
designated and qualify as hedging instruments, a company must designate the hedging instrument,
based upon the exposure being hedged, as either a fair value hedge,  cash flow hedge or a hedge of a
net investment in a foreign operation.  As the Company’s derivative instrument is  designated and
qualifies as a cash flow hedge (i.e., hedging the exposure to  variability  in expected future cash flows
that is attributable to a particular risk), the  effective  portion of the gain or  loss on the derivative
instrument is reported as a component  of other comprehensive income and  reclassified into earnings  in
the same period or periods during which the hedged transaction  affects earnings. Any ineffective
portion of a derivative instrument’s change in fair value is  immediately recognized in earnings.

The Company implemented the provisions of FASB Statement  No. 133 on January  1, 2001. The
implementation of FASB Statement No. 133 resulted in a reduction in consolidated stockholders’ equity
of approximately $910,000 as of January  1, 2001.

During 2002 and 2001, the Company reclassified  to  interest expense approximately $1,720,000 and

$325,000, respectively, of the net amount recorded in  other  comprehensive loss.

Income Taxes

The Company accounts for income taxes  under  FASB Statement No. 109, Accounting for Income
Taxes. Deferred income tax assets and liabilities are determined based upon  differences between the
financial reporting and tax bases of assets  and  liabilities and  are  measured using the enacted tax  rates
and laws that will be in effect when the  differences are expected to reverse.

Reclassifications

Certain 2001 and 2000 amounts have been reclassified to conform to the 2002 presentation.

Recently Issued Accounting Standards

In April 2002, the FASB issued FASB  Statement No.  145, Rescission of Statements 4, 44, and 64,

Amendment of FASB Statement No. 13, and Technical Corrections. This Statement rescinds FASB
Statement No. 4, Reporting Gains and Losses from Extinguishment  of Debt, and an amendment of that
Statement, FASB Statement No. 64, Extinguishments of Debt Made to Satisfy Sinking-Fund Requirements.
This Statement also rescinds FASB Statement No. 44, Accounting for Intangible Assets of Motor Carriers.
This Statement amends FASB Statement  No. 13, Accounting for Leases, to eliminate an inconsistency
between the required accounting for  sale-leaseback transactions and the required accounting for certain
lease modifications that have economic effects that are  similar  to  sale-leaseback transactions. This

F-13

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

2. Summary of Significant Accounting Policies (Continued)

Statement also amends other existing  authoritative pronouncements to make various technical
corrections, clarify meanings, or describe  their applicability under changed conditions. The Company
has not adopted the provisions of this  Statement as of December 31, 2002.  The provisions of  this
Statement related to the rescission of  Statement  4 are effective for fiscal years beginning after May 15,
2002. Any gain or loss on extinguishment  of debt that was classified as an  extraordinary item  in prior
periods presented that does not meet the  criteria in  Opinion 30 for classification as an extraordinary
item shall be reclassified. Accordingly, the  extraordinary loss on early extinguishment of debt will  be
reclassified upon adoption of this standard in  the year ending December  31, 2003.

In July 2002, the FASB issued FASB  Statement No. 146, Accounting for Costs Associated with Exit
or Disposal Activities. FASB Statement No. 146 requires that a  liability  for  a cost that  is associated  with
an exit  or disposal  activity be recognized when the liability is incurred. It nullifies  the guidance in  EITF
Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other  Costs to Exit an
Activity (including Certain Costs Incurred in a Restructuring). Under EITF 94-3, an entity recognized a
liability for an exit cost on the date that the  entity  committed itself to an exit plan.

Under FASB Statement No. 146, an entity’s  commitment to a plan does not, by itself,  create a
present  obligation to other parties that  meets  the definition  of a liability. FASB  Statement No. 146 will
be effective for exit or disposal activities  that are initiated after December 31,  2002. The Company  has
not adopted the provisions of FASB Statement No. 146 in  the December  31, 2002 consolidated
financial statements, or for any prior  periods. The adoption of  FASB No. 146 is expected  to  impact  the
timing of  recognition of costs associated  with future  exit and disposal activities.

3. Goodwill and Other Identifiable  Intangible Assets

As of December 31, 2002 and 2001, the Company  had  the following acquired  intangible assets:

December 31, 2002

December 31,  2001

Gross Carrying
Amount

Accumulated
Amortization

Net Carrying Gross Carrying

Amount

Amount

Accumulated
Amortization

Net Carrying
Amount

Intangible assets
subject  to
amortization:

Database . . . . . . . . .
Hospital relations
. . .
Non-compete

$ 11,445,000
3,988,750

$ 7,692,129
813,402

$ 3,752,871
3,175,348

$ 11,350,000
3,820,000

$ 5,382,526
548,694

$ 5,967,474
3,271,306

agreements . . . . . .

503,000

318,556

184,444

253,000

183,555

69,445

$ 15,936,750

$ 8,824,087

$ 7,112,663

$ 15,423,000

$ 6,114,775

$ 9,308,225

Intangible assets not

subject  to
amortization:

. . . . . . . . .
Goodwill
Trademarks . . . . . . . .

$246,988,940
17,150,000

$20,873,294
1,401,169

$226,115,646
15,748,831

$239,622,152
16,800,000

$20,873,294
1,401,169

$218,748,858
15,398,831

$264,138,940

$22,274,463

$241,864,477

$256,422,152

$22,274,463

$234,147,689

F-14

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

3. Goodwill and Other Identifiable  Intangible Assets (Continued)

Aggregate amortization expense for intangible  assets subject to amortization was approximately

$2,709,000, $2,626,000 and $2,602,000 for the years ended December 31, 2002, 2001 and 2000,
respectively. Estimated annual amortization expense is approximately as follows:

Year ending December 31:

2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2006 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2007 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$2,653,000
934,000
722,000
692,000
267,000
1,845,000
$7,113,000

The changes in the carrying amount of goodwill  by segment  are as  follows: 

Healthcare

Other Human Capital
Staffing Segment Management Services

Unamortized
Goodwill

Balance as of December 31, 2001 . . . . . . . . . . . . .
Goodwill acquired . . . . . . . . . . . . . . . . . . . . . . . .
Earnout paid to Heritage . . . . . . . . . . . . . . . . . . .
Earnout paid to Gill/Balsano . . . . . . . . . . . . . . . . .

$200,873,357
4,668,127
—
—

Balance as of December 31, 2002 . . . . . . . . . . . . .

$205,541,484

$17,875,501
699,911
1,500,000
498,750

$20,574,162

$218,748,858
5,368,038
1,500,000
498,750

$226,115,646

The following reconciliation adjusts net income to exclude amortization expense  related to

intangible assets that would not have  been  amortized, under the provisions of FASB Statement No. 142,
if the Company adopted the standard  as of January  1, 2000:

Year Ended December 31,

2001

2000

Net income, as reported . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill amortization, net of tax . . . . . . . . . . . . . . . . . . . . . . . .
Trademark amortization, net of tax . . . . . . . . . . . . . . . . . . . . . . .

$ 8,672,042
6,763,799
399,245

$ 4,598,196
5,986,109
358,680

Adjusted net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$15,835,086

$10,942,985

Basic earnings per share:
Net income, as reported . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill amortization, net of tax . . . . . . . . . . . . . . . . . . . . . . . .
Trademark amortization, net of tax . . . . . . . . . . . . . . . . . . . . . . .

Adjusted net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Diluted earnings per share:
Net income, as reported . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Goodwill amortization, net of tax . . . . . . . . . . . . . . . . . . . . . . . .
Trademark amortization, net of tax . . . . . . . . . . . . . . . . . . . . . . .

$

$

$

Adjusted net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$

0.35
0.27
0.02

0.64

0.34
0.27
0.02

0.63

$

$

$

$

0.20
0.26
0.01

0.47

0.20
0.26
0.01

0.47

Basic weighted average shares outstanding . . . . . . . . . . . . . . . . . .
Diluted weighted average shares outstanding . . . . . . . . . . . . . . . .

24,881,218
25,222,936

23,205,388
23,205,388

F-15

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

4. Acquisitions

Effective December 26, 2000, Cross Country Seminars acquired substantially all of  the assets of

Heritage Professional Education, LLC  (Heritage),  a Tennessee limited liability company.  Heritage
provides continuing professional education  courses to medical and healthcare personnel through
seminars and study programs servicing the healthcare industry. The acquisition met the accounting
criteria of a purchase and, accordingly,  the accompanying consolidated financial statements include  the
results of Heritage from the acquisition  date. The consideration  for this acquisition included $6,200,000
in cash and a post-closing adjustment of approximately $422,000. The excess of  the aggregate purchase
price over the fair market value of the  assets acquired of approximately $6,655,000 was allocated to
goodwill and, prior to the adoption of FASB Statement  No. 142, was being amortized  over 25 years. In
addition, the asset purchase agreement provides for potential earnout payments of approximately
$6,500,000 based on adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA)
(as defined in the asset purchase agreement) of Heritage  over  a three-year period ending December  31,
2003. This contingent consideration is  not  related to the  seller’s employment.  Upon  payment, the
earnouts will be allocated to goodwill  as additional purchase price. To date, earnout payments were
$3,500,000, of which $1,500,000 was paid  in 2002 and $2,000,000 was  paid in 2003.

On December 15, 2000, the Company  entered  into  a stock purchase agreement to acquire

substantially all of the outstanding stock of  two subsidiaries that  comprise ClinForce, Inc., a Delaware
corporation that provides temporary staffing and permanent placement of clinical  trials support services
personnel. The acquisition was consummated on March 16, 2001 and met the accounting criteria of a
purchase. Accordingly, the accompanying consolidated financial statements include the results of
ClinForce from the acquisition date.  The transaction was primarily funded through the  issuance  of
additional debt. The purchase price of approximately  $31,400,000 exceeded the fair value of assets
acquired less liabilities assumed by approximately  $28,000,000 of which $3,400,000 was allocated to
certain identifiable intangible assets ($2,100,000—trademark,  $890,000-workforce, and $410,000—
hospital relations). The remaining $24,600,000 was  allocated to goodwill and, prior to the  adoption of
FASB Statement No. 142, was being  amortized over 25 years. Subsequent to the adoption of  FASB
Statement No. 142, workforce was reclassified to goodwill. The purchase price was subject  to  a
post-closing adjustment based on changes  in the  net working capital of the acquired companies between
October 31, 2000 and March 16, 2001. The  post closing adjustment  of  approximately  $1,415,000 was
calculated and allocated to goodwill as  additional purchase  price.

In May 2001, Cejka acquired substantially all  of  the assets of Gill/Balsano Consulting,  L.L.C. (Gill/

Balsano), a Delaware limited liability  company. Gill/Balsano provides management consulting services
to the healthcare industry. The acquisition  met the  accounting criteria of a purchase, and, accordingly,
the accompanying consolidated financial  statements  include the results of Gill/Balsano  from the
acquisition date. The consideration for  this acquisition was $1,831,000 in cash. The excess of  the
aggregate purchase price over the fair market value  of the  assets acquired of approximately $1,674,000
was allocated to goodwill and, prior to  the  adoption of FASB Statement No.  142, was being amortized
over 25 years. In addition, the asset purchase agreement provides for potential earnout payments of
approximately $1,995,000 based on adjusted EBITDA (as defined in  the asset purchase agreement) of
Gill/Balsano over a 3 year period ending  March  31, 2004. This contingent consideration is not related
to the seller’s employment. Upon payment,  the earnouts will be allocated to goodwill as additional
purchase  price.  To  date,  earnout  payments  were  $1,163,750,  of  which  $665,000  was  paid  in  2003.

F-16

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

4. Acquisitions (Continued)

The Company adopted the provisions  of  FASB Statement No. 141, Business Combinations, as of
January 1, 2002. FASB Statement No. 141 eliminates the  pooling-of-interests method of  accounting for
business combinations. In January 2002, the  Company acquired substantially all of the assets of
NovaPro, the healthcare staffing division of HRLogic Holdings, Inc., a professional  employer
organization, for approximately $7,100,000 in  cash and a post-closing adjustment of  approximately
$544,000. Approximately $4,668,000 was  allocated to goodwill, which is  not subject to amortization
under the provisions of FASB Statement  No. 142. NovaPro targets nurses seeking more  customized
benefits packages.

In March 2002, the Company acquired all of the outstanding stock of Jennings,  Ryan & Kolb, Inc.

(JRK),  a healthcare management consulting company, for approximately $1,800,000  in cash and  the
assumption of $300,000 in debt. Approximately $700,000 was allocated  to  goodwill, which is not subject
to amortization under the provisions  of FASB Statement No. 142. In addition, the agreement  provides
for potential earnout payments of approximately $1,800,000, of which approximately $530,000 was
earned in 2002 and was paid in 2003.

Both acquisitions were accounted for  in accordance with FASB  Statement No. 141 and,
accordingly, their results of operations  have been included  in the 2002  consolidated  statement  of
operations from their respective dates of acquisition.

The following unaudited pro forma summary presents the consolidated results of operations as if

the Company’s acquisitions had occurred as of the beginning of each period  presented,  after giving
effect to certain adjustments, including  amortization of  goodwill  and other specifically identifiable
intangibles, interest expense incurred  on  additional borrowings and  related income tax effects. E-Staff,
Gill/Balsano, NovaPro and JRK’s results of  operations have been excluded  from the pro forma
financial information as amounts are considered immaterial  to  the Company.  The  pro forma  financial
information does not purport to be indicative of the results  of operations that would have  occurred had
the transactions taken place at the beginning  of the periods presented  or of future results  of
operations.

Revenue from services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$512,056,388

$408,1374,982

Income before extraordinary item . . . . . . . . . . . . . . . . . . . . .

$ 13,363,097

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 8,579,392

Net income per common share—basic and diluted . . . . . . . . .

$

0.34

$

$

$

4,611,097

4,611,097

0.20

Year ended December 31,

2001

2000

F-17

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

5. Property and Equipment

At December 31, 2002 and 2001, property and equipment consist of the following:

December 31,

2002

2001

Computer equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Computer software . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Office equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Furniture and fixtures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Leasehold improvements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 8,494,676
10,853,523
1,462,272
2,739,264
1,773,038

$6,628,166
6,219,647
1,189,137
1,799,142
1,451,642

Less accumulated depreciation and amortization . . . . . . . . . . . . . .

25,322,773
(12,928,611)

17,287,734
(8,785,801)

$12,394,162

$8,501,933

6. Accrued Employee Compensation  and  Benefits

At December 31, 2002 and 2001, accrued  employee compensation and  benefits consist of the

following:

December 31,

2002

2001

Salaries . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Bonuses
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Accrual  for workers’ compensation claims . . . . . . . . . . . . . . . . . .
Accrual  for health care benefits . . . . . . . . . . . . . . . . . . . . . . . . .
Accrual  for professional liability insurance . . . . . . . . . . . . . . . . . .
Accrual  for vacation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$12,873,362
9,238,079
3,117,259
1,822,202
1,870,090
742,240

$10,665,237
10,486,648
2,639,607
1,701,696
533,632
672,848

$29,663,232

$26,699,668

7. Long-Term Debt and Notes Payable

At December 31, 2002 and 2001, long-term  debt  consists of the  following:

Term Loan, interest at 3.05% and 3.03% on  principal of

$33,266,444 and $9,308,962, respectively,  at December 31, 2002
and 4.92% and 4.85% on principal of $35,303,165 and
$9,696,835, respectively, at December 31, 2001 . . . . . . . . . . . . .

Revolving Loan Facility at 6.50% on principal of $2,500,000,  at

December 31, 2001 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Less current portion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

December 31,

2002

2001

$42,575,406

$45,000,000

—
188,533

2,500,000
—

42,763,939
(14,311,336)

47,500,000
(2,424,594)

$28,452,603

$45,075,406

F-18

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

7. Long-Term Debt and Notes Payable (Continued)

On July 29, 1999, the Company entered into  a $105,000,000 senior secured credit facility consisting

of a $75,000,000 term loan and a $30,000,000 revolving loan facility. In March 2001, the senior  credit
facility was amended to increase the term  loan facility to $144,900,000. The Company is required to pay
a quarterly commitment fee at a rate  of 0.50% per year on unused commitments under the revolving
loan facility. The term loan and the revolving loan facility bear interest based on either an  alternate
base rate plus a margin of 0.63% and 1.75% at December  31, 2002 and 2001 respectively, or LIBOR
plus a margin of 1.63% and 2.75% at  December 31,  2002 and 2001, respectively (each as defined in the
senior secured credit facility). During fiscal year  2002, the Company met certain covenants that
provided for the above reduction in interest rates.  The Company  has pledged all of the assets of the
Company as collateral for the senior  credit  facility.

The senior credit facility allows for the issuance of letters of credit  in an aggregate face amount at
any time outstanding not in excess of  $15,000,000 at December 31, 2002.  Additionally, swingline loans,
as defined in the senior credit facility, not  to exceed an aggregate principal amount at any time
outstanding of $7,000,000 are available  under the  senior credit facility.  As of December 31, 2002,
$9,774,693 was outstanding under the  letter  of credit facility.

The senior credit facility requires that the Company meet certain covenants,  including the

maintenance of certain debt and interest  expense  ratios, capital expenditure limits, and the maintenance
of a minimum level of EBITDA (as defined in the  senior credit facility). The senior credit facility also
limits the Company’s ability to repurchase its common stock and  declare and pay cash dividends on its
common stock.

On July 29, 1999, the Company issued $30,000,000 in senior subordinated pay-in-kind notes to two

financial institutions. The proceeds of the  loan were  used  by the Company solely to finance the CCS
acquisition and to pay fees and expenses  incurred in connection  therewith. The interest rate on  the
subordinated notes was 12% per annum,  compounded quarterly. The Company made no  interest
payments on the pay-in-kind notes; rather, accrued  interest was converted into additional pay-in-kind
notes on a monthly basis. The maturity date was the earlier of six months after the final maturity of the
term and revolving debt issuances (January  29, 2006) or  change in control of the Company.

In connection with the issuance of the subordinated debt,  the Company issued 504,468 shares of its
common stock to the financial institutions. Debt issuance costs of $6,920,000 relating to this transaction
were recorded in 1999, which represented  the fair market value of the shares at  the time  of issuance.

On October 30, 2001, the Company completed its initial  public offering of 7,812,500 shares of
common stock at $17.00 per share. Additionally,  the underwriters  exercised the over-allotment option
of 1,171,875 shares, bringing the total  number of  shares issued to 8,984,375. The  proceeds were used to
repay $89,580,000  of the outstanding balance under  the term  loan portion of  the Company’s senior
secured credit facility, $6,100,000 under the revolver portion of the Company’s senior secured credit
facility, and $38,779,000 to redeem the Company’s outstanding senior subordinated pay-in-kind notes.
Prepayment of the pay-in-kind notes  resulted in a  $1,567,000  redemption premium, which, along with
the write-off of $6,433,000 of debt issuance costs discussed in Note 2, has been recorded as  an
extraordinary loss on early extinguishment  of debt  in  the 2001  consolidated statement of  operations.
After a tax benefit of approximately  $3,216,000, extraordinary loss on early extinguishment of debt
totaled approximately $4,784,000 for  the  year ended December 31, 2001.

F-19

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

7. Long-Term Debt and Notes Payable (Continued)

Subsequent to December 31, 2002, the  Company  repaid $15,289,809 of its borrowings under the

term loan portion of the senior credit facility.  The senior credit  facility matures on July 29, 2005.
Subsequent to the payments made in 2003  the aggregate  scheduled maturities of long-term debt are as
follows:

Year ending December 31:

2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2006 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2007 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 6,003,248
14,053,145
7,296,404
22,400
22,400
76,533

$27,474,130

On August 30, 2001, the Company entered into notes payable with a  third-party. The proceeds
from the notes payable were used to pay  the Company’s insurance premiums.  Principal and interest on
these notes are payable over an 11-month  period  at an interest  rate  of 5.75%. At December 31, 2001,
the outstanding balance on these notes  was $1,247,000. The entire  balance was repaid  during  2002.

8. Employee Benefit Plans

The Company maintains a voluntary defined contribution 401(k) profit-sharing  plan covering all
eligible employees as defined in the plan documents. The plan provides  for a discretionary  matching
contribution, which is equal to a percentage  of  each contributing participant’s elective deferral,  which
the Company, at its sole discretion, determines from year to year. Eligible employees  who elect to
participate in the plan are generally vested  in any matching  contribution after three  years  of service
with the Company. Contributions by  the Company, net  of  forfeitures, under  this plan amounted to
approximately $3,030,000, $2,467,000  and $885,000, for the years ended  December 31, 2002, 2001  and
2000, respectively.

TVCM employees  were covered under  a separate benefit plan for 2000. TVCM had  a 401(k)
defined contribution plan for eligible employees. Eligible employees made pretax savings contributions
to the 401(k) plan of up to 20% of their  earnings to a certain statutory limit. TVCM  matched
employee contributions from 1% to 3% of compensation based on years of service. Contributions  to
the 401(k) plan were approximately $630,000 for the year ended December 31, 2000. Effective fiscal
2001, TVCM employees participated  in  the Company’s defined contribution 401(k)  profit-sharing  plan.

F-20

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

9. Commitments and Contingencies

The Company has entered into non-cancelable operating  lease agreements for the rental of space.
Certain of these leases include options to renew  as well  as rent escalation clauses. The rent escalations
have been reflected in the table below. Future  minimum lease payments associated with these
agreements with terms of one year or more  are approximately as follows:

Year ending December 31:

2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2004 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2005 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2006 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2007 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Thereafter . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 3,341,000
3,406,000
2,830,000
2,377,000
2,033,000
3,361,000

$17,348,000

Rent expense related to office facilities  was  approximately $3,345,000,  $2,455,000 and $1,527,000,

for the years ended December 31, 2002, 2001 and  2000, respectively.

The Company is subject to legal proceedings and claims that arise  in the ordinary course of its
business. In the opinion of management, the outcome of  these  matters will not have a  significant effect
on the Company’s consolidated financial position or results of operations.

10. Estimated Fair Value of Financial Instruments

The carrying amounts reported in the consolidated balance sheets  for cash and cash  equivalents,
accounts receivable, and accounts payable and accrued expenses approximate fair  value because of their
short maturity. The carrying amount of the revolving credit  note and  term loan  approximates fair  value
because the interest rate is tied to a quoted variable index.

The Company’s interest rate swap agreement is carried at fair value in accordance with  FASB

Statement No. 133 as discussed in Note  14.

F-21

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

11.

Income Taxes

The components of the Company’s income tax expense (benefit) are  as follows:

Year ended December 31,

2002

2001

2000

Continuing operations:

Current

Federal . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$15,061,237
2,214,552

$9,689,651
1,341,743

$5,966,385
1,004,552

Deferred . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

17,275,789
3,978,365

11,031,394
(169,137)

6,970,937
(164,055)

21,254,154

10,862,257

6,806,882

Discontinued operations—current

Tax  benefit on loss from discontinued  operations . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . .
Tax  benefit on loss on disposal

(2,451,696)
—

(498,134)
(330,961)

(1,235,871)
(327,963)

Tax  benefit on extraordinary item—current . . . . . . . . . . . . . .

(2,451,696)

(829,095)
— (3,215,801)

(1,563,834)
—

$18,802,458

$6,817,361

$5,243,048

Deferred income taxes reflect the net  tax  effect of temporary differences between the  carrying
amount of assets and liabilities for financial  reporting purposes and the amounts used for income tax
purposes.

Significant components of the Company’s deferred tax assets and liabilities are as  follows:

December 31,

2002

2001

Current deferred tax assets and (liabilities):

Accrued and prepaid expenses . . . . . . . . . . . . . . . . . . . . . . . .
Allowance for doubtful accounts . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$ 1,726,154
980,562
(2,061,539)

$ 3,263,323
967,725
167,150

645,177

4,398,198

Non-current deferred tax assets and (liabilities):

Depreciation and amortization . . . . . . . . . . . . . . . . . . . . . . . .
Identifiable intangibles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest rate swap . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(7,911,383)
(3,099,297)
231,931

(6,130,392)
(3,448,537)
1,008,568

(10,778,749)

(8,570,361)

Net deferred taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$(10,133,572) $(4,172,163)

FASB Statement No. 109 requires a valuation  allowance  to  reduce the deferred tax  assets reported
if, based on the weight of the evidence, it  is more likely than not that  some  of  or all of the deferred tax
assets will not be realized. After consideration of all the evidence,  both  positive and negative,

F-22

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

11.

Income Taxes (Continued)

management has determined that a valuation allowance at  December  31, 2002 and 2001 is not
necessary.

The reconciliation of income tax computed at  the U.  S. federal statutory rate to income tax

expense is as follows:

December 31,

2002

2001

Tax  at U.S. statutory rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
State taxes, net of federal benefit . . . . . . . . . . . . . . . . . . . . . . . . .
Non-deductible goodwill . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Non-deductible meals and entertainment . . . . . . . . . . . . . . . . . . . .
Non-deductible other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

$19,222,103
1,784,910
—
43,579
39,415
164,147

$8,843,002
884,300
792,525
61,122
—
281,308

Benefit from discontinued operations and extraordinary loss . . . . . .

21,254,154
(2,451,696)

10,862,257
(4,044,896)

$18,802,458

$6,817,361

12. Stockholders’ Equity

Effective April 27, 2001, the 760,284 issued and outstanding  shares  of  the Company’s Class B

common stock were converted to an  equal  number of  shares of Class A common stock of the
Company. All common stock data in  these consolidated financial statements have been adjusted  to  give
retroactive effect to the conversion.

Effective August 23, 2001, the Company amended  and restated its certificate of  incorporation to
provide for, among other things: 1) the reclassification of the  common stock of the Company, whereby,
the Class B common stock was converted  into  5.80135 shares of common stock, par  value $.0001  per
share; 2) authorization of 100,000,000  shares of  common  stock; and 3) authorization of 10,000,000
shares of preferred stock of the Company, par value $0.01  per  share. All  common stock data in these
consolidated financial statements have  been  adjusted to give  retroactive effect to the  stock split.

In March 2002, the Company filed a registration statement with the Securities and Exchange
Commission for the sale of 9,000,000  shares of  common  stock by existing shareholders.  Additionally,
the underwriters exercised the over-allotment option to purchase 700,000 shares from the selling
stockholders. The Company did not receive any of the proceeds from the  sale of these shares. Costs
associated with this secondary offering  of  $886,036 are included in  non-recurring secondary  offering
costs in the 2002 consolidated statement  of operations.

On November 5, 2002, the Company’s Board of Directors authorized a stock  repurchase program

whereby the Company may purchase up to 1,500,000  of its common shares  at an  aggregate  price not to
exceed $25,000,000. As of December 31,  2002, the Company purchased and retired  435,000 shares  of its
common stock at an average cost of  $13.83 per share pursuant to the  current authorization. The cost of
such purchases was approximately $6,000,000.  Under this program, the shares may be purchased  from
time to time on the open market. The repurchase program may be discontinued  at any time at the
discretion of the Company.

F-23

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

12. Stockholders’ Equity (Continued)

Stock Options

On December 16, 1999, the Company’s Board of  Directors  approved the 1999 Stock Option Plan

and Equity Participation Plan (collectively, the Plans), which was amended and restated on October  25,
2001 and provides for the issuance of  incentive  stock options (ISOs) and non-qualified stock options to
eligible employees and non-employee directors for the purchase of up to 4,398,001 shares of common
stock. Non-qualified stock options may also be issued to consultants. The Plans were approved by the
security holders at the Company’s 2002  Annual Meeting of Stockholders. Under the  Plans,  the exercise
price of options granted is determined  by the compensation committee of the Company’s Board of
Directors. In the case of 10% or more stockholders, the exercise price  of  the ISOs granted may not be
less  than 110% of such fair market. Options granted during 2002, 2001  and 2000 under the Amended
and Restated 1999 Stock Option Plan  generally vest ratably over 4 years.  Options  granted during 2002,
2001 and 2000 under the Amended and Restated 1999 Equity Participation Plan vest 25% on the first
anniversary of the date of grant and then  vest 12.5% every 6 months thereafter. All options expire on
the tenth  (or, in the case of a 10% shareholder, the  fifth) anniversary of the date of grant.

Changes under these stock option plans for 2002, 2001 and 2000  were as  follows:

December 31, 2002

December 31, 2001

December  31, 2000

Shares

Option
Price

Weighted
Average
Exercise
Price

Shares

Option
Price

Weighted
Average
Exercise
Price

Shares

Option
Price

Weighted
Average
Exercise
Price

Options outstanding
at  beginning  of
.
.
.
year .
.
Granted .
.
.
Canceled .
.
Exercised .

.
.
.
.

.
.
.
.

.
.
.
.

Options outstanding
at end of year .

Options exercisable
at end of year .

.
.
.
.

.

.

3,520,068
53,279
(145,443)
(452,921)

$ 7.75-$37.13
$12.31-$26.15
$ 7.75-$26.15
$ 7.75-$23.25

$13.00
$17.89
$14.74
$ 9.72

3,121,252
527,915
(107,027)
(22,072)

$ 7.75-$32.35
$10.13-$37.13
$ 7.75-$17.00
$ 7.75-$10.13

$11.93
$18.19
$ 8.11
$ 9.31

3,465,817
173,450
(518,015)
—

$ 7.75-$23.25
$10.13-$32.35
$ 7.75-$23.25
—

$11.87
$15.64
$12.80
—

2,974,983

$ 7.75-$37.13

$13.50

3,520,068

$ 7.75-$37.13

$13.00

3,121,252

$ 7.75-$32.35

$11.93

1,856,412

$ 7.75-$37.13

$12.97

1,535,826

$ 7.75-$32.35

$12.02

823,936

$ 7.75-$23.25

$11.93

The following table represents information about stock options granted in each year:

Weighted average exercise price of options granted during the year:
Issued at market price . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Issued above market price . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Issued below market price . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Weighted average fair value of options granted during the year:
Issued at market price . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Issued above market price . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Issued below market price . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Year Ended December 31,

2002

2001

2000

$17.90
N/A
N/A

$10.72
N/A
N/A

$16.69
21.95
15.08

$10.12
11.43
6.03

$10.47
19.74
N/A

$ 6.35
4.96
N/A

F-24

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

12. Stockholders’ Equity (Continued)

The following table describes outstanding options as of December 31, 2002:

Exercise Price

Options
Outstanding

Remaining
Contractual
Life

Options
Exercisable

610,240
14,797
6,748
7,005
420,289
—
8,687
6,229
5,863
422,570
12,702
67,134
1,395
9,375
9,527
11,725
92,442
5,863
12,702
92,443
9,527
11,725
1,284
—
2,779
1,284
2,084
2,565
2,779
2,084
2,565

1,856,412

$ 7.75
10.13
10.78
10.78
11.62
12.31
12.38
12.38
15.19
15.50
16.17
17.00
17.00
17.00
18.57
18.57
19.37
20.26
21.56
23.25
24.76
24.76
25.32
26.15
26.96
30.39
30.95
30.95
32.35
37.13
37.13

12.97

6.96
7.50
7.75
7.79
6.96
9.60
8.25
8.29
7.50
6.96
7.75
8.50
8.81
8.82
8.25
8.29
6.96
7.50
7.75
6.96
8.25
8.29
7.50
9.23
7.75
7.50
8.25
8.29
7.75
8.25
8.29

7.28

892,565
34,440
13,496
15,995
566,005
30,400
27,999
16,610
11,724
568,286
25,404
268,443
5,580
37,500
25,404
31,266
124,314
11,724
25,404
124,314
25,404
31,266
2,565
20,400
5,557
2,567
5,557
6,840
5,557
5,557
6,840

2,974,983

F-25

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

12. Stockholders’ Equity (Continued)

The fair value of options granted used to compute pro  forma net income disclosures here and
within footnote 2 were estimated on  the date  of  grant  using the Black-Scholes option-pricing model
based on the following weighted average assumptions:

Year ended December 31,

2002

2001

2000

Expected dividend yield . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected volatility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Risk-free interest rate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expected life . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

0.00% 0.00% 0.00%
60.00
4.28
6 years

60.00
5.19
6 years

60.00
5.19
6 years

The effect of applying FASB Statement No.  123 for providing  pro forma  disclosures is  not  likely to

be representative of the effect on reported net income in future years.

13. Earnings Per Share

In accordance with the requirements of  FASB  Statement No.  128, Earnings Per Share, basic

earnings per share is computed by dividing net income by the weighted  average  number of  shares
outstanding and diluted earnings per share  reflects the dilutive effects  of  stock  options  (as  calculated
utilizing the treasury stock method). Certain shares of common stock that are issuable upon the
exercise of options have been excluded from the  2002, 2001 and 2000 per share calculations because
their effect would have been anti-dilutive.  Such  shares amounted to 1,362,195,  268,565 and  3,121,252
during the fourth quarters ending December 31, 2002, 2001  and 2000, respectively. For the  years  ended
December 31, 2002 and 2001, respectively, 1,221,407 and 341,718, incremental  shares of common  stock
were included in diluted weighted average  shares outstanding.

14.

Interest Rate Swap

The Company’s senior credit facility required  that  the Company maintain  an interest rate
protection agreement to manage the impact of interest rate changes  on the Company’s variable  rate
obligations. Effective February 7, 2000, the  Company entered into an interest  rate swap agreement (the
Agreement) with a financial institution. Interest  rate  swap agreements involve  the exchange  of floating
interest rate payments for fixed interest rate  payments over the life  of  the agreement without an
exchange of the underlying notional  amount. The Company entered into the Agreement to reduce the
exposure to adverse fluctuations in floating  interest rates on the underlying debt obligation as  required
by the senior credit facility and not for  trading purposes.

The interest rate swap matures on February 7, 2003 and has an underlying notional amount of
$45,000,000. The floating interest rate  to  be paid to the  Company is  based on  the three-month U.S.
dollar London Interbank Offered Rate (LIBOR), which  is reset quarterly, while  the fixed interest  rate,
through December 31, 2000, to be paid  by the Company is 6.625% if the three-month  US dollar
LIBOR is less than 7.25%, the three-month U.S. dollar  LIBOR if  LIBOR is  greater  than or equal  to
7.25% but less than 8.5%, and 8.5% if  the three-month U.S. dollar LIBOR is  greater than or equal  to
8.5% over the term of the Agreement.  Effective January 1, 2001, the Agreement was amended to
change the fixed rate to be paid by the Company to 6.705%. In addition, the maturity date of the
Agreement was extended to February 28, 2003. Any differences paid or received under the terms  of  the

F-26

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

14.

Interest Rate Swap (Continued)

Agreement are recognized as adjustments to interest expense over the life of the  swap, thereby
adjusting the effective interest rate on the  underlying  debt obligation.

For the period from February 7, 2000  through December  31, 2000, the Company paid a fixed
interest rate of 6.625% based on an underlying notional  amount of $45,000,000. The floating interest
rate paid by the financial institution  to  the Company  approximated 6.7503%. The  carrying value of the
interest rate swap at December 31, 2000  was immaterial as to the net amount due from the financial
institution. The fair value of the interest rate swap approximated a  $606,000 and $2,509,000 net  payable
based on quoted market prices for similar instruments  at December 31, 2002 and 2001, respectively.
The estimated fair value of the swap fluctuated over time based  on changes in floating interest rates;
however, these fair value amounts should not be viewed in isolation but  rather in relation to the overall
reduction in the Company’s exposure to adverse fluctuations in floating interest rates. The Company
recorded  the fair value of the interest rate swap transaction at January  1, 2001,  which resulted  in a
reduction in consolidated stockholders’  equity of approximately $910,000. To test effectiveness of the
interest rate swap, the Company compared the present value of the cumulative change in the fair value
of the interest rate swap with the present value of the  cumulative change  in the expected variable
interest payments.

The Company was exposed to credit loss  in the event of nonperformance by the counterparty to
the Agreement. The amount of such  exposure was  limited  to the unpaid portion of  amounts due to the
Company, if any, pursuant to the Agreement.  However,  management believed that this exposure was
mitigated by provisions in the Agreement  that allow  for the legal right of offset of any amounts due to
the Company from the counter party with any amounts payable to the counterparty by the Company.
As a result, management considered  the risk  of counter-party default to be minimal. At December 31,
2002 and 2001, the Company expected to reclassify approximately $606,000 and $1,939,000,  respectively,
of net losses on the interest rate swap from accumulated other comprehensive income to earnings
during the twelve months following December 31, 2002 and 2001, respectively. On February 28, 2003,
the maturity date,  the Company paid  the last payment  on  the agreement.

15. Related Party Transactions

The Company provides services to three  hospitals,  which are affiliated with certain Board of
Director members. Revenue related to  these transactions amounted  to  approximately $6,323,000,
$8,671,000, and $4,345,000 in 2002, 2001 and 2000,  respectively. Accounts receivable due from these
hospitals at December 31, 2002 and 2001 were  approximately $703,000 and $1,007,000,  respectively.

16. Discontinued Operations

In August 2001, the FASB issued Statement No. 144, Accounting for the Impairment or Disposal  of

Long-Lived Assets, which addresses financial accounting and reporting for the impairment  or disposal  of
long-lived assets and supercedes FASB Statement No.  121, Accounting for the Impairment of Long-Lived
Assets and for Long-Lived Assets to be  Disposed Of, and the accounting and reporting provisions of APB
Opinion No. 30, Reporting the Results of Operations-Reporting  the Effects  of Disposal of a Segment of a
Business and Extraordinary, Unusual and  Infrequently Occurring Events and  Transactions. The Company
adopted the provisions of FASB Statement No.  144 as of  January  1, 2002.

F-27

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

16. Discontinued Operations (Continued)

On December 20, 2000, the Company  committed itself to a  formal plan  to  dispose of its wholly-

owned subsidiary, HospitalHub, through  a  sale or  liquidation of this business segment. Under the
provisions of FASB Statement No. 144,  disposal activities  that were initiated prior to the initial
application of the Statement should continue  to  be  accounted for  in accordance with the prior
pronouncement. Pursuant to APB Opinion No.  30, Reporting the Results of Operations-Reporting  the
Effects of Disposal of a Segment of a Business, and  Extraordinary,  Unusual and Infrequently Occurring
Events and Transactions, the consolidated financial statements of the Company  have  been reclassified  to
reflect the discontinuance of HospitalHub.  Accordingly, the  revenue and costs and  expenses of
HospitalHub have been segregated and reported  as discontinued  operations in  the accompanying
consolidated statements of operations. There were  no  assets or  liabilities relating to HospitalHub at
December 31, 2002 or 2001. The divestiture was completed in  the second quarter of 2001.

In March 2002, the Company committed  itself to a formal plan  to  dispose  of its  subsidiary,  E-Staff,

a Pennsylvania corporation, through a sale of this business. E-Staff was previously included in the
Company’s other human capital management services  segment. The Company  had acquired
substantially all of the assets of E-Staff, effective July 31,  2000,  for $1,500,000. The acquisition met  the
accounting criteria of a purchase and,  accordingly,  the accompanying consolidated financial statements
include the results of E-Staff from the  acquisition date. The consideration for this acquisition included
$1,500,000 in cash. The excess of the aggregate purchase price  over the fair market  value of  the assets
acquired of approximately $927,000 was  allocated to goodwill and was being amortized over  five  years
through  December 31, 2001. In addition,  the asset purchase agreement provided for  potential earnout
payments of up to $3,750,000 based on achievement of a defined  development  milestone and the
profits of E-Staff over a three-year period ending  July 31, 2003. This  contingent  consideration is not
related to the seller’s employment. The Company paid $500,000 upon achievement of the
developmental milestone in the first quarter of 2002. The amount was recorded to assets from
discontinued operations, net. Due to the discontinuance of the E-Staff business, the  Company expects
no additional earnout payments to be made.

E-Staff is an application service provider that  has developed an internet subscription  based
communication, scheduling, credentialing and training service  business  for  healthcare providers. As  an
application service provider E-Staff maintains the  database  of the client’s employees  on E-Staff’s
servers and prospective E-Staff clients  are  concerned about placing their healthcare employees’ names
and  credentials on servers owned or controlled by one of the nation’s largest healthcare staffing
companies. Accordingly, the Company decided  to  sell this subsidiary. Pursuant to FASB  Statement
No. 144, the consolidated financial statements of the Company have been reclassified to reflect the
discontinuance of E-Staff. Accordingly certain costs and expenses, assets and liabilities of E-Staff have
been segregated and reported as discontinued operations in  the accompanying  consolidated  balance
sheets and statements of operations.

In September 2002, the Company decided to retain a portion  of  the E-Staff software and related

equipment for internal use. As a result, in September  2002,  approximately $436,000 of related  software
and  equipment were reclassified from assets  from discontinued operations, net, to property  and
equipment, net. These assets and the related depreciation expense have been reclassified to continuing
operations for all periods presented in the accompanying consolidated balance sheets and statements of
operations. These reclassifications did not have a material impact on the  Company’s consolidated

F-28

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

16. Discontinued Operations (Continued)

financial position or results of operations. Based on discussions with potential buyers of the E-Staff
technology during the three months ended September 30,  2002, the Company  evaluated  the ongoing
value of E-Staff and determined that  approximately  $4,143,000  of the carrying amount of the net assets
from discontinued operations was impaired. The Company wrote down the net assets from discontinued
operations to their estimated fair value  of  approximately $134,000. Fair value was based on the latest
offer received for the sale and included  the  estimated  cash flows from the sale of E-Staff to a potential
buyer, adjusted for the estimated probability of the sale.  Because of deteriorating market conditions, it
is reasonably possible that the estimate of discounted cash flows may change  in the near  term resulting
in the need to adjust the determination  of fair value. The effect of any additional charge would be
immaterial. The impairment charge of $2,539,506, net of  income tax benefit  of $1,603,244, is  included
in the accompanying consolidated statement of operations  as loss  from discontinued operations  for the
year ended December 31, 2002.

Loss from discontinued operations during  the year  ended December 31, 2000 represents

HospitalHub operations as well as E-Staff results. E-Staff and HospitalHub operations generated an
after tax loss of approximately $76,000 and $1,604,000, respectively,  for the year  ended December 31,
2000. HospitalHub, which was discontinued in December 2000, was  sold  in the second quarter of 2001
and did not generate a loss from discontinued  operations for the years ended December  31, 2002 or
2001. Loss from discontinued operations  for the year ended December 31, 2002  include the after tax
E-Staff  impairment charge of $2,539,506.

17. Segment Information

The Company has two reportable operating  segments: healthcare staffing and  other human capital

management services. The healthcare  staffing operating segment includes travel staffing, clinical
research and trials staffing and per diem  staffing.  This segment provides temporary staffing services of
healthcare professionals primarily to hospitals, laboratories, and pharmaceutical and biotechnology
companies. The other human capital management  services segment includes the  combined results of
our  education and training, healthcare consulting services, physician search and resource management
services.

The Company’s management evaluates  performance of  each  segment primarily based on revenues

and  contribution  income  (which  is  defined  as  earnings  before  interest,  income  taxes,  depreciation,
amortization and corporate expenses not  specifically identified to a reported segment). The Company’s
management does not evaluate, manage  or measure performance of segments using  asset information;
accordingly, asset information by segment is not prepared or disclosed. The accounting policies of  the
segments are the same as those described  in  the summary of significant accounting policies (see
Note 2). The information in the following  table is derived from the segments’ internal financial
information as used for corporate management purposes. Certain corporate expenses are not allocated
to and/or among the operating segments.

F-29

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

17. Segment Information (Continued)

Information on operating segments and  a reconciliation of such information to income from

continuing operations for the periods  indicated are as follows:

Year ended December 31,

2002

2001

2000

Revenue from unaffiliated customers (a):

Healthcare staffing . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other human capital management services . . . . . . . . . .

$588,743,378
51,209,537

$466,985,416
37,378,221

$350,856,054
17,476,130

$639,952,915

$504,363,637

$368,332,184

Contribution income (b):

Healthcare staffing . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other human capital management services . . . . . . . . . .
Unallocated corporate overhead . . . . . . . . . . . . . . . . . . .

$ 81,159,968
6,520,861
(21,449,824)

$ 70,852,551
4,701,442
(18,314,805)

$ 61,936,676
1,315,188
(18,041,169)

Adjusted EBITDA . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interest expense, net . . . . . . . . . . . . . . . . . . . . . . . . . . .
Depreciation and amortization . . . . . . . . . . . . . . . . . . . .
Nonrecurring indirect transaction costs . . . . . . . . . . . . . .
Nonrecurring secondary offering costs . . . . . . . . . . . . . . .

66,231,005
3,752,718
6,671,956
—
886,036

57,239,188
14,422,170
17,551,298
—
—

45,210,695
15,435,236
14,947,558
1,289,217
—

Income from continuing operations before  income  taxes .

$ 54,920,295

$ 25,265,720

$ 13,538,684

(a) The Company adopted EITF Issue  No. 01-14, which states that reimbursements received for

out-of-pocket expenses should be characterized as  revenue in the income statement. This required
certain reclassifications of revenue, cost  of sales  and  selling, general and  administrative  expenses as
described in footnote 2. This change  has been reflected in all periods presented.

(b) The Company defines contribution income as earnings before interest, income taxes,  depreciation,

amortization and corporate expenses not specifically identified to a reporting segment.
Contribution income is not a measure of financial performance under generally accepted
accounting principles and is only used by management  when assessing segment  performance.
During  the year ended December 31,  2002,  the Company refined  its methodology  for allocating
corporate overhead expenses to its segments to more accurately  reflect the profitability of each
segment. Upon review, certain individuals’ salaries and related benefits were more specifically
identified to the healthcare staffing segment. In addition,  certain direct  mail expenses were more
specifically identified. Prior year segment  data  has been  reclassified to reflect this improvement in
the allocation methodology. Due to the  organizational structure  in 2000, post-merger and prior  to
the Company’s initial public offering,  allocations of general and  administrative salaries to the
segments would not have provided meaningful comparisons. Additionally,  direct mail expenses
were immaterial. Accordingly, 2000 segment data has  not  been reclassified  for this change in
allocation methodology. This change in  the allocation of overhead  expenses does not impact prior
year consolidated financial statements. In  addition, E-Staff, which was previously included in other
human capital management services,  has been included in discontinued operations.

F-30

Cross Country, Inc.

Notes to Consolidated Financial Statements (Continued)

December 31, 2002

18. Quarterly Financial Data (Unaudited)

First Quarter Second Quarter Third Quarter Fourth  Quarter

2002
Revenue from services (a) . . . . . . . . . . . . . . . . . . . $158,165,456
38,010,786
Gross profit (a) . . . . . . . . . . . . . . . . . . . . . . . . . .
7,213,226
Income from continuing operations (b) . . . . . . . . . .
(216,404)
Loss from discontinued operations (b) . . . . . . . . . . .

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ 6,996,822

Net income (loss) per common share-basic  (b):
Income from continuing operations . . . . . . . . . . . . . $
Loss from discontinued operations

. . . . . . . . . . . . .

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $

Net income (loss) per common share-diluted (b):
Income from continuing operations . . . . . . . . . . . . . $
Loss from discontinued operations

. . . . . . . . . . . . .

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $

0.23
(0.01)

0.22

0.21
(0.00)

0.21

$158,738,288
40,670,059
8,452,414
(420,643)

$160,152,688
40,702,880
8,753,302
(2,881,396)

$162,896,483
42,019,555
9,247,199
(364,993)

$

$

$

$

$

8,031,771

0.26
(0.01)

0.25

0.25
(0.01)

0.24

$

$

$

$

$

5,871,906

0.27
(0.09)

0.18

0.26
(0.09)

0.17

$

$

$

$

$

8,882,206

0.28
(0.01)

0.27

0.28
(0.01)

0.27

2001
Revenue from services (a) . . . . . . . . . . . . . . . . . . . $104,135,971
25,105,948
Gross profit (a) . . . . . . . . . . . . . . . . . . . . . . . . . .
1,208,631
Income from continuing operations (b) . . . . . . . . . .
(1,200,080)
(Loss) income from discontinued operations (b) . . . .
—
. .
Extraordinary loss on early extinguishment of debt

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $

8,551

Net income (loss) per common share-basic  (b):
Income from continuing operations . . . . . . . . . . . . . $
(Loss) income from discontinued operations . . . . . . .
. .
Extraordinary loss on early extinguishment of debt

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $

Net income (loss) per common share-diluted (b):
Income from continuing operations . . . . . . . . . . . . . $
(Loss) income from discontinued operations . . . . . . .
. .
Extraordinary loss on early extinguishment of debt

0.05
(0.05)
—

0.00

0.05
(0.05)
—

Net income . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $

0.00

$

$119,275,925
31,045,536
2,324,800
340,997
—

$133,954,471
34,391,379
4,097,428
(175,384)
—

$146,997,270
36,529,652
6,772,604
86,751
(4,783,705)

$

$

$

$

2,665,797

0.10
0.01
—

0.11

0.10
0.01
—

0.11

$

$

$

$

$

$

$

$

$

3,922,044

0.18
(0.01)
—

0.17

0.18
(0.01)
—

0.17

$

2,075,650

0.23
—
(0.16)

0.07

0.22
—
(0.15)

0.07

(a) The Company adopted EITF Issue  No. 01-14, which  states  that  reimbursements  received  for out-of-pocket

expenses should be characterized as revenue  in the  income  statement.  This required  certain reclassifications of
the Company’s revenue, gross profit and  SG&A  expenses.  This change  has been  reflected  in all  periods
presented. The quarterly  impact of these  reclassifications  are  as  follows:

First Quarter Second Quarter Third Quarter Fourth  Quarter

2002
Increase in revenue from  services . . . . . . . .
. . . . . . . . . . . . . . .
Increase in gross  profit

2001
Increase in revenue from services . . . . . . . .
. . . . . . . . . . . . . . .
Increase in gross  profit

$3,304,425
305,449

$2,761,557
542,620

$2,495,975
422,127

$2,400,979
364,510

$ 264,232
235,615

$ 441,178
308,277

$ 467,571
291,512

$2,688,087
385,629

(b) Pursuant to FASB Statement No.  144, the consolidated financial statements of the  Company  have been

reclassified in all periods presented to  reflect the discontinuance of  E-Staff.

F-31

Schedule II

Description

Balance at
Beginning
of Period

Charged to
Costs and
Expenses

Write-offs Recoveries Changes

Other

Balance at End
of Period

Valuation and Qualifying Accounts (for  continuing operations)

Allowance for Doubtful Accounts
Year ended December 31, 2000 . . . $2,144,110 $ 432,973 $(565,012) $ 75,676 $ — $2,087,747
— 52,499(a) 2,424,865
Year ended December 31, 2001 . . .
76,541(b) 2,250,047
Year ended December 31, 2002 . . .

(989,037)
(599,332) 105,743

1,273,656
242,230

2,087,747
2,424,865

(a) —Allowance for doubtful accounts  for receivables  acquired in ClinForce acquisition.

(b) —Allowance for doubtful accounts  for receivables  acquired in NovaPro acquisition.

II-1

Corporate Information

Board of Directors

Executive Officers

Karen H. Bechtel (a)
Managing Director of Morgan Stanley Private Equity 
and Morgan Stanley & Co. Incorporated

Joseph A. Boshart
President and Chief Executive Officer 

Joseph A. Boshart
President and Chief Executive Officer
Cross Country, Inc.

W. Larry Cash (b)
Executive Vice President and Chief Financial Officer 
of Community Health Systems

Thomas C. Dircks (a)
Managing Partner 
of Charterhouse Group International, Inc.

A. Lawrence Fagan
Partner of Charterhouse Group International, Inc.

Emil Hensel
Chief Financial Officer
Cross Country, Inc.

M. Fazle Husain
Managing Director of Morgan Stanley Private 
Equity and Morgan Stanley & Co. Incorporated

Joseph Swedish (b)
President, Chief Executive Officer 
and Director of Centura Health

Joseph Trunfio (b)
President, Chief Executive Officer
of Atlantic Health System

(a) Member of the Compensation Committee
(b) Member of the Audit Committee 

Emil Hensel
Chief Financial Officer

Vickie Anenberg
President, Cross Country Staffing

Kevin Conlin
President, Consulting Division

Annette Gardner, RN
President, Cross Country Local

Victor Kalafa
Vice President, Corporate Development and Strategy 

Daniel J. Lewis
Principal Accounting Officer

Dr. Franklin A. Shaffer, EdD, RN, FAAN
President, Education and Training Division

Tony Sims
President, Clinical Trials Staffing Division

Carol D. Westfall
President, Search and Recruitment Division

Jonathan W. Ward
Executive Vice President, Cross Country Staffing

Forward-Looking Statements
The matters described herein contain forward-looking statements that are made pursuant to the Safe
Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements
are predictive in nature, that depend upon or refer to future events or conditions or that include
words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions
are forward-looking statements. These statements involve known and unknown risks, uncertainties and
other factors that may cause our actual results and performance to be materially different from any
future results or performance expressed or implied by these forward-looking statements. These factors
include, but are not limited to, our ability to attract and retain qualified nurses and other healthcare
personnel, costs and availability of short-term leases for our travel nurses, demand for the healthcare
services we provide, both nationally and in the regions in which we operate, the functioning of our
information systems, the effect of existing or future government regulation and federal and state
legislative and enforcement initiatives on our business, our clients’ ability to pay us for our services, our
ability to successfully implement our acquisition and development strategies, the effect of liabilities and
other claims asserted against us, the effect of competition in the markets we serve, and other factors set
forth under the caption “Risk Factors” in the Company’s 10-K for the year ended December 31, 2002.
We undertake no obligation to release any revisions to any forward-looking statements.

Corporate Headquarters
Cross Country, Inc.

6551 Park of Commerce Blvd.

Boca Raton, Florida 33487

Phone:  561.998.2232

Web site:  www.crosscountry.com

Shareholders Inquiries
News releases, including those on financial
performance, as well as additional information
about Cross Country are available at no cost
online at our Web site. Current and prospective
investors can register online to automatically
receive press releases by email and receive our
Annual Report, Forms 10-K, 10-Q, and other SEC
filings, as well as other information about the
Company either online at our Web site or by
writing or contacting:

Howard A. Goldman
Director of Investor Relations
Phone:
561.998.2232
Toll-Free: 877.686.9779
Email:

ir@crosscountry.com

Transfer Agent
SunTrust Bank

P.O. Box 4625

Atlanta, Georgia 30302-4625

Toll Free Phone:  800.568.3476

Independent Auditors

Ernst & Young LLP

Phillips Point, West Tower

Suite 1200

777 South Flagler Drive

West Palm Beach, Florida 33401

Stock Listing
The Company’s Common Stock is listed 
on the NASDAQ National Market®
and traded under the symbol CCRN.

6551 Park of Commerce Blvd. 
Boca Raton, FL  33487
561.998.2232
www.crosscountry.com